Quarterlytics / Consumer Defensive / Tobacco / Universal Corporation

Universal Corporation

uvv · NYSE Consumer Defensive
Claim this profile
Ticker uvv
Exchange NYSE
Sector Consumer Defensive
Industry Tobacco
Employees 10800
← All annual reports
FY2016 Annual Report · Universal Corporation
Sign in to download
Loading PDF…
ABOUT THE COMPANY

Universal  Corporation,  headquartered  in  Richmond,  Virginia,  is  the 

leading global leaf tobacco supplier. Tobacco has been its principal focus 

since its founding in 1918. The largest portion of the company’s business 

involves  procuring  and  processing  flue-cured  and  burley  leaf  tobacco 

for manufacturers of consumer tobacco products. Universal conducts its 

business  in  more  than  30  countries  on  5  continents  and  employs  over 

24,000 permanent and seasonal workers.

$            3.92 

$            4.06 

$            5.25 

2.10 

2.12 

56.81 

2.06 

2.08 

47.16 

2.02 

2.04 

55.89 

$   1,392,276 

$   1,329,770 

$   1,200,023 

1,414,222 

1,362,725 

1,378,230 

Net Income per Diluted Share *

Dividends Declared

Operating Income

in dollars

in dollars

in millions of dollars

5
2
.
5

6
6
.
4

2
9
.
3

6
0
.
4

5
2
.
3

0
1
.
2

6
0
.
2

2
0
.
2

8
9
.
1

4
9
.
1

2
.
6
4
2

0
.
3
2
2

3
.
0
8
1

6
.
1
8
1

9
.
7
6
1

16

15

14

13

12

16

15

14

13

12

16

15

14

13

12

  *  Attributable to Universal Corporation common shareholders after deducting amounts attributable to noncontrolling interests in 

consolidated subsidiaries.

1

FINANCIAL HIGHLIGHTSOPERATIONSSales and other operating revenues  Operating incomeSegment operating income  Net income Net income attributable to Universal CorporationPER COMMON SHARENet income attributable to Universal Corporation        common shareholders—dilutedDividends declaredIndicated 12-month dividend rateMarket price at year endAT YEAR ENDWorking capitalTotal Universal Corporation shareholders’ equityin thousands, except per share dataFiscal Year EndedMarch 31, 2014Fiscal Year EndedMarch 31, 2015$   2,271,801 167,874 167,225120,461 114,608 $  2,120,373 181,647 186,068118,148 109,016 Fiscal Year EndedMarch 31, 2016$   2,542,115 246,151 175,175155,155 149,009 BOARD OF DIRECTORS
Universal Corporation

George C. Freeman, III 1 * 3
Chairman, President, and  
Chief Executive Officer 
Universal Corporation

Chester A. Crocker 2 3
Professor 
Georgetown University 

Lennart R. Freeman 1 4 5
Retired Executive  
Vice President 
Swedish Match AB

Eddie N. Moore, Jr. 2 3 4 *
President and  
Chief Executive Officer 
Norfolk State University

John B. Adams, Jr. 2 3 4
President and  
Chief Executive Officer  
Bowman Companies

Charles H. Foster, Jr. 1 5 *
Retired Chairman  
LandAmerica Financial  
Group, Inc.

Thomas H. Johnson 1 5
Chief Executive Officer  
The Taffrail Group, LLC 

Robert C. Sledd 2 * 3 4
Managing Partner 
Pinnacle Ventures, LLC

Diana F. Cantor 2 3 *
Partner 
Alternative Investment 
Management, LLC

1  Executive Committee 
2  Pension Investment Committee 
3  Finance Committee 
4  Audit Committee    
5 

 Executive Compensation, Nominating, 
 and Corporate Governance Committee

*  Committee Chairman

CHAIRMEN EMERITUS
Henry H. Harrell
Allen B. King

2

 
OFFICERS
Universal Corporation

George C. Freeman, III
Chairman, President, and  
Chief Executive Officer

Candace C. Formacek
Vice President and  
Treasurer

H. Michael Ligon
Vice President, 
Corporate Affairs 

Pamela J. Kepple
Corporate Director,  
Taxes

Airton L. Hentschke
Senior Vice President and 
Chief Operating Officer

Robert M. Peebles
Vice President and  
Controller

Harvard B. Smith
Vice President and Chief 
Compliance Officer

Jennifer S. Rowe
Assistant Vice President,  
Capital Markets

David C. Moore
Senior Vice President and 
Chief Financial Officer

Preston D. Wigner
Vice President, General 
Counsel, and Secretary

Joseph W. Hearington, Jr.
Vice President,  
Internal Auditing

Catherine H. Claiborne
Assistant Secretary

DIRECTORS 
Universal Leaf Tobacco Company, Inc.

George C. Freeman, III
Chairman, President and  
Chief Executive Officer

Airton L. Hentschke
Executive Vice President and 
Chief Operating Officer

Paul G. Beevor
Managing Director, 
Asia Region

David C. Moore
Executive Vice President and 
Chief Financial Officer

James A. Huffman
Senior Vice President, 
Information and Planning

Friedrich G. Bossert
Managing Director,  
Dark Air-Cured Region

Domenico Cardinali
Managing Director,  
Europe Region 

Clayton G. Frazier
Managing Director,  
North America Region

Theodore G. Broome
Executive Vice President and 
Sales Director 

Preston D. Wigner
Senior Vice President,  
General Counsel, and 
Assistant Secretary

Cesar A. Bünecker
Managing Director,  
South America Region

Gary S. Taylor
Managing Director,  
Africa Region

Jonathan R. Wertheimer
President,  
Socotab, L.L.C.

3

George C. Freeman, III  Chairman, P re s i d e n t ,   a n d   C h i e f   E x e c u t i v e   O f f  c e r  

TO OUR SHAREHOLDERS

I am very pleased with the results that your company achieved in fiscal year 2016. We successfully managed 

a  second  year  of  oversupplied  markets,  achieving  modest  growth  in  overall  volumes  for  the  year  and 

improved margins. Our selling, general, and administrative expenses were also lower due in part to the 

strong U.S. dollar this year. We continued to handle our inventories in a prudent fashion, with our fiscal 

year end uncommitted stocks at lower levels than last year, comfortably within our target range. 

Net  income  for  the  fiscal  year  ended  March  31,  2016,  was  $109.0  million,  or  $3.92  per  diluted  share, 

compared with last year’s net income of $114.6 million, or $4.06 per diluted share. Those results included 

certain  non-recurring  items,  detailed  in  our  Form  10-K,  which  increased  diluted  earnings  per  share  by 

$0.02  and  $0.46  for  the  years  ended  March  31,  2016  and  2015,  respectively.  Excluding  those  items  in 

both years, net income for the fiscal year increased $6.8 million ($0.30 per diluted share) compared to 

the same period last year. Segment operating income, which excludes those items, was $186.1 million for 

fiscal year 2016, an increase of $18.8 million, or 11%, from the prior year. That improvement was primarily 

attributable to a reduction in selling, general, and administrative costs, as well as improved gross margins 

on this year’s modestly higher sales volumes. Revenues of $2.1 billion for fiscal year 2016 declined 7% 

compared with the previous year, driven mainly by lower green leaf costs and lower processing revenues, 

partly mitigated by the increase in volumes.

We  continue  to  believe  that  financial  strength  is  critical.  It  enables  us  to  fund  our  global  operations 

efficiently and to facilitate investment when suitable opportunities arise. In fiscal year 2016, our operations 

generated $184 million in operating cash flows, and we returned more than $60 million in dividends to our 

shareholders, closed the year with higher cash balances, which will support upcoming seasonal working 

capital requirements in fiscal year 2017, and preserved our solid financial position.

We  have  also  been  working  hard  this  year  to  give  more  visibility  to  the  many  good  things  that  your 

company does around the world to benefit the communities in which we operate. We are calling these 

actions the “Universal Effect” to remind us that every decision each of us takes, whether immediate or 

long-term, impacts the communities we both serve and on whom we depend. We are also focusing on 

4

 
George C. Freeman, III  Chairman, P re s i d e n t ,   a n d   C h i e f   E x e c u t i v e   O f f  c e r  

six areas where we are taking actions that ripple outward, and we believe have a major impact—farmer 

support, sustainability, education, community support, youth support, and our Universal Leaf Foundation. 

Our programs and actions have directly impacted more than 2 million people thus far in tobacco growing 

areas, showing how every action ripples out to affect another.

We have featured the Universal Effect in this annual report and on our website, and I encourage you to 

read more about it. We also believe that it is such an essential element of your company and how we do 

business that we’ve incorporated it into our refreshed logo, which should serve as a constant reminder to 

all of us to be mindful of the lasting impacts of our actions.

Two of our Board of Directors who have had a positive impact on our Company have reached the end of 

their terms. Chet Crocker joined the Board in 2004, and recently has served on the Finance and Pension 

Investment Committees. Chet’s vast knowledge and experience in the politics of sub-Saharan Africa has 

been invaluable to me and the Company. It is no coincidence that during his tenure we have expanded 

in that area, particularly in Mozambique. Charlie Foster is our longest serving director, having been part 

of  the  Board  for  almost  23  years.  Charlie  has  served  on  many  committees  during  his  tenure,  but  most 

recently  has  been  our  Lead  Independent  Director,  Chair  of  the  Executive  Compensation,  Nominating, 

and  Corporate  Governance  Committee,  and  a  member  of  the  Executive  Committee.  Charlie  has  been 

a great resource to me and the Company, having run a major public company himself and having a vast 

knowledge of the Company. Both Chet and Charlie have been true gentlemen-- pleasant, professional, 

and honorable. We thank them for their distinguished service. 

As we move into fiscal year 2017, we remain excited about our prospects and look forward to continuing our 

leadership role in the industry. We will continue to work for and with our customers to improve efficiencies 

in our markets and to provide a sustainable, compliant, and competitively priced product, allowing us to 

fulfill their needs and to continue to provide value to our shareholders.

George C. Freeman, III
Chairman, President, and Chief Executive Officer 

5

 
THE UNIVERSAL EFFECT

There is so much more than meets the eye when it comes to procuring high-quality tobacco. Every step 

of the production process requires action, and each action impacts many lives. At Universal, we have long 

recognized that every move we make has an impact that ripples out into communities. And we realize that 

we can’t work effectively without investing in and strengthening the communities where we operate.

 We can’t have good growers if they aren’t healthy and well-trained, and we can’t have a good product if 

it’s not grown under the right conditions. Therefore, we have spent decades training growers, setting up 

health clinics, digging wells, and building schools. These efforts allow us ultimately to produce an excellent 

product  for  our  customers,  and  the  effects  ripple  out  into  the  communities,  improving  the  lives  of  the 

people where we work in what we call the “Universal Effect.”

 Universal has more than 24,000 employees, and we work with half a million farmers around the world. We 

are highly aware that our decisions and actions profoundly impact the lives of our people, the needs of 

our investors, the requirements of our customers, and the future of our planet. For example, when we train 

a  grower  in  good  agricultural  practices,  he  becomes  more  productive,  more  environmentally  sensitive, 

more prosperous, and better prepared to help improve living standards in his own community. This is the 

Universal Effect in action.

6

 There are many examples of how the Universal Effect has directly impacted communities around the world. 

A few highlights of our work include:

• 

• 

• 

 Supporting the production of millions of tree seedlings;

 Building or improving schools and providing educational materials; and
 Supporting communities by digging wells.

 These actions and others like them have positively impacted more than 2 million people in the growing 

areas from which we purchase tobacco. 

 Seeing  the  results  of  our  achievements  motivates  us  to  continue  finding  ways  Universal  can  make  a 

difference. We are currently focusing on six main areas where our actions can ripple out into communities 

and make a major impact: farmer support, sustainability, education, community support, youth support, 

and our Universal Leaf Foundation.

FARMER SUPPORT 

The  welfare  and  skill  of  our  growers  is  a  top  priority  for  Universal.  By  offering  them  knowledge  and 

technology based on the application of good agricultural practices, we not only support them, but also 

their families and communities. Globally, Universal employs more than 800 agronomists and technicians 

who serve as crop advisors, assisting and training growers throughout production. We’ve discovered that 

investing in good agricultural practices pays big dividends. 

To  learn  more  about  the  Universal  Effect,  visit  our  website  at  
www.universalcorp.com.

7

SUSTAINABILITY

We are mindful every day of our responsibility to make a sustainable impact on the people and communities 

on  whom  we  depend,  as  well  as  the  planet  that  supports  us  all.  We  focus  on  factors  that  protect  the 

environment  and  improve  human  communities  throughout  the  supply  chain,  including,  reforestation, 

water  conservation,  reduced  carbon  emissions,  environmentally  sensitive  agricultural  practices,  and 

the  elimination  of  child  labor.  We  also  invest  in  infrastructure  and  social  programs  that  improve  living 

conditions, promote education, and make communities stronger and healthier. 

EDUCATION

We  know  that  education  is  the  key  that  opens  the  door  to  opportunity,  and  we’ve  witnessed  firsthand 

what happens when grower communities create an environment that embraces education. Simply, they 

are stronger for it. We’ve made investments in building schools, creating tutoring programs, and providing 

learning materials. We believe that education, perhaps more than any other factor, is the foundation of 

strong communities.

COMMUNITY SUPPORT

We are committed to enriching the quality of life in communities that are home to our growers and their 

families. We have established health clinics and programs in some of the developing areas in which we 

operate. We have also implemented projects to drill boreholes so communities can access safe and clean 

drinking water close to home. We will continue to invest in the communities we depend on every day.

8

 
YOUTH SUPPORT

Universal is a leader in our industry’s efforts to eliminate child labor, which supports responsible sourcing 

of our products. Sometimes, children spend time in the fields because of inadequate school facilities and 

a lack of structured after-school activities. Therefore, we work to implement community and school-based 

initiatives that provide more options and opportunities for children. We have found that such investments 

help with these issues and ultimately strengthen communities. 

UNIVERSAL LEAF FOUNDATION

The  Universal  Leaf  Foundation,  founded  in  1975,  is  our  philanthropic  institution  dedicated  to  fulfilling 

our  social  responsibility  to  the  communities  where  we  operate  in  the  United  States.  The  Foundation  is 

committed to good corporate citizenship by investing in community programs, giving financial support 

for  community  events,  and  promoting  employee  volunteerism.  Our  foundation  focuses  on  four  areas: 

Education and Well-being of Children, At-risk Individuals, Families and Groups; Higher Education; Civic/

Community/the Arts; and Environment/Sustainability/Conservation. 

 At Universal, we strive to be mindful every day of how our work impacts all those around us. Our leaders 

and  employees  take  pride  in  seeing  the  effects  of  our  actions  ripple  throughout  the  communities  and 

around the globe—watching the Universal Effect in action.

” 

We  are  also  focusing  on  six  areas  where  we  are  taking  actions 
that ripple outward, and we believe have a major impact—farmer 
support,  sustainability,  education,  community  support,  youth 
support, and our Universal Leaf Foundation.”

— George C. Freeman, III

9

PERFORMANCE GRAPH
Comparison of 5 Year Cumulative Total Return*

$180

$160

$140

$120

$100

$80

$60

$40

$20

$0

3/11

3/12

3/13

3/14

3/15

3/16

Universal Corporation

S&P Smallcap 600

Peer Group

*$100 invested on 3/31/11 in stock or index, including reinvestment of dividends. Fiscal year ending March 31.

Copyright© 2016 S&P, a division of McGraw Hill Financial. All rights reserved.

 The  performance  graph  compares  the  cumulative  total  shareholder  return  on  Universal  Corporation 

common  stock  for  the  last  five  fiscal  years  with  the  cumulative  total  return  for  the  same  period  of  the 

Standard & Poor’s Smallcap 600 Stock Index and the peer group index. The peer group represents Alliance 

One International, Inc. The graph assumes that $100 was invested in Universal Corporation common stock 

at the end of the Company’s 2010 fiscal year, and in each of the comparative indices, in each case with 

dividends reinvested.

CUMULATIVE TOTAL RETURN ON UNIVERSAL CORPORATION COMMON STOCK

2011

2012

2013

2014

2015

2016

At March 31

Universal Corporation

$    100.00

$  112.11

$  140.32

$  145.22

$  128.04

$  160.54

S&P Smallcap 600

Peer Group

100.00

100.00

105.03

93.78

121.98

96.77

155.90

72.64

169.50

27.36

164.07

43.68

10

10-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
FORM 10-K

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE FISCAL YEAR ENDED MARCH 31, 2016
OR
 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE TRANSITION PERIOD FROM ______________TO_______________

Commission File Number:  001-00652
UNIVERSAL CORPORATION
(Exact name of registrant as specified in its charter)

Virginia
(State or other jurisdiction of
incorporation or organization)

9201 Forest Hill Avenue,
Richmond, Virginia 
(Address of principal executive offices)

54-0414210
(I.R.S. Employer
Identification Number)

23235
(Zip Code)

 Registrant's telephone number, including area code:  804-359-9311

Securities registered pursuant to Section 12(b) of the Act:

Title of each class
Common Stock, no par value

Name of each exchange on
which registered
New York Stock Exchange

Securities registered pursuant to Section 12(g) of the Act:    None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.   
Yes 

No 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15 (d) of the Act.  
Yes 

  No 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities 
Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), 
and (2) has been subject to such filing requirements for the past 90 days.    Yes 

  No 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive 
Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such 
shorter period that the registrant was required to submit and post such files).   Yes 

  No 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not 
be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III 
of this Form 10-K or any amendment to this Form 10-K.   

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller 
reporting company.  See definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of 
the Exchange Act. 

Large accelerated filer 

         Accelerated filer 

         Non-accelerated filer 

        Smaller reporting company 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).  Yes 

   No 

The aggregate market value of the registrant's voting and non-voting common equity held by non-affiliates, based upon the closing 
sales price on the New York Stock Exchange of the registrant's common stock on September 30, 2015, the last day of the registrant's 
most recently completed second fiscal quarter, was approximately $1.1 billion.  

As of May 20, 2016, the total number of shares of common stock outstanding was 22,717,735.

DOCUMENTS INCORPORATED BY REFERENCE

Certain information contained in the 2016 Proxy Statement for the Annual Meeting of Shareholders of the registrant is incorporated 
by reference into Part III hereof.

 
UNIVERSAL CORPORATION
FORM 10-K
TABLE OF CONTENTS

Item No.

Page

PART I

1.

1A.

1B.

2.

3.

4.

5.

6.

7.

Business ....................................................................................................................................................

Risk Factors...............................................................................................................................................

Unresolved Staff Comments .....................................................................................................................

Properties ..................................................................................................................................................

Legal Proceedings .....................................................................................................................................

Mine Safety Disclosures ...........................................................................................................................

PART II

Market for Registrant's Common Equity, Related Stockholder Matters 
and Issuer Purchases of Equity Securities.................................................................................................

Selected Financial Data.............................................................................................................................

Management's Discussion and Analysis of Financial Condition and Results of Operations....................

7A.

Quantitative and Qualitative Disclosures About Market Risk ..................................................................

8.

9.

9A.

9B.

10.

11.

12.

13.

14.

Financial Statements and Supplementary Data.........................................................................................

Changes in and Disagreements With Accountants on Accounting and Financial Disclosure...................

Controls and Procedures ...........................................................................................................................

Other Information .....................................................................................................................................

PART III

Directors, Executive Officers, and Corporate Governance.......................................................................

Executive Compensation...........................................................................................................................

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

Certain Relationships and Related Transactions, and Director Independence..........................................

Principal Accounting Fees and Services ...................................................................................................

PART IV

15.

Exhibits, Financial Statement Schedules ..................................................................................................

Signatures..................................................................................................................................................

3

9

13

14

15

15

16

17

19

33

34

83

83

83

84

85

85

85

85

86

88

2

General

This Annual Report on Form 10-K, which we refer to herein as our Annual Report, contains “forward-looking statements” 
within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended 
(the “Exchange Act”).  Among other things, these statements relate to Universal Corporation’s financial condition, results of operations 
and future business plans, operations, opportunities, and prospects.  In addition, Universal Corporation and its representatives may  
make written or oral forward-looking statements from time to time, including statements contained in other filings with the Securities 
and Exchange Commission (the “SEC”) and in reports to shareholders.  These forward-looking statements are generally identified 
by the use of words such as we “expect,” “believe,” “anticipate,” “could,” “should,” “may,” “plan,” “will,” “predict,” “estimate,” 
and  similar  expressions  or  words  of  similar  import.    These  forward-looking  statements  are  based  upon  management’s  current 
knowledge and assumptions about future events and involve risks and uncertainties that could cause actual results, performance, or 
achievements to be materially different from any anticipated results, prospects, performance, or achievements expressed or implied 
by such forward-looking statements.  Such risks and uncertainties include, but are not limited to:  anticipated levels of demand for 
and supply of our products and services; costs incurred in providing these products and services; timing of shipments to customers; 
changes in market structure; government regulation; product taxation; industry consolidation and evolution; changes in exchange 
rates and interest rates; impacts of regulation and litigation on our customers; and general economic, political, market, and weather 
conditions.  For a description of factors that may cause actual results to differ materially from such forward-looking statements, see 
Item 1A, “Risk Factors.”  We caution investors not to place undue reliance on any forward-looking statements as these statements 
speak only as of the date when made, and we undertake no obligation to update any forward-looking statements made in this report.  
In addition, the discussion of the impact of current trends on our business in “Management’s Discussion and Analysis of Financial 
Condition and Results of Operations – Other Information Regarding Trends and Management’s Actions” in Item 7 should be read 
carefully in connection with evaluating our business and the forward-looking statements contained in this Annual Report.

This Annual Report uses the terms “Universal,” “the Company,” “we,” “us,” and “our” to refer to Universal Corporation 
and its subsidiaries when it is not necessary to distinguish among Universal Corporation and its various operating subsidiaries or 
when any distinction is clear from the context in which it is used.

 See the “Results of Operations” section in “Management’s Discussion and Analysis of Financial Condition and Results of 
Operations” in Item 7 for a discussion of segment operating income, a non-GAAP financial measure that we refer to in this Annual 
Report on Form 10-K and consider useful in understanding our business results and trends.

PART I

Item 1.   Business 

A. 

The Company 

Overview 

We are the leading global leaf tobacco supplier.  We operate in over 30 countries on five continents and procure, finance, 
process, pack, store and ship leaf tobacco and other agri-products.  Tobacco has been our principal focus since our founding in 
1918.  The largest portion of our business involves procuring and processing flue-cured and burley leaf tobacco for manufacturers 
of consumer tobacco products.  We do not manufacture any consumer products.  Rather, we support consumer product manufacturers 
by selling them processed raw products and performing related services for them.  Our reportable segments for our flue-cured and 
burley tobacco operations are North America and Other Regions.  We also have a third reportable segment, Other Tobacco Operations, 
which comprises our dark tobacco business, our oriental tobacco joint venture, and certain tobacco- and non-tobacco-related services.  
We generated approximately $2.1 billion in consolidated revenues and earned $186.1 million in total segment operating income in 
fiscal  year  2016.    Universal  Corporation  is  a  holding  company  that  operates  through  numerous  directly  and  indirectly  owned 
subsidiaries.   Universal  Corporation’s  primary subsidiary  is Universal  Leaf Tobacco Company, Incorporated.   See  Exhibit 21, 
“Subsidiaries of the Registrant,” for additional subsidiary information.   

3

Key Operating Principles

We believe that by following several key operating principles we can continue to produce good financial returns from our 

business and enhance shareholder value.  These key operating principles are: 

• 

• 

Strategic market position. We work closely with both our customers and suppliers to ensure that we deliver a product 
that meets our customers' needs while cultivating a strong, sustainable supplier base. We balance purchases of leaf 
tobacco against indicated customer demand and maintain global procurement and production operations to maximize 
supply chain efficiencies.

Strong local management. Having strong local management in all of our key supply origins allows us to identify 
and react to constantly shifting market conditions.  Empowered and experienced local management, coupled with 
global coordination, affords us the flexibility and knowledge necessary to adapt quickly in order to continually deliver 
high quality, competitively-priced products and services. 

•  Compliant products. Customers expect a sustainable supply of compliant, traceable, competitively-priced product, 
and we believe that we lead in delivering these products. Among other initiatives, we invest in training farmers in 
good agricultural practices that encompass crop quality, environmental stewardship and agricultural labor standards. 

•  Diversified sources.  We operate in over 30 countries on five continents and maintain a presence in all major flue-
cured, burley, oriental, and dark air-cured tobacco origin markets.  This global presence allows us to meet our customers' 
diverse  leaf  requirements  while  minimizing  the  effects  of  adverse  crop  conditions  and  other  localized  supply 
disruptions.

•  Financial strength.  Financial strength is critical and enables us to fund our global operations efficiently and to 
facilitate investment when suitable opportunities arise. Management of liquidity, interest expense and capital costs 
provides us with a competitive advantage and affords us flexibility when responding to customer requirements and 
market changes. 

Additional Information

Our website address is www.universalcorp.com. We post regulatory filings on this website as soon as reasonably practicable 
after they are electronically filed with or furnished to the SEC.  These filings include annual reports on Form 10-K, quarterly reports 
on Form 10-Q, current reports on Form 8-K, proxy statements, Section 16 reports on Forms 3, 4, and 5, and any amendments to 
those reports filed with or furnished to the SEC.  Access to these filings on our website is available free of charge.  Copies are also 
available, without charge, from Universal Corporation Investor Relations, 9201 Forest Hill Avenue, Richmond, VA 23235. Reports 
filed with the SEC may be viewed at www.sec.gov or obtained at the SEC Public Reference Room at 100 F Street, NE, Washington, 
D.C. 20549. Information regarding the operation of the Public Reference Room may be obtained by calling the SEC at 1-800-
SEC-0330.  We also post our press releases on our website.  Information on our website is not deemed to be incorporated by reference 
into this Annual Report.

In addition, our Corporate Governance Guidelines, Code of Conduct, and charters for the Audit Committee, the Executive 
Committee, the Executive Compensation, Nominating and Corporate Governance Committee, the Pension Investment Committee, 
and the Finance Committee are available free of charge to shareholders and the public through the “Corporate Governance” section 
of our website.  Printed copies of the foregoing are available to any shareholder upon written request to our Treasurer at the address 
set forth on the cover of this Annual Report or may be requested through our website, www.universalcorp.com.

4

B. 

Description of Business 

General 

Our  primary  business  is  procuring,  financing,  processing,  packing,  storing,  and  shipping  leaf  tobacco  for  sale  to 
manufacturers of consumer tobacco products.  Procuring leaf tobacco involves contracting with, providing agronomy support to, 
and financing farmers in many origins.  We do not manufacture cigarettes or other consumer tobacco products.  Rather, we support 
consumer product manufacturers by selling them processed leaf tobacco and performing related services for them. Through various 
operating subsidiaries and unconsolidated affiliates located in tobacco-growing origins around the world, we contract, purchase, 
process, and sell flue-cured and burley tobaccos, as well as dark air-cured and oriental tobaccos.  Flue-cured, burley, and oriental 
tobaccos are used principally in the manufacture of cigarettes, and dark air-cured tobaccos are used mainly in the manufacture of 
cigars, smokeless, and pipe tobacco products.  We also provide value-added services to our customers, including blending, chemical 
and physical testing of tobacco, service cutting for select manufacturers, manufacturing reconstituted leaf tobacco, and managing 
just-in-time inventory.  

Several important operating factors characterize our company and our primary business, leaf tobacco:

•  Experience dealing with large numbers of farmers,
•  Expertise in delivering a sustainable supply of compliant, traceable, competitively-priced leaf tobacco,
•  Capability to meet unique customer requirements for style, volume and quality,
•  Longstanding customer relationships,
• 
• 

Presence in all major leaf tobacco sourcing areas, and 
Financial strength and flexibility.

In addition to our leaf tobacco business, we are involved in other agribusiness opportunities.   We participate in a joint 
venture that supplies liquid nicotine, manufactured in the United States, to the vapor products industry.  During fiscal year 2015, 
we entered a new business to produce high-quality dehydrated and juiced fruit and vegetable products.  Initially, this business is 
focusing on producing value-added ingredients derived from sweet potatoes.  When looking at new opportunities, we seek prospects 
where we believe we can earn an adequate return, leverage our assets and expertise, and enhance our farmer base.  For example, 
with our food ingredients business, we identified a business that we believe will enhance the value of our company, build on our 
expertise as a business-to-business supplier of agricultural ingredients to companies that produce consumer products, and support 
tobacco farmers who grow sweet potatoes as a rotational crop.

With respect to our leaf tobacco business, we generate our revenues from product sales of processed, packed tobacco that 
we source, from processing fees for tobacco owned by third parties, and from fees for other services.  Sales to our five largest 
customers, with whom we have longstanding relationships, have accounted for more than 60% of our consolidated revenues for 
each of the past three fiscal years.  Our sales consist primarily of flue-cured and burley tobaccos.  For the fiscal year ended March 31, 
2016, our flue-cured and burley operations accounted for 90% of our revenues and 94% of our segment operating income.

We  conduct  our  business  in  varying  degrees  in  a  number  of  countries,  including  Bangladesh,  Brazil,  the  Dominican 
Republic,  Germany,  Guatemala,  Hungary,  India,  Indonesia,  Italy,  Malawi,  Mexico,  Mozambique,  the  Netherlands,  Nicaragua, 
Paraguay, the People’s Republic of China, the Philippines, Poland, Russia, Singapore, South Africa, Spain, Switzerland, Tanzania, 
the United Arab Emirates, the United States, and Zimbabwe.  In addition, our oriental tobacco joint venture, Socotab, L.L.C. has 
operations in Bulgaria, Greece, Macedonia, and Turkey.

Because unprocessed, or “green,” leaf tobacco is a perishable product, timely processing is an essential service to our 
customers. Our processing of leaf tobacco includes grading in the factories, blending, removal of non-tobacco material, separation 
of leaf from the stems, drying, packing to precise moisture targets for proper aging, as well as temporary storage.  Accomplishing 
these tasks generally requires investments in factories and machinery in areas where the tobacco is grown.  Processed tobacco that 
has been properly packed can be stored by customers for a number of years prior to use, but most processed tobacco is used within 
two to three years.   

We are a major purchaser and processor in the chief exporting regions for flue-cured and burley tobacco throughout the 
world.  Africa, Brazil, and the United States produce approximately 60% of the flue-cured and burley tobacco grown outside of 
China.  We estimate that we have historically handled, through leaf sales or processing, between 35% and 45% of the annual 
production of such tobaccos in Africa, between 15% and 25% in Brazil, and between 25% and 35% in the United States.  These 
percentages can change from year to year based on the size, price, and quality of the crops.  As tobacco growing regions have 
expanded in Africa, we have handled a larger proportion of the crops there.  We participate in the procurement, processing, storage, 
and sale of oriental tobacco through ownership of a 49% equity interest in Socotab, L.L.C., a leading supplier of oriental tobaccos.  
In addition, we maintain a presence, and in certain cases, a leading presence, in virtually all other major tobacco growing regions 
in the world.  We believe that our leading position in the leaf tobacco industry is based on our operating presence in all of the major 
sourcing areas, our ability to meet customer style, volume, and quality requirements, our expertise in dealing with large numbers 
of farmers, our long-standing relationships with customers, our development of processing equipment and technologies, and our 

5

 
financial  position.     The  efficiencies  that  we  offer  our  customers,  due  to  our  established  network  of  operational  expertise  and 
infrastructure on the ground and our ability to market most styles and grades of leaf to a diverse customer base, are also key to our 
success.

We also have a leading position in worldwide dark tobacco markets.  Our dark tobacco operations are located in most of 
the major producing countries and in other smaller markets.  We operate in major dark tobacco producing countries, including the 
United States, the Dominican Republic, Indonesia, Paraguay, the Philippines, Nicaragua, and Brazil.  Dark tobaccos are typically 
used in the manufacture of cigars, pipe tobacco, and smokeless tobacco products, and as components of certain “roll-your-own” 
cigarette products.

Sales are made by our sales force and, to a much smaller degree, through the use of commissioned agents.  Most customers 
are long-established tobacco product manufacturers.  Customer contract arrangements vary around the world and include negotiated 
pricing as well as cost plus arrangements.  Discussions of a customer’s longer-term needs may begin as early as one to two years 
in advance of a particular crop purchase.  These discussions are key to our future crop production planning.  Prior to planting each 
year, we use early customer indications for type, style, processing, and volume requirements for the upcoming season’s crop to help 
us determine our farmer contracting and grower input needs in our origins. We work with our farmers and customers continually 
throughout the crop season. As crops progress through the growing season, customers will inspect the crop, and a customer’s early 
indications may be refined based upon emerging crop qualities and quantities and market pricing expectations.  Ultimately, purchase 
agreements specifying quantity, quality, grade and price are executed, leading to inventory allocations of harvested green or processed 
leaf that we have acquired.

In the majority of the countries where we operate, we contract directly with tobacco farmers or tobacco farmer cooperatives.  
In most countries outside the United States, we advance seed, fertilizer, and other agricultural inputs to farmers.  These advances 
are repaid by farmers with the tobacco they produce.  We are dedicated to promoting a sustainable farmer base and provide our 
farmers with agronomy support.  Our Good Agricultural Practices programs educate farmers in such matters as the reduction of 
non-tobacco  related  materials,  product  traceability,  environmental  sustainability,  agricultural  labor  standards,  and  social 
responsibility.  In Malawi and Zimbabwe, we also purchase some tobacco under auction systems.

Our foreign operations are subject to international business risks, including unsettled political conditions, expropriation, 
import and export restrictions, exchange controls, and currency fluctuations.  During the tobacco season in many of the countries 
listed above, we advance funds, guarantee local loans, or do both, each in substantial amounts, for the eventual purchase of tobacco. 
The majority of these seasonal advances and loan guarantees mature in one year or less upon the farmers’ delivery of contracted 
tobaccos.  Most advances to farmers are denominated in local currency, which is a source of foreign currency exchange rate risk.  
Most tobacco sales are denominated in U.S. dollars, which reduces our foreign currency exchange risk after the tobacco has been 
purchased.  See Item 1A, “Risk Factors” for more information about our foreign currency exchange and other risks.

For a discussion of recent developments and trends in our business, along with factors that may affect our business, see 
Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and Item 1A, “Risk Factors.”

Seasonality 

Our operations are seasonal in nature.  Tobacco in Brazil is usually purchased from January through July, while buying in 
Malawi, Mozambique, and other African countries typically begins around April and continues through November.  Farmers begin 
to sell U.S. flue-cured tobacco in late July, and the marketing season lasts for approximately four months.  

We normally operate each of our processing plants for seven to nine months of the year.  During this period for each region, 
inventories  of  green  tobacco,  inventories  of  processed  tobacco,  and  trade  accounts  receivable  normally  reach  peak  levels  in 
succession.  We normally finance this expansion of current assets with cash, short-term borrowings from banks, and customer 
advances, and these funding sources normally reach their peak usage in each region during its respective purchasing or processing 
period.  Our balance sheet at our fiscal year end reflects seasonal expansions in working capital in South America and Central 
America.  Our financial performance is also impacted by the seasonality of our business.  As a result of customer shipment preferences, 
we have seen a larger portion of our volumes shipped in the second half of our fiscal year.   These changes in customer shipment 
schedules or changes in crop timing in a season can also shift recognition of revenue in a given fiscal year.

Customers 

A material part of our business is dependent upon a few customers.  Our five largest customers are Philip Morris International, 
Inc., British American Tobacco plc, Imperial Brands plc, Japan Tobacco, Inc. and China Tobacco International, Inc.   In the aggregate, 
these customers have accounted for more than 60% of our consolidated revenues for each of the past three fiscal years.  For the 
fiscal  year  ended  March 31,  2016,  each  of  Philip  Morris  International,  Inc.  and  British American Tobacco  plc,  including  their 
respective affiliates, accounted for 10% or more of our revenues, while Imperial Brands plc, Japan Tobacco, Inc. and China Tobacco 
International, Inc. each accounted for between 7% and 10% of our revenues.  The loss of, or substantial reduction in business from, 
any of these customers could have a material adverse effect on our results.  We have longstanding relationships with all of these 
customers.   

6

We had commitments from customers for approximately $516 million of the tobacco in our inventories at March 31, 2016. 
Based upon historical experience, we expect that at least 90% of such orders will be delivered during fiscal year 2017.  Most of our 
product requires shipment via trucks and oceangoing vessels to reach customer destinations.  Delays in the delivery of orders can 
result from such factors as truck and container availability, port access and capacity, vessel scheduling, and changing customer 
requirements for shipment. 

As more fully described in Note 1 to the consolidated financial statements in Item 8 of this Annual Report, we recognize  
revenue from the sale of tobacco when title and risk of loss is transferred to our customer.  Individual shipments may be large, and 
since the customer typically specifies shipping dates, our financial results may vary significantly between reporting periods due to 
timing of sales.  In some markets, including the United States, Italy, and Brazil, we process tobacco that is owned by our customers, 
and we recognize the revenue for that service when the processing is completed.

Competition 

Competition among leaf tobacco suppliers is based on the ability to meet customer specifications in the growing, buying, 
processing, and financing of tobacco, and on the price charged for products and services.  Competition varies depending on the 
market or country involved.  The number of competitors varies from country to country, but there is competition in most areas to 
buy and sell the available tobacco.  Our principal competitor is Alliance One International, Inc. (“Alliance One”).  Alliance One 
operates in most of the countries where we operate.  Based on our estimates, we do not believe that worldwide market shares differ 
substantially between the two companies.  Most of our major customers are partially vertically integrated, and thus also compete 
with us for the purchase of leaf tobacco in several of the major markets.

In most major markets, smaller competitors are very active.  These competitors typically have lower overhead requirements 
and provide less support to customers and farmers.  Due to their lower cost structures, they can often offer a price on products that 
is lower than our price.  However, we believe that we provide quality controls and farm programs that add value for our customers 
in an increasingly regulated world and make our products highly desirable.  For example, we have established worldwide farm 
programs designed to prevent non-tobacco related materials from being introduced into the green tobacco delivered to our factories.  
In addition, we have established programs for sustainable tobacco production which include promoting Good Agricultural Practices 
that encompass crop quality, environmental stewardship, and agricultural labor practices.  We believe that our major customers 
increasingly require these services and that our programs increase the quality and value of the products and services we offer.  We 
also believe that our customers value the security of supply that we are able to provide due to our strong relationships with our 
farmer base and our global footprint.

Reportable Segments

We evaluate the performance of our leaf tobacco business by geographic region, although the dark air-cured and oriental 
tobacco businesses are each evaluated on the basis of their worldwide operations.  Performance of the oriental tobacco operations 
is evaluated based on our equity in the pretax earnings of our affiliate.  Under this structure, we have the following primary operating 
segments:  North America, South America, Africa, Europe, Asia, Dark Air-Cured, Oriental, and Special Services.  North America, 
South America, Africa, Europe, and Asia are primarily involved in flue-cured and burley leaf tobacco operations for supply to 
cigarette manufacturers.  Our Dark Air-Cured group supplies dark air-cured tobacco principally to manufacturers of cigars, pipe 
tobacco, and smokeless tobacco products, and our Oriental business supplies oriental tobacco to cigarette manufacturers.  Our 
Special Services group provides laboratory services, including physical and chemical product testing, e-cigarette and e-liquid testing, 
and smoke testing for customers.  Our liquid nicotine joint venture and our fruit and vegetable ingredients business are also included 
in the Special Services group.

The five regional operating segments serving our cigarette manufacturer customers share similar characteristics in the 
nature  of  their  products  and  services,  production  processes,  class  of  customer,  product  distribution  methods,  and  regulatory 
environment.  Based on the applicable accounting guidance, four of the regions – South America, Africa, Europe, and Asia – are 
aggregated into a single reporting segment, Other Regions, because they also have similar economic characteristics.  North America 
is reported as an individual operating segment, because its economic characteristics differ from the other regions, generally because 
its operations require lower working capital investments for crop financing and inventory.  The Dark Air-Cured, Oriental, and 
Special Services segments, which have differing characteristics in some of the categories mentioned above, are reported together 
as Other Tobacco Operations, because each is below the measurement threshold for separate reporting. 

Financial Information about Segments

Our North America and Other Regions reportable segments, which represent our flue-cured and burley tobacco operations, 
accounted for 17% and 73% of our revenues and 17% and 77% of our segment operating income, respectively, in fiscal years 2016
and 2015.  Our Other Tobacco Operations reportable segment accounted for 10% of our revenues and 6% of our segment operating 
income in fiscal year 2016.   Sales and other operating revenues and operating income attributable to our reportable segments for 
each of the last three fiscal years, along with segment assets for each reportable segment at March 31, 2016, 2015, and 2014, are 
set forth in Note 14 to the consolidated financial statements, which are included in Item 8 of this Annual Report.  Information with 

7

respect to the geographic distribution of our revenues and long-lived assets is also set forth in Note 14 to the consolidated financial 
statements. 

C. 

Employees 

We employed over 24,000 employees throughout the world during the fiscal year ended March 31, 2016.  We estimated 

this figure because the majority of our personnel are seasonal employees. 

D. 

Research and Development 

We did not expend material amounts for research and development during the fiscal years ended March 31, 2016, 2015, 

or 2014. 

E. 

Patents, etc. 

We hold no material patents, licenses, franchises, or concessions. 

F. 

Government Regulation, Environmental Matters, and Other Matters 

Our business is subject to general governmental regulation in the United States and in foreign jurisdictions where we 
conduct business. Such regulation includes, but is not limited to, matters relating to environmental protection.  To date, governmental 
provisions regulating the discharge of material into the environment have not had a material effect upon our capital expenditures, 
earnings, or competitive position.  See Item 1A, “Risk Factors” for a discussion of government regulations and other factors that 
may affect our business. 

8

Item 1A.   Risk Factors

Operating Factors

In areas where we purchase leaf tobacco directly from farmers, we bear the risk that the tobacco we receive will not meet quality 
and quantity requirements.

When we contract directly with tobacco farmers or tobacco farmer cooperatives, which is the method we use to purchase 
tobacco in most countries, we bear the risk that the tobacco delivered may not meet customer quality and quantity requirements.  If 
the tobacco does not meet such market requirements, we may not be able to fill all of our customers’ orders, and such failure would 
have an adverse effect on profitability and results of operations. In a contract market our obligation is to purchase the entire tobacco 
plant, which encompasses many leaf styles, therefore, we also have a risk that not all of that production will be readily marketable 
at prices that support acceptable margins.  In addition, in many foreign countries where we purchase tobacco directly from farmers, 
we provide them with financing.  Unless we receive marketable tobacco that meets the quality and quantity specifications of our 
customers, we bear the risk that we will not be able to fully recover our crop advances or recover them in a reasonable period of 
time.  

The leaf tobacco industry is competitive, and we are heavily reliant on a few large customers.

We are one of two major independent global competitors in the leaf tobacco industry, both of whom are reliant upon a few 
large customers.  The loss of one of those large customers or a significant decrease in their demand for our products or services could 
significantly decrease our sales of products or services, which would have a material adverse effect on our results of operations.  The 
competition among leaf tobacco suppliers and dealers is based on the ability to meet customer requirements in the buying, processing, 
and financing of tobacco, and on the price charged for products and services.  We believe that we consistently meet our customers’ 
requirements and charge competitive prices.  Since we rely upon a few significant customers, the consolidation or failure of any of 
these large customers, or a significant increase in their vertical integration, could contribute to a significant decrease in our sales of 
products and services.

We compete for both the purchase and sale of leaf with smaller leaf tobacco suppliers in some of the markets where we 
conduct business.  Some of these smaller leaf tobacco suppliers operate in more than one country.  Since they typically provide little 
or no support to farmers, these leaf tobacco suppliers typically have lower overhead requirements than we do.  Due to their lower 
cost structures, they often can offer prices on products and services that are lower than our prices.  Our customers also directly source 
leaf tobacco from farmers to meet some of their raw material needs.  Direct sourcing provides our customers with some qualities 
and quantities of leaf tobacco that they prefer not to use in their existing blends and that may be offered for sale.  This competition 
for both the sale and purchase of leaf could reduce the volume of the leaf we handle and could negatively impact our financial results.

Our financial results can be significantly affected by changes in the balance of supply and demand for leaf tobacco.

As a leaf tobacco supplier, our financial results can be significantly affected by changes in the overall balance of worldwide 
supply and demand for leaf tobacco.  The demand for leaf tobacco, which is based upon customers’ expectations of their future 
requirements,  can  change  from  time  to  time  depending  upon  factors  affecting  the  demand  for  their  products.    Our  customers’ 
expectations and their demand for leaf tobacco are influenced by a number of factors, including: 

• 

• 

• 

• 

• 

trends in the global consumption of cigarettes,

trends in consumption of cigars and other tobacco products, 

trends in consumption of alternative tobacco products, such as e-cigarettes,

levels of competition among our customers, and

regulatory and governmental factors.

The  world  supply  of  leaf  tobacco  at  any  given  time  is  a  function  of  current  tobacco  production,  inventories  held  by 
manufacturers, and the stocks of leaf tobacco held by leaf tobacco suppliers.  Production of tobacco in a given year may be significantly 
affected by such factors as:

• 

• 

• 

demographic shifts that change the number of farmers or the amount of land available to grow tobacco,

decisions by farmers to grow crops other than leaf tobacco,

volume of annual tobacco plantings and yields realized by farmers,

availability of crop inputs, 

• 
•  weather and natural disasters, including any adverse weather conditions that may result from climate change, and

• 

crop infestation and disease.

Any significant change in these factors could cause a material imbalance in the supply of and demand for tobacco, which 

would affect our results of operations.  

9

Our financial results will vary according to tobacco growing conditions, customer requirements, and other factors.  These factors 
may also limit the ability to accurately forecast our future performance and increase the risk of an investment in our common stock 
or other securities.

Our financial results, particularly our year-over-year quarterly comparisons, may be significantly affected by variations in 
tobacco growing seasons and fluctuations in crop sizes.  The timing of the cultivation and delivery of tobacco is dependent upon a 
number  of  factors,  including  weather  and  other  natural  events,  and  our  processing  schedules  and  results  of  operations  can  be 
significantly altered by these factors.  In addition, the potential impact of climate change is uncertain and may vary by geographic 
region.  The possible effects, as described in various public accounts, could include changes in rainfall patterns, water shortages, 
changing storm patterns and intensities, and changing temperature levels that could adversely impact our costs and business operations 
and the supply and demand for leaf tobacco.  Our operations also rely on dependable and efficient transportation services.  A disruption 
in transportation services, as a result of climate change or otherwise, may also significantly impact our results of operations.

Further, the timing and unpredictability of customer orders and shipments may require us to keep tobacco in inventory and 
may also result in variations in quarterly and annual financial results.  We base sales recognition on the passage of ownership.  Since 
individual shipments may represent significant amounts of revenue, our quarterly and annual financial results may vary significantly 
depending on the timing of needs and shipping instructions of our customers and the availability of transportation services.  These 
fluctuations result in varying volumes and sales in given periods, which also reduce the comparability of financial results.

Major shifts in customer requirements for tobacco supply may significantly affect our operating results.

If our customers significantly alter their requirements for tobacco volumes from certain regions, we may have to change 
our production facilities and alter our fixed asset base in certain origins.  Permanent or long-term reduction in demand for tobacco 
from origins where we have operations may trigger restructuring and impairment charges.  We may also need to make significant 
capital investments in other regions to develop the needed infrastructure to meet customer supply requirements.

Weather and other conditions can affect the marketability of our products.

Tobacco crops are subject to vagaries of weather and the environment that can, in some cases, change the quality or size of 
the crops.  If a weather event is particularly severe, such as a major drought or hurricane, the affected crop could be destroyed or 
damaged to an extent that it would be less desirable to manufacturers, which would result in a reduction in revenues.  If such an 
event is also widespread, it could affect our ability to acquire the quantity of tobacco required by our customers.  In addition, other 
factors can affect the marketability of tobacco, including, among other things, the presence of excess residues of crop protection 
agents or non-tobacco related materials.  A significant event impacting the condition or quality of a large amount of any of the crops 
that we buy could make it difficult for us to sell these products or to fill customers’ orders.

Our food ingredient business is subject to industry-specific risks which could adversely affect our operating results.

Our food ingredients business is subject to risks posed by food spoilage or food contamination; shifting consumer preferences; 
federal, state, and local food processing regulations; product tampering; and product liability claims.  If one or more of these risks 
were to materialize, our revenues and operating results could be adversely affected, and our Company’s reputation might be damaged.

Regulatory and Governmental Factors

Government efforts to regulate the production and consumption of tobacco products could have a significant impact on the businesses 
of our customers, which would, in turn, affect our results of operations.

Nationally, the U.S. federal government and certain state and local governments have taken or proposed actions that may 
have the effect of reducing U.S. consumption of tobacco products and indirectly reducing demand for our products and services.  
These activities have included:

• 

• 

• 

• 

restrictions on the use of tobacco products in public places and places of employment,

legislation authorizing the U.S. Food and Drug Administration (the “FDA”) to regulate the manufacturing and marketing 
of all tobacco products,

increases in the federal, state, and local excise taxes on cigarettes and other tobacco products, and

the policy of the U.S. government to link certain federal grants to the enforcement of state laws restricting the sale of 
tobacco products.

Numerous other legislative and regulatory anti-smoking measures have been proposed at the federal, state, and local levels. 

About 5% of cigarettes manufactured worldwide are consumed in the United States. 

Globally, a number of foreign governments and non-government organizations also have taken or proposed steps to restrict 
or prohibit tobacco product advertising and promotion, to increase taxes on tobacco products, to indirectly limit the use of certain 
types of tobacco, and to discourage tobacco product consumption.  A number of such measures, including plain packaging, are 
included in the Framework Convention on Tobacco Control (“FCTC”), which was negotiated and promoted globally under the 

10

auspices of the World Health Organization (“WHO”).  We cannot predict the extent or speed at which the efforts of governments or 
non-governmental agencies to reduce tobacco consumption might affect the business of our primary customers.  However, a significant 
decrease in worldwide tobacco consumption brought about by existing or future governmental laws and regulations would reduce 
demand for tobacco products and services and could have a material adverse effect on our results of operations.

Government actions can have a significant effect on the sourcing of tobacco.  If some of the current efforts are successful, we could 
have  difficulty  obtaining  sufficient  tobacco  to  meet  our  customers’  requirements,  which  could  have  an  adverse  effect  on  our 
performance and results of operations.

The WHO, through the FCTC, has created a formal study group to identify and assess crop diversification initiatives and 
alternatives to growing leaf tobacco in countries whose economies depend upon tobacco production.  The study group began its work 
in February 2007.   If certain countries were to partner with the FCTC study group and seek to eliminate or significantly reduce leaf 
tobacco production, we could encounter difficulty in sourcing leaf tobacco to fill customer requirements, which could have an adverse 
effect on our results of operations.

 Certain recommendations by the WHO, through the FCTC, may cause shifts in customer usage of certain styles of tobacco.  
As seen in countries like Canada and Brazil and in the European Union, efforts have been taken to eliminate ingredients from the 
manufacturing  process  for  tobacco  products.    Recently,  the  FCTC  and  the  FDA  have  discussed  formulating  a  nicotine  strategy 
(limitations on the level of nicotine allowed in tobacco and tobacco smoke).  Such decisions could cause a change in requirements 
for certain styles of tobacco in particular countries.  Shifts in customer demand from one type of tobacco to another could create 
sourcing challenges as requirements move from one origin to another.  

Trade  proposals  currently  under  consideration  include  provisions  that  could  effectively  allow  governments  to  regulate 
tobacco products differently than other products.  These “carve outs”, as negotiated in the TransPacific Partnership Agreement, could 
negatively impact the industry and reduce requirements for leaf tobacco.

In addition, continued government and public emphasis on environmental issues, including climate change, conservation, 
and natural resource management, could result in new or more stringent forms of regulatory oversight of industry activities, which 
may lead to increased levels of expenditures for environmental controls, land use restrictions affecting us or our suppliers, and other 
conditions that could have a material adverse effect on our business, financial condition, and results of operations.  For example, 
certain aspects of our business generate carbon emissions.  Regulatory restrictions on greenhouse gas emissions have been proposed.  
These may include limitations on such emissions, taxes or emission allowance fees on such emissions, various restrictions on industrial 
operations, and other measures that could affect land-use decisions, the cost of agricultural production, and the cost and means of 
processing and transporting our products.  These actions could adversely affect our business, financial condition, and results of 
operations.

Because we conduct a significant portion of our operations internationally, political and economic uncertainties in certain countries 
could have an adverse effect on our performance and results of operations.

Our  international  operations  are  subject  to  uncertainties  and  risks  relating  to  the  political  stability  of  certain  foreign 
governments, principally in developing countries and emerging markets, and also to the effects of changes in the trade policies and 
economic regulations of foreign governments.  These uncertainties and risks, which include undeveloped or antiquated commercial 
law, the expropriation, indigenization, or nationalization of assets, and the authority to revoke or refuse to renew business licenses 
and work permits, may adversely impact our ability to effectively manage our operations in those countries.  We have substantial 
capital investments in South America and Africa, and the performance of our operations in those regions can materially affect our 
earnings.  If the political situation in any of the countries where we conduct business were to deteriorate significantly, our ability to 
recover assets located there could be impaired.  To the extent that we do not replace any lost volumes of tobacco with tobacco from 
other sources, or we incur increased costs related to such replacement, our financial condition or results of operations, or both, would 
suffer.

Changes in tax laws in the countries where we do business may adversely affect our results of operations.

Through our subsidiaries, we are subject to the tax laws of many jurisdictions.  Changes in tax laws or the interpretation of 
tax laws can affect our earnings, as can the resolution of various pending and contested tax issues. In most jurisdictions, we regularly 
have audits and examinations by the designated tax authorities, and additional tax assessments are common.  We believe that we 
comply with applicable tax laws in the jurisdictions where we operate, and we vigorously contest all significant tax assessments 
where we believe we are in compliance with the tax laws.  

11

Financial Factors

Failure of our customers or suppliers to repay extensions of credit could materially impact our results of operations.

We extend credit to both suppliers and customers.  A significant bad debt provision related to amounts due could adversely 
affect our results of operations.  In addition, crop advances to farmers are generally secured by the farmers’ agreement to deliver 
green tobacco.  In the event of crop failure, delivery failure, or permanent reductions in crop sizes, full recovery of advances may 
never be realized, or otherwise could be delayed until future crops are delivered.  See Notes 1 and 13 to the consolidated financial 
statements in Item 8 for more information on these extensions of credit. 

Fluctuations in foreign currency exchange rates may affect our results of operations.

We account for most of our tobacco operations using the U.S. dollar as the functional currency.  The international tobacco 
trade generally is conducted in U.S. dollars, and we finance most of our tobacco operations in U.S. dollars.  Although this generally 
limits foreign exchange risk to the economic risk that is related to leaf purchase and production costs, overhead, and income taxes 
in the source country, significant currency movements could materially impact our results of operations.  Changes in exchange rates 
can make a particular crop more or less expensive in U.S. dollar terms.  If a particular crop is viewed as expensive in U.S. dollar 
terms, it may be less attractive in the world market.  This could negatively affect the profitability of that crop and our results of 
operations.  In certain tobacco markets that are primarily domestic, the local currency is the functional currency.  Examples of these 
markets are Hungary, Poland, and the Philippines.  Similarly, the local currency is the functional currency in other markets, such as 
Western Europe, where export sales have been denominated primarily in local currencies. In these markets, reported earnings are 
affected by the translation of the local currency into the U.S. dollar. See Item 7A, “Qualitative and Quantitative Disclosure About 
Market Risk” for additional discussion related to foreign currency exchange risk.

Our purchases of tobacco are generally made in local currency, and we also provide farmer advances that are denominated 
in the local currency.  We account for currency remeasurement gains or losses on those advances as period costs, and they are usually 
accompanied by offsetting increases or decreases in the purchase cost of tobacco, which is priced in the local currency.  The effect 
of differences in the cost of tobacco is generally not realized in our earnings until the tobacco is sold, which often occurs in a quarter 
or fiscal year subsequent to the recognition of the related remeasurement gains or losses.  The difference in timing could affect our 
profitability in a given quarter or fiscal year.   

We have used currency hedging strategies to reduce our foreign currency exchange rate risks in some markets.  In addition, 
where we source tobacco in countries with illiquid or nonexistent forward foreign exchange markets, we often manage our foreign 
exchange risk by matching funding for inventory purchases with the currency of sale and by minimizing our net investment in these 
countries.  To the extent that we have net monetary assets or liabilities in local currency, and those balances are not hedged, we may 
have currency remeasurement gains or losses that will affect our results of operations.    

Changes in interest rates may affect our results of operations.

We generally use both fixed and floating interest rate debt to finance our operations.  Changes in market interest rates expose 
us to changes in cash flows for floating rate instruments and to changes in fair value for fixed-rate instruments.   We normally maintain 
a proportion of our debt in both variable and fixed interest rates to manage this exposure, and from time to time we may enter hedge 
agreements to swap the interest rates.  In addition, our customers may pay market rates of interest for inventory purchased on order, 
which could mitigate a portion of the floating interest rate exposure on short-term borrowings.  To the extent we are unable to match 
these interest rates, a decrease in interest rates could increase our net financing costs.  We also periodically have large cash balances 
and may receive deposits from customers, both of which we use to fund seasonal purchases of tobacco, reducing our financing needs.  
Decreases in short-term interest rates could reduce the income we derive from those investments.  Changes in interest rates also 
affect expense related to our defined benefit pension plan, as described below. 

12

Low investment performance by our defined benefit pension plan assets and changes in pension plan valuation assumptions may 
increase our pension expense and may require us to fund a larger portion of our pension obligations, thus diverting funds from other 
potential uses. 

We sponsor domestic defined benefit pension plans that cover certain eligible employees.  Our results of operations may 
be positively or negatively affected by the amount of expense we record for these plans.  U.S. generally accepted accounting principles 
(“GAAP”) require that we calculate expense for the plans using actuarial valuations.  These valuations reflect assumptions about 
financial market and other economic conditions that may change based on changes in key economic indicators.  The most significant 
year-end assumptions we used to estimate pension expense for fiscal year 2016 were the discount rate, the expected long-term rate 
of return on plan assets, and the mortality rates.  In addition, we are required to make an annual measurement of plan assets and 
liabilities, which may result in a significant change to shareholders’ equity through a reduction or increase to the “Pension and other 
postretirement benefits plan” component of Accumulated Other Comprehensive Loss.  At the end of fiscal year 2016, the projected 
benefit obligation of our qualified U.S. pension plan was $222 million and plan assets were $197 million.  For a discussion regarding 
how our financial statements can be affected by pension plan valuation assumptions, see “Critical Accounting Estimates – Pension 
and Other Postretirement Benefit Plans” in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” 
in Item 7 and in Note 10 to the consolidated financial statements in Item 8.  Although GAAP expense and pension funding contributions 
are not directly related, key economic factors that affect GAAP expense can also affect the amount of cash we are required to contribute 
to our pension plans under requirements of the Employee Retirement Income Security Act (“ERISA”).  Failure to achieve expected 
returns on plan assets could also result in an increase to the amount of cash we would be required to contribute to our pension plans.  
In order to maintain or improve the funded status of our plans, we may also choose to contribute more cash to our plans than required 
by ERISA regulations.

Item 1B.   Unresolved Staff Comments

None 

13

Item 2.    Properties

We own the following significant properties (greater than 500,000 square feet):

Location

Flue-Cured and Burley Leaf Tobacco Operations:

North America:

United States

Principal Use

Building Area
(Square Feet)

Nash County, North Carolina .......................................................................... Factory and storages

1,323,000

Other Regions:

Brazil

Santa Cruz ....................................................................................................... Factory and storages

2,386,000

Malawi

Lilongwe.......................................................................................................... Factory and storages

942,000

Mozambique

Tete .................................................................................................................. Factory and storages

770,000

Philippines

Agoo, La Union ............................................................................................... Factory and storages

770,000

Tanzania

Morogoro......................................................................................................... Factory and storages

895,000

Zimbabwe
Harare (1) .......................................................................................................... Factory and storages

1,445,000

Other Tobacco Operations:

United States

Lancaster, Pennsylvania .................................................................................. Factory and storages

793,000

(1) 

Owned by an unconsolidated subsidiary.

We lease headquarters office space of about 50,000 square feet at 9201 Forest Hill Avenue in Richmond, Virginia, which 

we believe is adequate for our current needs.  

Our business involves, among other things, storing and processing green tobacco and storing processed tobacco.  We operate 
processing facilities in major tobacco growing areas.  In addition, we require tobacco storage facilities that are in close proximity to 
the processing facilities.  We own most of the tobacco storage facilities, but we lease additional space as needs arise, and expenses 
related to such leases are not material.  We believe that the properties currently utilized in our tobacco operations are maintained in 
good operating condition and are suitable and adequate for our purposes at our current volumes.  

In addition to our significant properties listed above, we own other processing facilities in the following countries: Germany, 
Guatemala, Hungary, Italy, the Netherlands, Poland, and the United States. In addition, we have an ownership interest in a processing 
plant in Mexico and have access to processing facilities in other areas, such as India, the People’s Republic of China, and South 
Africa.  Socotab L.L.C., an oriental tobacco joint venture in which we own a noncontrolling interest, owns tobacco processing plants 
in Turkey, Macedonia, and Bulgaria.  

Except for the Lancaster, Pennsylvania facility, the facilities described above are engaged primarily in processing tobaccos 
used by manufacturers in the production of cigarettes.  The Lancaster facility, as well as facilities in Brazil, the Dominican Republic, 
Indonesia, and Paraguay, process tobaccos used in making cigar, pipe, and smokeless products, as well as components of certain 
“roll-your-own” products.  

We completed the construction of a 120,000 square-foot processing facility for our new fruit and vegetable ingredients 

business and began operations in that facility during fiscal year 2016.  The facility is located in Nash County, North Carolina.

14

Item 3.   Legal Proceedings 

Some of our subsidiaries are involved in litigation or legal matters incidental to their business activities.  While the outcome 
of these matters cannot be predicted with certainty, we are vigorously defending the matters and do not currently expect that any of 
them will have a material adverse effect on our business or financial position.  However, should one or more of these matters be 
resolved in a manner adverse to our current expectation, the effect on our results of operations for a particular fiscal reporting period 
could be material. 

Item 4.   Mine Safety Disclosures 

Not applicable.

15

PART II

Item 5.  Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 

Common Equity 

Our common stock is traded on the New York Stock Exchange (“NYSE”) under the symbol “UVV.” The following table 
sets forth the high and low sales prices per share of the common stock on the NYSE Composite Tape, based upon published financial 
sources, and the dividends declared on each share of common stock for the quarter indicated.

Fiscal Year Ended March 31, 2016

  Cash dividends declared ...................................................................................

$

0.52   $

0.52   $

0.53   $

0.53

First Quarter

Second Quarter    Third Quarter

   Fourth Quarter

  Market price range:

  High................................................................................................................

  Low ................................................................................................................

57.76   

46.80   

58.41   

46.98   

57.72   

49.70   

57.27

51.49

Fiscal Year Ended March 31, 2015

  Cash dividends declared ...................................................................................

$

0.51   $

0.51   $

0.52   $

0.52

  Market price range:

  High................................................................................................................

  Low ................................................................................................................

56.82

52.16

56.35   

44.39   

45.63   

38.53   

48.10

39.27

Our current dividend policy anticipates the payment of quarterly dividends in the future.  However, the declaration and 
payment of dividends to holders of common stock is at the discretion of the Board of Directors and will be dependent upon our future 
earnings, financial condition, and capital requirements.  Under the terms of our Series B 6.75% Convertible Perpetual Preferred 
Stock (the “Preferred Stock”), we may not declare or pay dividends on our common stock unless dividends on the Preferred Stock 
for the four most recent consecutive dividend periods have been declared and paid.  The Preferred Stock contains provisions that 
prohibit the payment of cash dividends if certain income and shareholders’ equity levels are not met.  Under certain of our credit 
facilities, we must meet financial covenants relating to minimum tangible net worth and maximum levels of debt.  If we were not in 
compliance with them, these financial covenants could restrict our ability to pay dividends.  We were in compliance with all such 
covenants at March 31, 2016.  At May 20, 2016, there were 1,172 holders of record of our common stock.  See Notes 5 and 11 to 
the consolidated financial statements in Item 8 for more information on debt covenants and equity securities.

Purchases of Equity Securities

As indicated in the following table, we did not repurchase shares of our common stock or our Series B 6.75% Convertible 

Perpetual Preferred Stock during the three-month period ended March 31, 2016:

Common Stock

Series B 6.75% Convertible Perpetual
Preferred Stock

Period (1)

Total Number
of Shares
Repurchased

Average 
Price Paid 
Per Share (2)

Total Number 
of Shares 
Repurchased 
as Part of 
Publicly 
Announced 
Plans or 
Programs (3)

Total Number
of Shares
Repurchased

Average 
Price Paid 
Per Share (2)

Total Number 
of Shares 
Repurchased 
as Part of 
Publicly 
Announced 
Plans or 
Programs (3)

Dollar Value of 
Shares that 
May Yet Be 
Purchased 
Under the 
Plans or 
Programs (3)

January 1-31, 2016 ..................

— $

February 1-29, 2016 ................

March 1-31, 2016 ....................

—

—

Total.........................................

— $

—

—

—

—

—

—

—

—

— $

—

—

— $

—

—

—

—

— $

100,000,000

—

—

100,000,000

100,000,000

— $

100,000,000

(1) 

(2) 

(3) 

Repurchases are based on the date the shares were traded.  This presentation differs from the consolidated statement of cash flows, where the cost of share 
repurchases is based on the date the transactions were settled.

Amounts listed for average price paid per share include broker commissions paid in the transactions.

A stock repurchase plan, which was authorized by our Board of Directors, became effective and was publicly announced on November 5, 2015.  This stock 
repurchase plan authorizes the purchase of up to $100 million in common and/or preferred stock in open market or privately negotiated transactions, subject to 
market conditions and other factors, and will expire on the earlier of November 15, 2017, or when we have exhausted the funds authorized for the program.

16

  
  
  
  
  
  
Item 6.   Selected Financial Data

Fiscal Year Ended March 31,

2016

2015

2014

2013

2012

(in thousands, except share and per share data, ratios, and
number of shareholders)

Summary of Operations

Sales and other operating revenues................................................................... $ 2,120,373

$ 2,271,801

$ 2,542,115

   $ 2,461,699

   $ 2,446,877

Operating income.............................................................................................. $
(1) .......................................................................... $

Segment operating income 

Net income ........................................................................................................ $
(2) ...................................... $

Net income attributable to Universal Corporation 

181,647

186,068

118,148

109,016

Earnings available to Universal Corporation common shareholders................ $

94,268

  $

   $

$

$

$

167,874

167,225

120,461

114,608

99,748

  $

   $

$

$

$

246,151

175,175

155,155

149,009

134,159

$

$

$

$

$

223,009

232,757

140,919

132,750

117,900

Return on beginning common shareholders’ equity .........................................

8.2%   

8.6%   

12.8%   

12.1%   

Earnings per share attributable to 

Universal Corporation common shareholders:

Basic............................................................................................................ $

Diluted......................................................................................................... $

4.16

3.92

$

$

4.33

4.06

$

$

5.77

5.25

$

$

5.05

4.66

$

$

$

$

$

$

$

180,304

233,548

100,819

92,057

77,207

7.9%

3.32

3.25

Financial Position at Year End

Current ratio ......................................................................................................

6.65

5.96

3.66

2.77

4.21

Total assets........................................................................................................ $ 2,232,797

  $ 2,188,449

$ 2,264,893

$ 2,287,177

$ 2,244,733

Long-term debt.................................................................................................. $

370,000

$

370,000

  $

240,000

  $

181,250

  $

392,500

Working capital................................................................................................. $ 1,392,276

$ 1,329,770

$ 1,200,023

$ 1,094,764

$ 1,250,200

Total Universal Corporation shareholders’ equity............................................ $ 1,414,222

  $ 1,362,725

$ 1,378,230

$ 1,258,571

$ 1,183,451

General

Ratio of earnings to fixed charges ....................................................................

Ratio of earnings to combined fixed charges and preference dividends...........

Number of common shareholders.....................................................................

10.22

4.59

1,182

8.46

4.05

1,225

10.73

5.49

1,295

8.87

4.69

1,354

7.53

4.07

1,408

Weighted average common shares outstanding:

Basic...............................................................................................................

22,683,290

23,035,920

23,238,978

23,354,793

23,227,884

Diluted............................................................................................................

27,825,491

28,221,264

28,392,033

28,478,058

28,339,307

Dividends per share of convertible perpetual preferred stock (annual)............ $

67.50

Dividends per share of common stock (annual) ............................................... $

2.10

Book value per common share.......................................................................... $

52.94

$

$

$

67.50

2.06

50.95

$

$

$

67.50

2.02

50.19

$

$

$

67.50

1.98

44.79

$

$

$

67.50

1.94

41.73

(1)    

The Company evaluates the performance of its segments based on operating income after allocated overhead expenses (excluding significant charges or credits),  
cplus equity in the pretax earnings of unconsolidated affiliates. See Note 14 to the consolidated financial statements in Item 8 of this Annual Report.

(2)  

We hold less than a 100% financial interest in certain consolidated subsidiaries, and a portion of net income is attributable to the noncontrolling interests in 

those subsidiaries.

17

  
  
  
  
  
  
  
  
The calculations of the ratio of earnings to fixed charges and the ratio of earnings to combined fixed charges and preference 
dividends are shown in Exhibit 12.  Fixed charges primarily represent interest expense we incurred during the designated fiscal 
year, and preference dividends represent the pre-tax equivalent of dividends on preferred stock.  

Significant items included in the operating results in the above table are as follows:

• 

• 

• 

• 

• 

Fiscal Year 2016 – a $3.4 million pretax gain arising from the acquisition of a joint venture partner's 50% ownership 
interest in a tobacco processing entity in Guatemala.  The transaction increased our ownership interest in the entity to 
100%, requiring us to consolidate the financial statements of the entity and to remeasure our original 50% ownership 
interest to fair value, resulting in the gain. In addition, we recorded restructuring and impairment costs of  $2.4 million
related to a decision to significantly scale back our operations in Zambia.  The net effect of the gain and the restructuring 
and impairment costs increased pretax income by $1 million and net income by $0.7 million, or $0.02 per diluted 
share.

Fiscal Year 2015 – a $12.7 million benefit to pretax earnings from the reversal of a valuation allowance on the remaining  
unused balance of the excise tax credits realized from the favorable outcome of litigation by our subsidiary in Brazil 
in fiscal year 2014.  In addition, we recorded a consolidated income tax benefit of $8.0 million arising from the ability 
of our subsidiary, Deltafina S.p.A. ("Deltafina"), to pay a significant portion of the European Commission fine and 
related interest charges settled during the first quarter following the unsuccessful appeal of the case related to tobacco 
buying practices in Italy.  The effect of those items was partially offset by restructuring costs of $4.9 million, primarily 
related  to  downsizing  certain  functions  at  our  operations  in  Brazil  and  the  decision  to  suspend  our  operations  in 
Argentina.  On a combined basis, the net effect of these items increased pretax income by $7.8 million and net income 
by $13.1 million, or $0.46 per diluted share.

Fiscal Year 2014 – an $81.6 million pretax gain resulting from the favorable outcome of litigation by our operating 
subsidiary in Brazil related to previous years’ excise tax credits.  In addition to the gain, we recorded restructuring 
costs of $6.7 million, primarily related to the closure of a tobacco processing facility in Brazil and the consolidation 
of these operations into our main processing facility there.  The net effect of the gain and the restructuring costs 
increased pretax income by $74.9 million and net income by $48.7 million, or $1.72 per diluted share. 

Fiscal Year 2013 – $4.1 million in restructuring costs, primarily related to workforce reductions in Africa.  The effect 
of these charges was a reduction in net income of $1.8 million, or $0.06 per diluted share.

Fiscal Year 2012 – a $49.1 million charge to accrue a fine and accumulated interest imposed jointly on the Company 
and  Deltafina  by  the  European  Commission  related  to  tobacco  buying  practices  in  Italy.   The  charge  reflected  a 
September 2011 appeals court decision rejecting Deltafina's application to reinstate its immunity in the case.  No 
income tax benefit was recorded on the non-deductible fine portion of the charge. In addition to that charge, we recorded 
restructuring costs of $11.7 million, including approximately $8.6 million for employee termination benefits, primarily 
related to our operations in the U.S. and South America, and $3.1 million for costs to exit a supplier arrangement in 
Europe. Results for the year also included a gain of $11.1 million on the sale of land and buildings in Brazil that were 
most recently used for storage activities and a $9.6 million gain on insurance settlement proceeds to replace factory 
and equipment lost in a fire at a plant in Europe.  On a combined basis, the net effect of these items reduced pretax 
income by $40.0 million and net income by $40.3 million, or $1.42 per diluted share.

18

Item 7.   Management’s Discussion and Analysis of Financial Condition and Results of Operations 

The following discussion and analysis of financial condition and results of operations is provided to enhance the understanding of, 
and should be read in conjunction with, Part I, Item 1, “Business” and Item 8, “Financial Statements and Supplementary Data.”  
For information on risks and uncertainties related to our business that may make past performance not indicative of future results, 
or cause actual results to differ materially from any forward-looking statements, see “General,” and Part I, Item 1A, “Risk Factors.”

OVERVIEW

We  are  the  leading  global  leaf  tobacco  supplier.   We  derive  most  of  our  revenues  from  sales  of  processed  tobacco  to 
manufacturers of tobacco products throughout the world and from fees and commissions for specific services.  We hold a strategic 
position in the world leaf markets where we work closely with both our customers and farmers to ensure that we deliver a compliant 
product that meets our customers' needs while promoting a strong supplier base.  We adapt to meet changes in customer requirements 
as well as broader changes in the leaf markets, while continuing to provide the stability of supply and high level of service that 
distinguishes us in the marketplace.  We believe that we have successfully met the needs of both our customers and suppliers while 
adapting to changes in leaf markets.  Consequently, we have delivered strong results to our shareholders.  Over the last three fiscal 
years, we have strengthened our balance sheet by repaying almost $60 million in debt, generated over $400 million in net cash flow 
from operations, and returned over $230 million to our shareholders through a combination of dividends and share repurchases.

We have also faced challenging market conditions over the last three fiscal years. In fiscal year 2014, crop production levels 
increased, and markets in Brazil were volatile. Shipping volumes in the second half of that fiscal year exceeded those in the comparable 
period of the prior year.  These increased volumes partially offset lower levels of carryover volumes in the first half of fiscal year 
2014, weaker margins in Brazil from the volatile Brazilian leaf markets, and negative foreign currency remeasurement and exchange 
loss comparisons.  Our higher working capital cash requirements in fiscal year 2014 were a sharp contrast to the returns of working 
capital seen in the prior fiscal year.  In fiscal year 2014, purchases of larger crops, higher green leaf costs in Brazil, and investments 
in production growth in Africa utilized much of the substantial levels of cash flow from fiscal year 2013.

In fiscal year 2015, declines in some of our customers’ sales volumes in the U.S. and Western European markets, partially 
due to weak economic conditions, reduced demand for leaf tobacco.  At the same time, crops sold in fiscal year 2015 were larger 
than those sold in fiscal year 2014.  Given fiscal year 2015’s oversupplied market conditions, we were pleased with the results we 
achieved.  We ended the year with strong fourth quarter results, which helped to bring our segment operating earnings for the fiscal 
year in line with our expectations. We also realized higher margins, maintained our solid financial position, and returned over $90 
million  to  our  shareholders  in  dividends  and  share  repurchases  in  fiscal  year  2015. We  believe  that  our  performance  that  year 
demonstrated our ability to execute well on our objective of delivering a compliant product in an efficient manner to our customers, 
under challenging circumstances.

We achieved improved results in fiscal year 2016, after managing through a second year of oversupplied market conditions.  
As anticipated, we ended the year with strong fourth quarter volumes, primarily driven by later timing of customer shipping orders 
in Brazil and Asia, and the positive change in leaf supply arrangements in our North America segment that we announced last year.  
We also achieved modest growth in overall volumes for the full fiscal year and improved our margins, and our selling, general, and 
administrative costs were lower.  Our inventories continue to be well-managed, and uncommitted stocks have declined from last 
year’s level, in line with our target.  In addition, we returned more than $60 million in dividends to our shareholders during the fiscal 
year, closed the year with higher cash balances, which will support upcoming seasonal working capital requirements in fiscal year 
2017, and preserved our solid financial position.

As we move into fiscal year 2017, global production estimates have continued to decline.  Plantings have been reduced in 
some origins where farmers received lower green leaf prices in fiscal year 2016, and El Nino weather patterns have negatively 
impacted some crops, particularly in Brazil. Consequently, and due to aggressive green leaf market pricing, our crop purchase levels 
and sales volumes, as well as third-party processing volumes from that origin, will be lower in fiscal year 2017.  However, we expect 
that Brazilian crop levels and our volumes will recover next season.

While we believe that total production levels have largely moved into balance with anticipated demand, imbalances in 
certain leaf quality styles or types remain, and our customers' inventory composition and durations may also impact their near-term 
demand requirements.  We also believe that seasonality will continue to influence our quarterly results, with some carryover crop 
deliveries expected in the first fiscal quarter of 2017.  Although it is still early in the season, we currently anticipate that customer-
mandated shipment timing will continue to be weighted toward the second half of the year.

Although oversupplied markets during the past two fiscal years have been less than optimal, we are pleased with our solid 
performance demonstrated throughout this period, particularly during fiscal year 2016.  We remain excited about our prospects and 
look forward to continuing our leadership role in the industry, as we work for and with our customers to improve efficiencies in our 
markets and to provide a sustainable, compliant, and competitively priced product, allowing us to fulfill their needs and to continue 
to provide value to our shareholders.

19

RESULTS OF OPERATIONS

Amounts described as net income and earnings per diluted share in the following discussion are attributable to Universal 
Corporation and exclude earnings related to non-controlling interests in subsidiaries.  The total for segment operating income 
referred to in the discussion below is a non-GAAP financial measure.  This measure is not a financial measure calculated in accordance 
with GAAP and should not be considered as a substitute for net income, operating income, cash flows from operating activities or 
any other operating performance measure calculated in accordance with GAAP, and it may not be comparable to similarly titled 
measures reported by other companies.  We have provided a reconciliation of the total for segment operating income to consolidated 
operating income in Note 14. "Operating Segments" to the consolidated financial statements in Item 8.  We evaluate our segment 
performance excluding certain significant charges or credits.  We believe this measure, which excludes these items that we believe 
are not indicative of our core operating results, provides investors with important information that is useful in understanding our 
business results and trends.

Fiscal Year Ended March 31, 2016, Compared to the Fiscal Year Ended March 31, 2015

Net income for the fiscal year ended March 31, 2016, was $109.0 million, or $3.92 per diluted share, compared with last 
year’s net income of $114.6 million, or $4.06 per diluted share.  Those results included certain non-recurring items, detailed in Other 
Items below, which increased diluted earnings per share by $0.02 and $0.46 for the years ended March 31, 2016 and 2015, respectively.  
Excluding those items in both years, net income for the fiscal year increased $6.8 million ($0.30 per diluted share) compared to the 
same period last year. Segment operating income, which excludes those items, was $186.1 million for fiscal year 2016, an increase 
of $18.8 million, or 11%, from the prior year.  That improvement was primarily attributable to a reduction in selling, general, and 
administrative costs, as well as improved gross margins on this year’s modestly higher sales volumes.  Revenues of $2.1 billion for 
fiscal year 2016 declined 7% compared with the previous year, driven mainly by lower green leaf costs and lower processing revenues, 
partly mitigated by the increase in volumes.

Flue-cured and Burley Leaf Tobacco Operations

Other Regions

Operating income for the Other Regions segment for the fiscal year ended March 31, 2016, was $143.6 million, up 14% 
compared to $125.8 million in the previous fiscal year.  Better margins, fewer inventory write-downs, and lower selling, general, 
and administrative expenses drove the earnings improvement. These positive factors outweighed lower margins in Europe and the 
currency translation effects of a stronger U.S. dollar which negatively impacted results from that region.  Strong volumes in most 
regions were offset by declines in Africa on smaller crop sizes in some origins compared to the prior year.    Selling, general, and 
administrative  expenses  for  the  segment  were  down  significantly  for  the  fiscal  year,  largely  on  reductions  in  local  currency-
denominated expenses from devaluation of foreign currencies, mainly in South America and Africa, and lower incentive compensation 
costs. Revenues for the segment were down about 12% to $1.5 billion, driven mostly by lower average green leaf prices and the 
modestly reduced volumes.

North America

Operating income for the North America segment for the fiscal year ended March 31, 2016, of $31.1 million was flat 
compared with the previous year.  Earnings improvements from sales volume increases, due in part to old crop sales in the first fiscal 
quarter, and the previously announced change in business with Philip Morris International, Inc. in the United States from a toll 
processing model to sales of processed tobacco, were offset by lower margins and lower earnings from Guatemala and Mexico.  In 
addition, processing volumes declined significantly compared with the prior year as a result of that change in business, and a portion 
of crop volumes sold under this new arrangement will carry over as shipments in fiscal year 2017.   Fiscal year 2016 revenues for 
the segment increased by 19% to $361.8 million compared to the prior fiscal year, on higher sales volumes at lower green leaf prices, 
a less favorable product mix, and lower processing revenues.

Other Tobacco Operations

For the fiscal year ended March 31, 2016, the Other Tobacco Operations segment operating income increased by $1.0 million 
to $11.3 million compared with the same period last year. Earnings were up significantly for the dark tobacco operations on higher 
volumes, better margins, and lower selling, general, and administrative costs.  That improvement was partly offset by lower results 
from the oriental joint venture as benefits from improved margins and lower overhead costs were outweighed by higher currency 
remeasurement losses and tax accruals.   The special services group incurred losses for the year, mainly from startup and production 
testing costs for the new food ingredients business.  Revenues for the segment were down by $7.4 million to $219.6 million for the 
year ended March 31, 2016, as the higher volumes for the dark tobacco operations were more than offset by reduced volumes at 
lower prices from the timing of shipments of oriental tobaccos into the United States compared to the previous year.

20

Other Items

Cost of goods sold decreased by about 8% to $1.7 billion for the fiscal year ended March 31, 2016, primarily due to lower 
green leaf prices and the effects of local-currency devaluations on factory costs compared with the previous year.  Selling, general, 
and administrative costs decreased by $23.5 million for the fiscal year ended March 31, 2016, compared with the prior year.  The 
decline for the fiscal year was mainly driven by reductions in local currency-denominated expenses from devaluation of foreign 
currencies in South America and Africa, and lower incentive compensation costs, reduced in part by higher net currency and exchange 
losses in Asia as well as costs to settle challenges regarding property rights and valuation in South America. 

Interest expense of $15.7 million for the fiscal year ended March 31, 2016, declined by about 8% compared to the prior 
fiscal year.  The reduction was mostly due to lower average short-term borrowings for seasonal working capital, offset in part by 
higher effective interest rates on long-term bank loans from fixed interest rate swaps entered on those loans in the fourth quarter of 
fiscal 2015.  The consolidated effective tax rate for the fiscal year ended March 31, 2016, was approximately 32% compared to about 
24% for the prior year comparable period.   Income taxes for fiscal year 2015 were reduced by a non-recurring benefit of $8.0 million 
arising from the partial payment of the European Commission fine by our Italian subsidiary in June 2014.  In both years, the decrease 
from the 35% U.S. statutory rate was also influenced by lower net effective tax rates on income from certain foreign subsidiaries, 
as well as the effects of changes in local currency exchange rates on deferred income tax balances. 

Results for the year ended March 31, 2016, included restructuring and impairment costs of $2.4 million ($0.06 per diluted 
share) and a gain of $3.4 million ($0.08 per diluted share) on remeasuring the Company’s interest in a tobacco processing joint 
venture to fair value upon acquiring our partner’s 50% ownership in the third fiscal quarter.  Results for the year ended March 31, 
2015, included an income tax benefit of $8.0 million ($0.28 per diluted share) arising from a subsidiary’s payment of a portion of a 
fine, restructuring costs of $4.9 million ($0.11 per diluted share), and a gain of $12.7 million ($0.29 per diluted share), from updated 
projections related to the favorable outcome in fiscal year 2014 of litigation in Brazil regarding previous years’ excise tax credits.  

Fiscal Year Ended March 31, 2015, Compared to the Fiscal Year Ended March 31, 2014

Net income for the fiscal year ended March 31, 2015, was $114.6 million, or $4.06 per diluted share, compared with fiscal 
year 2014’s net income of $149.0 million, or $5.25 per diluted share.  Fiscal year 2014’s results included a gain of $81.6 million 
before tax ($53.1 million after tax, or $1.87 per diluted share), from the favorable outcome of litigation in Brazil related to previous 
years’ excise tax credits. Results for fiscal year 2015 included a further gain related to those tax credits, of $12.7 million before tax 
($0.29 per diluted share) recorded in the fourth fiscal quarter from updated projections of the utilization of the credits before expiration.  
Fiscal year 2015 results also included an income tax benefit of $8.0 million ($0.28 per diluted share) arising from a subsidiary’s 
payment of a portion of a fine following the resolution of a court case. Pretax restructuring costs of $4.9 million ($0.11 per diluted 
share) and $6.7 million ($0.15 per diluted share) were also incurred for fiscal years 2015 and 2014, respectively.  Excluding those 
items in both years, net income for fiscal year 2015 increased $1.2 million ($0.07 per diluted share) compared to the same period of 
fiscal year 2014. Segment operating income, which excludes those items, was $167.2 million for fiscal year 2015, a decrease of $8.0 
million from fiscal year 2014.  That reduction was primarily attributable to fiscal year 2015’s lower sales volumes, partially mitigated 
by a reduction in selling, general, and administrative costs.  Revenues of $2.3 billion for fiscal year 2015 declined 11% compared 
with the fiscal year 2014, driven mainly by those lower overall volumes and modestly lower green leaf costs.

Flue-cured and Burley Leaf Tobacco Operations

Other Regions

Operating income for the Other Regions segment for the fiscal year ended March 31, 2015, was $125.8 million, down 6% 
compared to $133.4 million in the fiscal year ended March 31, 2014.  The decrease was attributable mainly to reduced sales volumes 
in all regions along with inventory writedowns, primarily in Africa and South America, reflecting fiscal year 2015’s oversupply 
market conditions. The impact of those factors was somewhat mitigated by improved gross margins, particularly in Brazil, where 
volatile markets increased green leaf costs in fiscal year 2014, as well as benefits from lower selling, general and administrative 
costs.  Results for Europe were also negatively influenced by currency translation effects from a stronger U.S. dollar.  Selling, general, 
and administrative expenses for the segment declined for fiscal year 2015, mostly from lower currency remeasurement and exchange 
losses in the Philippines and Brazil, lower provisions for supplier advances, and positive comparisons of value-added tax valuation 
allowances, partly offset by higher customer claims.  Revenues for the segment were down about 10% to $1.7 billion, on reduced 
volumes and lower average green leaf prices.

North America

Operating income for the North America segment for the fiscal year ended March 31, 2015 was $31.1 million, up $7.8 
million compared with the fiscal year ended March 31, 2014, on increased third party processing business and a more favorable sales 
mix, despite lower overall sales volumes.  Revenues for the segment for fiscal year 2015 decreased by 13% to $305.0 million on 
reduced sales volumes and lower green leaf prices.  Selling, general, and administrative costs for this segment were relatively flat 
for fiscal year 2015.

21

Other Tobacco Operations

For the fiscal year ended March 31, 2015, the Other Tobacco Operations segment operating income was down $8.2 million 
to $10.3 million compared with the same period of fiscal year 2014. Results for the dark tobacco operations contributed significantly 
to the decline, as lower sales volumes, in part due to shipment timing, were partially mitigated by favorable currency remeasurement 
comparisons, mainly in Indonesia.  Results for the special services group also contributed to the decline, reflecting startup costs for 
the new food ingredients business.  However, results from the oriental joint venture improved for fiscal year 2015 despite sales 
volume declines influenced by shipment timing comparisons.  The impact from the volume declines was more than offset by favorable 
variances from fiscal year 2014’s currency remeasurement losses and lower selling, general and administrative costs.  Revenues for 
the segment were down by $34.3 million to $227.0 million for the year ended March 31, 2015, compared to the year ended March 
31, 2014, primarily attributable to the lower volumes for the dark tobacco operations, as well as lower overall volumes and the timing 
of shipments of oriental tobaccos into the United States.

Other Items

Cost of goods sold decreased by about 12% to $1.9 billion for the fiscal year ended March 31, 2015, consistent with lower 
overall sales volumes and lower green leaf prices compared with fiscal year 2014. Selling, general, and administrative costs decreased 
by $11.8 million for fiscal year 2015, compared with fiscal year 2014.  The decline for fiscal year 2015 was primarily related to 
lower currency remeasurement and exchange costs, provisions for suppliers, and value-added tax allowances, partly offset by higher 
customer claims. 

Interest expense of $17.1 million for fiscal year 2015 declined by about 16%, compared to fiscal year 2014.  The reduction 
was  mostly  due  to  lower  average  interest  rates  during  the  period,  offset  in  part  by  slightly  higher  average  debt  balances.   The 
consolidated effective income tax rates on pretax earnings were approximately 24% and 33% for the fiscal years ended March 31, 
2015 and 2014, respectively.  Income taxes for fiscal year 2015 were reduced by a non-recurring benefit of $8.0 million arising from 
the partial payment of the European Commission fine by our Italian subsidiary in June 2014.  Excluding that item, the consolidated 
effective tax rate for fiscal 2015 was about 29%. The rates for both years, excluding adjustments, were below the 35% federal statutory 
rate mainly because of the effect of changes in exchange rates on deferred income tax assets and liabilities, as well as lower effective 
rates on dividend income from certain foreign subsidiaries.

On December 30, 2014, the Company executed a new senior unsecured credit facility agreement with a group of banks, 
which consolidated and extended maturities of its previous short-term revolving credit and long-term borrowing facilities.  The new 
agreement includes a $430 million five-year revolving credit facility, a $150 million five-year term loan, and a $220 million seven-
year term loan.  The revolving credit facility contains terms and conditions that are substantially similar to the Company’s previous 
revolving credit facility.  The term loans, which were fully funded at closing, require no amortization and are prepayable without 
penalty prior to maturity.  The facilities include a customary accordion feature allowing for additional borrowings of up to $100 
million under certain conditions.  Currently, borrowings under the revolving credit agreement bear interest at variable rates based 
on LIBOR plus a margin of 1.50% to 1.75%.  The Company subsequently entered interest rate swap agreements to fix the variable 
interest component of the five- and seven-year term loans to 1.44% and 1.73%, respectively.  The effective rates on the five- and 
seven-year term loans were 2.94% and 3.48%, respectively, as of May 18, 2015.

Accounting Pronouncements

See "Accounting Pronouncements" in Note 1 to the consolidated financial statements in Item 8 of this Annual Report for a 
discussion of recent accounting pronouncements issued by the Financial Accounting Standards Board ("FASB") that will become 
effective and be adopted by the Company in future reporting periods.

22

 
Overview 

LIQUIDITY AND CAPITAL RESOURCES

Our working capital requirements in fiscal year 2016 were higher than those in fiscal year 2015 in part due to increased 
working capital needs in our North America segment.  Similar to last year, our shipments were heavily weighted to the second half 
of the fiscal year, with even more shipments in the fourth quarter this fiscal year, which also extended the duration of our working 
capital needs in some origins.  In fiscal year 2016, we generated $183.6 million in net cash flows to fund our operating activities, 
and our liquidity was sufficient to meet our needs.  We also continued our conservative financial policies, maintained our discipline 
on using our free cash flow, and returned funds to shareholders.

Our liquidity and capital resource requirements are predominately short-term in nature and primarily relate to working 
capital required for tobacco crop purchases.  Working capital needs are seasonal within each geographic region. The geographic 
dispersion and the timing of working capital needs permit us to predict our general level of cash requirements, although crop sizes, 
prices paid to farmers, shipment and delivery timing, and currency fluctuations affect requirements each year.  Peak working capital 
requirements are generally reached during the first and second fiscal quarters.  Each geographic area follows a cycle of buying, 
processing, and shipping tobacco, and in many regions we also provide agricultural materials to farmers during the growing season.  
The timing of the elements of each cycle is influenced by such factors as local weather conditions and individual customer shipping 
requirements, which may change the level or the duration of crop financing.  Despite a predominance of short-term needs, we maintain 
a portion of our total debt as long-term to reduce liquidity risk.  We also periodically have large cash balances that we utilize to meet 
our working capital requirements.

We believe that our financial resources are adequate to support our capital needs for at least the next twelve months.  Our 
seasonal borrowing requirements primarily relate to purchasing crops in South America and Africa and can increase from March to 
September by more than $300 million.  The funding required can vary significantly depending upon such factors as crop sizes, the 
price of leaf, the relative strength of the U.S. dollar, and the timing of shipments and customer payments.  We deal with this uncertainty 
by maintaining substantial credit lines and cash balances.  In addition to our operating requirements for working capital, we expect 
to spend around $45 to $50 million during fiscal year 2017 for capital expenditures to maintain our facilities and invest in opportunities 
to grow and improve our businesses.  We also expect to provide about $7 million in funding to our pension plans.  We have no long-
term debt maturing before fiscal year 2020.  After balancing our capital structure, any excess cash flow from operations after dividends 
and capital expenditures will be available to fund expansion, purchase our stock, or otherwise enhance shareholder value.

Cash Flow

Our operations generated about $183.6 million in operating cash flows in fiscal year 2016.   That amount was about $42.9 
million lower than the $226.5 million we generated during the same period last fiscal year, in part due to carryover shipments delayed 
into fiscal year 2017 and our change in business with Philip Morris International, Inc. in the United States from a toll processing 
model to sales of processed tobacco that we purchase.  This change in business impacts the timing of earnings recognition, as sales 
under the new model are recorded when the product ships.  During the fiscal year ended March 31, 2016, we increased our cash 
balances by $70.7 million, spent $47.2 million on capital projects, and returned $62.1 million to shareholders in the form of dividends.  
At March 31, 2016, cash balances totaled $319.4 million.

Working Capital

Working capital at March 31, 2016, was about $1.4 billion, up $62.5 million from last year's level of about $1.3 billion, 
largely due to our change in business with a customer in the United States that increased the amount of tobacco that we purchase 
there.  The $70.7 million increase in cash and cash equivalents was partially offset by fewer advances to suppliers, down $13.0 
million, on our previously announced scaling down of our operations in Zambia and smaller anticipated 2016 crops. We have no 
principal payments due on our long-term debt over the next twelve months.

Tobacco inventories of $637.1 million at March 31, 2016, were flat compared to inventory levels at the end of the prior 
fiscal year.  We usually finance inventory with a mix of cash, notes payable, and customer deposits, depending on our borrowing 
capabilities, interest rates, and exchange rates, as well as those of our customers.  We generally do not purchase material quantities 
of tobacco on a speculative basis. However, when we contract directly with farmers, we are often obligated to buy all stalk positions, 
which may contain less marketable leaf styles.  Our uncommitted tobacco inventories decreased by approximately $30.3 million to 
$120.8 million, or about 19% of tobacco inventory, at March 31, 2016.  Uncommitted inventories at March 31, 2015, were $151.1 
million, which represented 24% of tobacco inventory.  The level of these uncommitted inventories is influenced by timing of farmer 
deliveries of new crops, as well as the timing of customer deliveries.

Share Repurchase Activity

Our Board of Directors approved our current share repurchase program in November 2015.  The program expires in November 
2017, authorizes the purchase of up to $100 million of our common and preferred stock, and replaced a $100 million program that 
had been approved in November 2013.  Under the current authorization, we may purchase shares from time to time on the open 
market or in privately negotiated transactions at prices not exceeding prevailing market rates. In determining our level of common 

23

and preferred share repurchase activity, our intent is to use only cash available after meeting our anticipated capital investment, 
dividend, and working capital requirements.  Repurchases of shares under the repurchase program may vary based on management 
discretion, as well as changes in cash flow generation and availability.  During fiscal year 2016, we did not purchase any shares of 
our common or preferred stock.  At March 31, 2016, our available authorization under our current share repurchase program was 
$100 million, and approximately 22.7 million common shares and 218,490 preferred shares were outstanding.

Capital Spending

Our capital expenditures are generally limited to those that add value, replace or maintain equipment, increase efficiency, 
or position us for future growth.  In deciding where to invest capital resources, we look for opportunities where we believe we can 
earn an adequate return, leverage our assets and expertise, and enhance our farmer base.  During fiscal years 2016 and 2015, we 
invested  $47.2  million  and  $58.4  million,  respectively,  in  our  property,  plant,  and  equipment,  inclusive  of  expenditures  for  the 
construction of our new manufacturing facility for our food ingredients business.  Depreciation expense was approximately $36.8 
million and $35.4 million, respectively, in fiscal years 2016 and 2015.  Generally, our routine capital spending is at a level below 
depreciation expense in order to maintain strong cash flow.  However, from time to time, we undertake projects that increase spending 
beyond those limits when we identify opportunities to improve efficiencies, add value for our customers, and position ourselves for 
future growth.  We currently plan to spend approximately $45 to $50 million in fiscal year 2017 on capital projects for maintenance 
of our facilities and other investments to grow and improve our businesses.

Outstanding Debt and Other Financing Arrangements

We consider the sum of notes payable and overdrafts, long-term debt (including any current portion), and customer advances 
and deposits, less cash, cash equivalents, and short-term investments on our balance sheet to be our net debt.  We also consider our 
net debt plus shareholders' equity to be our net capitalization.  Net debt decreased by $78.1 million to $133.2 million during the fiscal 
year ended March 31, 2016.  The decrease primarily reflects higher cash balances and slightly lower debt levels.  Net debt as a 
percentage of net capitalization was approximately 9% at March 31, 2016, down from 13% at March 31, 2015, and it remains lower 
than our target limit for peak borrowings of 30% to 40% of net capitalization.

As of March 31, 2016, we had $430 million available under a committed revolving credit facility that will mature in December 
2019, and we, together with our consolidated affiliates, had approximately $372 million in uncommitted lines of credit, of which 
approximately $306 million were unused and available to support seasonal working capital needs.  The financial covenants under 
our committed revolving credit facility require us to maintain certain levels of tangible net worth and observe restrictions on debt 
levels.  As of  March 31, 2016, we were in compliance with all covenants of our debt agreements. We also have an active, undenominated 
universal shelf registration filed with the SEC in November 2014 that provides for future issuance of additional debt or equity 
securities.  We have no long-term debt maturing in fiscal year 2017.

Derivatives

From time to time, we use interest rate swap agreements to manage our exposure to changes in interest rates.  Currently, 
we have interest rate swap agreements that convert the variable benchmark LIBOR rate on our two outstanding term loans to fixed 
rates.  With the swap agreements in place, the effective interest rates on our $150 million five-year term loan and $220 million seven-
year term loan were 2.94% and 3.48%, respectively, as of March 31, 2016.  These agreements were entered into to eliminate the 
variability of cash flows in the interest payments on our variable rate five- and seven-year term loans and are accounted for as cash 
flow hedges.  Under the swap agreements, we receive variable rate interest and pay fixed rate interest.  At March 31, 2016, the fair 
value of our open interest rate hedge swaps was a net liability of approximately $11 million.

We also enter forward contracts from time to time to hedge certain foreign currency exposures, primarily related to forecast 
purchases of tobacco and related processing costs in Brazil, as well as our net monetary asset exposure in local currency there.  We 
generally account for our hedges of forecast tobacco purchases as cash flow hedges.  At March 31, 2016, the fair value of those open 
contracts was a net asset of approximately $0.5 million.   We also had other forward contracts outstanding that were not designated 
as hedges, and the fair value of those contracts was a net asset of approximately $0.3 million at March 31, 2016.  For additional 
information, see Note 8 to the consolidated financial statements in Item 8.

Pension Funding

Funds supporting our ERISA-regulated U.S. defined benefit pension plan decreased by $7 million during fiscal year 2016 
to $197 million, as benefit payments exceeded contributions and asset returns.  Following changes to the plan benefit formula during 
fiscal year 2014, the accumulated benefit obligation (“ABO”) and the projected benefit obligation (“PBO”) were both approximately 
$222 million as of March 31, 2016. The ABO and PBO are calculated on the basis of certain assumptions that are outlined in Note 
10 to the consolidated financial statements in Item 8. We expect to make contributions of about $7 million to our pension plans, 
including $5 million to our ERISA-regulated plan, during the next year.  It is our policy to regularly monitor the performance of the 
funds and to review the adequacy of our funding and plan contributions.

24

Contractual Obligations

Our contractual obligations as of March 31, 2016, were as follows:

(in thousands of dollars)

Total

2017

2018-2019

2020-2021

After 2021

Notes payable and long-term debt 

(1) ........................................................................

$

497,717

$

79,263

$

24,113

$

168,604

$

225,737

Operating lease obligations ........................................................................................

47,697

10,324

13,152

9,173

15,048

Inventory purchase obligations:

Tobacco ....................................................................................................................

675,765

565,692

110,073

Agricultural materials...............................................................................................

Other purchase obligations.........................................................................................

43,739

9,142

43,739

9,142

—

—

—

—

—

—

—

—

Total..........................................................................................................................

$ 1,274,060

$

708,160

$

147,338

$

177,777

$

240,785

(1) 

Includes interest payments.  Interest payments on $436.2 million of variable rate debt were estimated based on rates as of March 31, 2016.  The Company has 
entered interest rate swaps that effectively convert the interest payments on the $370.0 million outstanding balance of its two bank term loans from variable to 
fixed.  The fixed rate has been used to determine the contractual interest payments for all periods.

In addition to principal and interest payments on notes payable and long-term debt, our contractual obligations include 
operating lease payments, inventory purchase commitments, and capital expenditure commitments.  Operating lease obligations 
represent minimum payments due under leases for various production, storage, distribution, and other facilities, as well as vehicles 
and equipment.  Tobacco inventory purchase obligations primarily represent contracts to purchase tobacco from farmers.  The amounts 
shown above are estimates since actual quantities purchased will depend on crop yield, and prices will depend on the quality of the 
tobacco delivered.  About 33% of our crop year contracts to purchase tobacco are with farmers in Brazil.  We have partially funded 
our tobacco purchases in Brazil and in other regions with advances to farmers and other suppliers, which totaled approximately $102 
million, net of allowances, at March 31, 2016.  In addition, we have guaranteed bank loans to farmers in Brazil that relate to a portion 
of our tobacco purchase obligations there.  At March 31, 2016, we were contingently liable under those guarantees for outstanding 
balances of approximately $13 million (including accrued interest), and we had recorded a liability of approximately $2 million for 
the fair value of those guarantees.  As tobacco is purchased and the related bank loans are repaid, our contingent liability is reduced.  

25

CRITICAL  ACCOUNTING ESTIMATES AND ASSUMPTIONS

In preparing the financial statements in accordance with GAAP, we are required to make estimates and assumptions that 
have an impact on the assets, liabilities, revenue, and expense amounts reported.  These estimates can also affect our supplemental 
information disclosures, including information about contingencies, risks, and financial condition.  We believe, given current facts 
and circumstances, that our estimates and assumptions are reasonable, adhere to GAAP, and are consistently applied.  However, 
changes in the assumptions used could result in a material adjustment to the financial statements.  Our critical accounting estimates 
and assumptions are in the following areas: 

Inventories   

Inventories of tobacco are valued at the lower of cost or market with cost determined under the specific cost method.  Raw 
materials are clearly identified at the time of purchase.  We track the costs associated with raw materials in the final product lots, 
and maintain this identification through the time of sale.  We also capitalize direct and indirect costs related to processing raw 
materials.  This method of cost accounting is referred to as the specific cost or specific identification method.  We write down 
inventory for changes in market value based upon assumptions related to future demand and market conditions if the indicated market 
value is below cost. Future demand assumptions can be impacted by changes in customer sales, changes in customers’ inventory 
positions and policies, competitors’ pricing policies and inventory positions, and varying crop sizes and qualities.  Market conditions 
that differ significantly from those assumed by management could result in additional write-downs.  We experience inventory write-
downs routinely.  Inventory write-downs in fiscal years 2016, 2015, and 2014 were $11.9 million, $18.6 million, and $7.6 million, 
respectively.  The Company incurred higher levels of inventory write-downs for fiscal years 2014 through 2016 primarily due to the 
effects of oversupply conditions in the global leaf tobacco markets.

Advances to Suppliers and Guarantees of Bank Loans to Suppliers

In many sourcing origins, we provide tobacco growers with agronomy services and seasonal crop advances of, or for, seed, 
fertilizer, and other supplies.  These advances are short term in nature and are customarily repaid upon delivery of tobacco to us.  In 
several origins, we have also made long-term advances to tobacco farmers to finance curing barns and other farm infrastructure.  In 
Brazil, we also guarantee bank loans made to farmers for seasonal crop financing.  In some years, due to low crop yields and other 
factors, individual farmers may not deliver sufficient volumes of tobacco to repay maturing advances.  In those cases, we may extend 
repayment of the advances into the following crop year or satisfy the guarantee by acquiring the loan from the bank.  In either 
situation, we will incur losses whenever we are unable to recover the full amount of the loans and advances.  At each reporting period, 
we must make estimates and assumptions in determining the valuation allowance for advances to farmers and the liability to accrue 
for our obligations under bank loan guarantees.  At March 31, 2016, the gross balance of advances to suppliers totaled approximately 
$134 million, and the related valuation allowance totaled approximately $29 million.  The fair value of the loan guarantees for farmers 
in Brazil was a liability of approximately $2 million at March 31, 2016.

Recoverable Value-Added Tax Credits

In  many  foreign  countries,  we  pay  significant  amounts  of  value-added  tax  (“VAT”)  on  purchases  of  unprocessed  and 
processed tobacco, crop inputs, packing materials, and various other goods and services.  In some countries, VAT is a national tax, 
and in other countries it is assessed at the state level.  Items subject to VAT vary from jurisdiction to jurisdiction, as do the rates at 
which the tax is assessed.  When we sell tobacco to customers in the country of origin, we generally collect VAT on those sales.  We 
are normally permitted to offset our VAT payments against those collections and remit only the incremental VAT collections to the 
tax authorities.  When tobacco is sold for export, VAT is normally not assessed.  In countries where our tobacco sales are predominately 
for export markets, we often do not generate enough VAT collections on downstream sales to fully offset our VAT payments.  In 
those situations, we can accumulate unused VAT credits.  Some jurisdictions have procedures that allow companies to apply for 
refunds of unused VAT credits from the tax authorities, but the refund process often takes an extended period of time and it is not 
uncommon for refund applications to be challenged or rejected in part on technical grounds.  Other jurisdictions may permit companies 
to sell or transfer unused VAT credits to third parties in private transactions, although approval for such transactions must normally 
be obtained from the tax authorities, limits on the amounts that can be transferred may be imposed, and the proceeds realized may 
be heavily discounted from the face value of the credits.  Due to these factors, in some countries we can accumulate significant 
balances of VAT credits over time.  We review these balances on a regular basis, and we record valuation allowances on the credits 
to reflect amounts that we do not expect to recover, as well as discounts anticipated on credits we expect to sell or transfer.  In 
determining the appropriate valuation allowance to record in a given jurisdiction, we must make various estimates and assumptions 
about factors affecting the ultimate recovery of the VAT credits.  At March 31, 2016, the gross balance of recoverable tax credits 
(primarily VAT) totaled approximately $52 million, and the related valuation allowance totaled approximately $19 million.

26

Goodwill

We review the carrying value of goodwill for potential impairment on an annual basis and at any time that events or business 
conditions indicate that it may be impaired.  As permitted under Accounting Standards Codification Topic 350 (“ASC 350”), at March 
31, 2016 and 2015, we elected to base our initial assessment of potential impairment on qualitative factors.  Those factors did not 
indicate any impairment of our recorded goodwill.  Prior to fiscal year 2015, we followed the quantitative approach in ASC 350 in 
assessing the fair value of our goodwill, which involved the use of discounted cash flow models (Level 3 of the fair value hierarchy 
under GAAP).  Under our current qualitative assessment, we would also use those discounted cash flow models to measure any 
expected impairment indicated by the assessment. The calculations in these models are not based on observable market data from 
independent sources and therefore require significant management judgment with respect to operating earnings growth rates and the 
selection of an appropriate discount rate.  Significant adverse changes in our operations or our estimates of future cash flows for a 
reporting unit with recorded goodwill, such as those caused by unforeseen events or changes in market conditions, could result in 
an impairment charge.  Over 90% of our goodwill balance relates to our reporting unit in Brazil. 

Fair Value Measurements

We hold various financial assets and financial liabilities that are required to be measured and reported at fair value in our 
financial statements, including money market funds, trading securities associated with deferred compensation plans, interest rate 
swaps, forward foreign currency exchange contracts, and guarantees of bank loans to tobacco growers.  We follow the relevant 
accounting guidance in determining the fair values of these financial assets and liabilities.  Quoted market prices (Level 1 of the fair 
value hierarchy) are used in most cases to determine the fair values of trading securities.  Money market funds are valued based on 
net asset value (“NAV”), which is computed based on amortized cost (Level 2 of the fair value hierarchy). Interest rate swaps, and 
forward foreign currency exchange contracts are valued based on dealer quotes using discounted cash flow models matched to the 
contractual terms of each instrument (Level 2 of the fair value hierarchy).  The fair value of the guarantees of bank loans to tobacco 
growers, which was approximately $2 million at March 31, 2016, is derived using an internally-developed discounted cash flow 
model.  The model requires various inputs, including historical loss percentages for comparable loans and a risk-adjusted interest 
rate.  Because significant management judgment is required in determining and applying these inputs to the valuation model, our 
process for determining the fair value of these guarantees is classified as Level 3 of the fair value hierarchy.  At March 31, 2016, a 
1% increase in the expected loss percentage for all guaranteed farmer loans would not have had a material effect on the fair value 
of the guarantee obligation.  In addition, a 1% change in the risk-adjusted interest rate would not have had a material effect on the 
fair value of the guarantee obligation.  We incorporate credit risk in determining the fair values of our financial assets and financial 
liabilities, but that risk did not materially affect the fair values of any of those assets or liabilities at March 31, 2016.

Income Taxes  

Our consolidated effective income tax rate is based on our expected taxable income, tax laws and statutory tax rates, and 
tax planning opportunities in the various jurisdictions in which we operate.  Significant judgment is required in determining the 
effective tax rate and evaluating our tax position.  We are subject to the tax laws of many jurisdictions, and could be subject to a tax 
audit in each of these jurisdictions, which could result in adjustments to tax expense in future periods.  In the event that there is a 
significant, unusual, or one-time item recognized in our results, the tax attributed to that discrete item would be recorded at the same 
time as the item. 

We have no undistributed earnings of consolidated foreign subsidiaries that are classified as permanently or indefinitely 
reinvested.  We assume that all undistributed earnings of our foreign subsidiaries will be repatriated back to their parent entities in 
the United States where the funds are best placed to meet our cash flow requirements.  In addition, we strive to mitigate economic, 
political, and currency risk by following a disciplined annual approach to the distribution of excess capital back to the U.S.  Based 
on these assumptions, in our income tax expense for each reporting period we fully provide for all additional U.S. income taxes that 
are expected to be due on these distributions.

Our accounting for uncertain tax positions requires that we review all significant tax positions taken, or expected to be 
taken, in income tax returns for all jurisdictions in which we operate.  In this review, we must assume that all tax positions will 
ultimately  be  audited,  and  either  accepted  or  rejected  based  on  the  applicable  tax  regulations  by  the  tax  authorities  for  those 
jurisdictions.  We must recognize in our financial statements only the tax benefits associated with tax positions that are “more likely 
than  not”  to  be  accepted  upon  audit,  at  the  greatest  amount  that  is  considered  “more  likely  than  not”  to  be  accepted.    These 
determinations require significant management judgment, and changes in any given quarterly or annual reporting period could affect 
our consolidated income tax rate.  

Tax regulations require items to be included in taxable income in the tax return at different times, and in some cases in 
different amounts, than the items are reflected in the financial statements.  As a result, our effective tax rate reflected in the financial 
statements is different than that reported in our tax returns. Some of these differences are permanent, such as expenses that are not 
tax deductible, while others are related to timing issues, such as differences in depreciation methods. Timing differences create 
deferred tax assets and liabilities.  Deferred tax liabilities generally represent tax expense recognized in our financial statements for 
which payment has been deferred or income taxes related to expenses that have not yet been recognized in the financial statements, 
but have been deducted in our tax return.  Deferred tax assets generally represent items that can be used as a tax deduction or credit 

27

in future tax returns for which we have already recorded the tax benefit in our financial statements. We record valuation allowances 
for deferred tax assets when the amount of estimated future taxable income is not likely to support the use of the deduction or credit.  
Determining the amount of such valuation allowances requires significant management judgment, including estimates of future 
taxable income in multiple tax jurisdictions where we operate.   Based on our periodic earnings forecasts, we project the upcoming 
year’s taxable income to help us evaluate our ability to realize deferred tax assets.    

The functional currency in most of our significant foreign operations is the U.S. dollar, as export tobacco sales are generally 
made in dollars.  Purchasing and processing costs are usually incurred in local currency.  When the U.S. dollar is weakening relative 
to the local currency, purchasing and processing costs increase in dollar terms, resulting in higher cost inventory.  The sale of that 
inventory in dollars generates less taxable income in local currency, which results in lower income taxes owed when translated into 
U.S. dollars.  This causes the effective income tax rate on dollar income to be lower than the statutory rate in the local country.  The 
reverse can occur when the local currency is weakening relative to the U.S. dollar, thereby causing the effective income tax rate on 
dollar earnings to be above the statutory rate.  This impact on our effective income tax rate in a country can be significant during a 
normal crop cycle.  A prolonged period of strengthening or weakening over more than one crop may increase the impact if we sell 
material quantities of old crop inventories.  Lower-taxed foreign source income increases our ability to use foreign tax credits.  Higher-
taxed foreign source income has the reverse effect.  When these changes occur in our larger operations, such as our operations in 
Brazil, they can have a material impact on our overall tax position.  

For additional disclosures on income taxes, see Notes 1 and 4 to the consolidated financial statements in Item 8.

Pension and Other Postretirement Benefit Plans 

The measurement of our pension and other postretirement benefit obligations and costs at the end of each fiscal year requires 
that we make various assumptions that are used by our actuaries in estimating the present value of projected future benefit payments 
to all plan participants.  Those assumptions take into consideration the likelihood of potential future events such as salary increases 
and demographic experience.  The assumptions we use may have an effect on the amount and timing of future contributions to our 
plans. The plan trustee conducts an independent valuation of the fair value of pension plan assets.  The significant assumptions used 
in the calculation of our pension and other postretirement benefit obligations are: 

•  Discount rate – The discount rate is based on investment yields on a hypothetical portfolio of actual long-term corporate 

bonds rated AA that align with the cash flows for our benefit obligations.

• 

Salary scale – The salary scale assumption is based on our long-term actual experience for salary increases, the near-
term outlook, and expected inflation. 

•  Expected long-term return on plan assets – The expected long-term return on plan assets reflects asset allocations and 

investment strategy adopted by the Pension Investment Committee of the Board of Directors. 

•  Retirement and mortality rates – Retirement rates are based on actual plan experience along with our near-term outlook. 
Early retirement assumptions are based on our actual experience.  Mortality rates are based on standard industry group 
annuity mortality tables which are updated to reflect projected improvements in life expectancy. 

•  Healthcare cost trend rates – For postretirement medical plan obligations and costs, we make assumptions on future 
inflationary increases in medical costs. These assumptions are based on our actual experience, along with third-party 
forecasts of long-term medical cost trends. 

From one fiscal year to the next, the rates we use for each of the above assumptions may change based on market developments 
and other factors.  The discount rate reflects prevailing market interest rates at the end of the fiscal year when the benefit obligations 
are actuarially measured and will increase or decrease based on market patterns.  The expected long-term return on plan assets may 
change based on changes in investment strategy for plan assets or changes in indicated longer-term yields on specific classes of plan 
assets.  Based on the high percentage of retired and inactive participants in our ERISA-regulated domestic defined benefit pension 
plan (approximately 75% of total participants), as well as the high funded status of the plan, the Pension Investment Committee 
adopted changes to the underlying plan assets during fiscal year 2015 to move toward a liability-driven investment strategy.  We 
reduced our expected long-term return on assets assumption by 50 basis points at March 31, 2015 and by an additional 25 basis 
points at March 31, 2016 primarily to reflect those changes.  We also adopted revised mortality tables in fiscal year 2015 based on 
updated actuarial studies reflecting improvements in life expectancy.  In addition to the changes in actuarial assumptions from year 
to year, actual plan experience affecting our net benefit obligations, such as actual returns on plan assets and actual mortality experience, 
will differ from the assumptions used to measure the obligations.  The effects of these changes and differences increase or decrease 
the  obligation  we  record  for  our  pension  and  other  postretirement  benefit  plans,  and  they  also  create  gains  and  losses  that  are 
accumulated and amortized over future periods, thus affecting the expense we recognize for these plans over those periods.   Changes 
in the discount rate from year to year generally have the largest impact on our projected benefit obligation and annual expense, and 
the effects may be significant, particularly over successive years where the discount rate moves in the same direction.

28

 
As of March 31, 2016, the effect of the indicated increase or decrease in the selected pension and other postretirement 

benefit valuation assumptions is shown below. The effect assumes no change in benefit levels.

(in thousands of dollars)

Changes in Assumptions for Pension Benefits

Discount Rate:

Effect on
2016 
Projected
Benefit 
Obligation
Increase
(Decrease) 

Effect on
2017 Annual 
Expense
Increase
(Decrease) 

1% increase ...............................................................................................................................................................................

$

(27,776) $

1% decrease ..............................................................................................................................................................................

33,720

Expected Long-Term Return on Plan Assets:

1% increase ...............................................................................................................................................................................

1% decrease ..............................................................................................................................................................................

Changes in Assumptions for Other Postretirement Benefits

Discount Rate:

1% increase ...............................................................................................................................................................................

1% decrease ..............................................................................................................................................................................

Healthcare Cost Trend Rate:

1% increase ...............................................................................................................................................................................

1% decrease ..............................................................................................................................................................................

—

—

(3,244)

3,847

981

(920)

(2,466)

2,862

(2,160)

2,161

(374)

264

43

(41)

A 1% increase or decrease in the salary scale assumption would not have a material effect on the projected benefit obligation 
or on annual expense for the Company's pension benefits.  See Note 10 to the consolidated financial statements in Item 8 for additional 
information on pension and other postretirement benefit plans.

Other Estimates and Assumptions 

Other management estimates and assumptions are routinely required in preparing our financial statements, including the 
determination of valuation allowances on accounts receivable and the fair value of long-lived assets.  Changes in market and economic 
conditions, local tax laws, and other related factors are considered each reporting period, and adjustments to the accounts are made 
based on management’s best judgment.

29

OTHER INFORMATION REGARDING TRENDS
AND MANAGEMENT’S ACTIONS

Our financial performance depends on our ability to obtain an appropriate price for our products and services, to secure 
the tobacco volumes and quality desired by our customers, and to maintain efficient, competitive operations.  We continually monitor 
issues and opportunities that may impact the supply of and demand for leaf tobacco, the volumes of leaf tobacco that we handle, 
and the services we provide.

Supply

Crops sold in fiscal year 2016 were smaller than in the prior fiscal year in many of our key sourcing areas for flue-cured 
and burley tobacco.  Flue-cured production outside of China was down approximately 10%, and burley production was down 
approximately 13%.  The smaller crops followed oversupplied tobacco markets in fiscal year 2015.  Crop sizes for flue-cured, burley 
and oriental tobaccos available for export are expected to decrease further in fiscal year 2017 due to the effect of El Nino weather 
patterns on certain crops, as well as reduced plantings in some origins.  While we believe that total production levels are moving 
into balance with anticipated demand, imbalances in certain leaf styles or types may remain through fiscal year 2017, particularly 
in Brazil, as current crop production declines have been exacerbated by weather conditions there.

Production

Worldwide flue-cured tobacco production outside of China decreased by about 10% in fiscal year 2016 to 2.0 billion kilos.  
China is an extremely large market that is predominately domestic.  Because very little of that tobacco is available outside of that 
country to trade, we generally exclude Chinese crops when we consider worldwide production.  However, the level of domestic 
stocks in China is still quite significant and may continue to influence the global supply/demand balance due to efforts to reduce 
production and imports there.  Burley crops decreased by about 13% in fiscal year 2016.  We estimate that at March 31, 2016, 
industry uncommitted flue-cured and burley inventories totaled about 115 million kilos, a decrease of about 12% from March 31, 
2015 levels.

In the near term, production decreases are expected in nearly all major origins, including more significant weather-related 
reductions in Brazil that should recover in subsequent seasons. We expect that flue-cured production (excluding China) will decrease 
by about 12%, to about 1.8 billion kilos, in fiscal year 2017.  Burley production is forecast to decrease by about 5%.  We also forecast 
that oriental tobacco and dark air-cured production will decline by 9% and 2%, respectively, in fiscal year 2017. Over the long term, 
we believe that global tobacco production will remain relatively stable to meet slightly declining total demand. South America, 
Asia, Africa, and North America will remain key sourcing regions for flue-cured and burley tobaccos.

Pricing

Factors that affect green tobacco prices include global supply and demand, market conditions, production costs, foreign 
exchange rates, and competition from other crops.  We work with farmers to maintain tobacco production and to secure product at 
price levels that are attractive to both the farmers and our customers.  Our objective is to secure compliant tobacco that is produced 
in a cost-effective manner under a sustainable business model with the desired quality for our customers.  In some areas, tobacco 
competes with agricultural commodity products for farmer production.  If prices for soybeans, wheat, rice, and seed oils rise in 
certain origins, green tobacco prices may have to rise to maintain tobacco production levels.  This could be a factor in efforts of the 
WHO to shift farmer production away from leaf tobacco to other crops.   In the past, leaf shortages in specific markets or on a 
worldwide basis have also led to green tobacco price increases.

Demand 

Industry data shows that over the past ten years, total world consumption of cigarettes fell at the compound annual rate of 
0.1%, including annual growth of about 2.2% in China.  Outside China, consumption fell by about 0.8% during the ten-year period. 
In addition, there are indications that growth in world consumption of cigarettes may have peaked and that the rate of growth is 
slowing in some key areas which had been experiencing growth, particularly China.  We expect that near term global demand for 
leaf tobacco will decline slightly primarily due to declining cigarette consumption in developed markets, partially offset by modest 
growth in consumption in emerging markets (Asia, the Middle East, and Africa), influenced by demographic trends such as population 
growth and increasing disposable income.

Our sales consist primarily of flue-cured and burley tobaccos. Those types of tobacco, along with oriental tobaccos, are 
used in American-blend cigarettes which are primarily smoked in Western Europe and the United States.  English-blend cigarettes 
which use flue-cured tobacco are mainly smoked in Asia and other emerging markets.  Industry data shows that consumption of 
American-blend cigarettes has declined at a compound annual rate of 2.2% for the ten years ended in 2015.  As cigarette consumption 
declines in developed markets and increases in the emerging markets, there may be less demand for burley and oriental tobaccos 
and more demand for flue-cured tobacco.  However, demand is affected by many factors, including regulation, product taxation, 
illicit trade, alternative tobacco products, and Chinese imports. To the extent that domestic leaf production and inventory durations 
in China do not meet requirements for Chinese cigarette blends, that tobacco could be sourced from other origins where we have 
major market positions.  On a year-to-year basis, we are also susceptible to fluctuations in leaf supply due to crop sizes and leaf 

30

demand as manufacturers adjust inventories or respond to changes in cigarette markets. For example, declines in some of our 
customers’ sales volumes in the U.S. and Western European markets, partially due to weak economic conditions, reduced demand 
for leaf tobacco in fiscal year 2015. With lower projected crop year 2016 leaf tobacco production, we currently expect supply for 
flue-cured and burley tobaccos to be largely in line with anticipated demand.  However, inventories held by our customers may 
affect their near-term demand for leaf tobacco.  We also sell dark tobacco which is used in cigars and other smokeless products.  
We expect demand for this category of tobacco to also decline slightly.

Regulation and Product Taxation

Decreased social acceptance of smoking and increased pressure from anti-smoking groups have had an ongoing adverse 
effect on the percentage of the population using tobacco products, particularly in the United States and Western Europe.  Also, many 
foreign governments have taken or proposed steps to restrict or prohibit cigarette advertising and promotion, to increase taxes on 
cigarettes, to prohibit smoking in public areas, and to discourage cigarette consumption.  A number of such measures are included 
in the Framework Convention on Tobacco Control (“FCTC”), which was negotiated under the auspices of the WHO and offers 
guidelines for discouraging or controlling tobacco use. Countries that are parties to the FCTC may choose the level of implementation 
of the guidelines that is most suitable with their approach to tobacco control.  In some cases, such restrictions are more onerous 
than those proposed or in effect in the United States.  We cannot predict the extent to which government efforts to reduce tobacco 
consumption might affect the business of our primary customers.  However, a significant decrease in worldwide tobacco consumption, 
as well as shifts to modified risk tobacco products brought about by existing or future governmental laws and regulations, could 
reduce demand for leaf tobacco and services and could have a material adverse effect on our results of operations.

 In addition, certain recommendations by the WHO, through the FCTC, may cause shifts in customer usage of certain types 
and styles of tobacco.  As seen in Canada, Brazil, and the European Union, efforts have been taken to eliminate flavorings from 
tobacco products.  Such decisions could cause a change in requirements for certain tobaccos in particular countries.  Shifts in 
customer demand from one type of tobacco to another could create sourcing issues as requirements move from one origin to another.  
Furthermore, instruction at the farm level may be required to produce the changing styles of tobacco needed by tobacco product 
manufacturers.  Given our established and well-developed programs at the farm level worldwide, we are particularly well positioned 
to meet manufacturer requirements.

In 2009, the U.S. Congress passed the Family Smoking Prevention and Tobacco Control Act (“the Act”). This legislation 
authorizes the FDA to regulate the manufacturing and marketing of all tobacco products.  The FDA has banned flavored cigarettes, 
restricted youth access to tobacco products, banned advertising claims regarding certain tobacco products, established new smokeless 
tobacco warnings, and issued new cigarette health warnings.  In addition, the FDA established the Center for Tobacco Products 
(“CTP”).  The CTP has focused on establishing the scientific foundation and regulatory framework for regulating tobacco products 
in the United States.  On May 10, 2016, the FDA released “deeming” regulations that extend FDA oversight to all tobacco products 
including e-cigarettes, cigars, hookah tobacco, pipe tobacco, dissolvables, and “novel and future products.”  The regulations require 
that tobacco product manufacturers register tobacco products that existed on February 15, 2007, and to seek FDA approval  to sell 
any products modified or introduced after such date.  All such submissions require manufacturers to list ingredients in their products.  
Regulations impacting our customer base that change the requirements for leaf tobacco or restrict their ability to sell their products 
will inherently impact our business.  As discussed, we have established programs that begin at the farm level to assist our customers 
with raw material information to support leaf traceability and customer testing requirements.  Additionally, given our global presence, 
we also have the ability to source different types and styles of tobacco for our customers should their needs change due to regulation.

A number of governments, particularly federal and local governments in the United States and the European Union, impose 
excise or similar taxes on tobacco products.  There has been, and will likely continue to be, new legislation proposing new or 
increased taxes on tobacco products.  In some cases, proposed legislation seeks to significantly increase existing taxes on tobacco 
products, or impose new taxes on products that to date have not been subject to tax.  Increases in product taxation may have an 
influence on the level of illicit trade, which will affect the global leaf markets.

Illicit Trade

Illicit trade is another factor which influences demand for leaf tobacco.  Industry estimates of the illegal, unregulated black 
market for cigarettes are approximately 10% of global stick consumption, representing $40-$50 billion in lost tax revenue globally. 
We support industry efforts to eradicate illicit trade.

Alternative Tobacco Products

Many of the major tobacco product manufacturers have been developing next generation and modified risk products.  These 
include e-cigarettes, liquid vaporizers, and heat-not-burn products.  E-cigarettes and liquid vaporizers use liquid nicotine, which is 
predominately derived from leaf tobacco, and heat-not-burn products use leaf tobacco.  At this time it is unclear as to how these 
new products will affect demand for leaf tobacco. Our AmeriNic joint venture produces liquid nicotine for the vapor products 
industry.  Currently, regulation of these products as well as consumer acceptance and their influence on smoking trends are unclear, 
and we continue to monitor industry developments.  E-cigarettes and other vapor products are now primarily consumed in the United 

31

States and Western Europe, and it is unclear what effect the consumption of vapor products may have on global demand for leaf 
tobacco in the future.

Current Industry Dynamics

Leaf tobacco is sourced directly by product manufacturers, by global leaf suppliers such as ourselves, and by other smaller, 
mostly regional or local, leaf suppliers.  We estimate that, of the flue-cured and burley tobacco grown outside of China, approximately 
one-third is purchased directly by manufacturers, slightly over one-third is handled by global leaf suppliers, and the remainder is 
sourced by the smaller regional or local suppliers.  Although we operate in a mature industry, where demand for the end products 
is slightly declining, we continually look for ways to grow our business.  We believe that there are several longer term trends in the 
industry that could provide opportunities for us to maintain or increase our market share and to offer additional services to our 
customers.

Manufacturers naturally seek to mitigate raw materials cost increases, and they are placing increased emphasis on cost 
containment as they address declining demand.  While this is not a new trend, it continues to offer opportunities to us as we bring 
supply chain efficiencies to the leaf markets.  We believe that global leaf suppliers add efficiencies to the markets through economies 
of scale, as well as through the vital role played in finding buyers for all styles and qualities of leaf tobacco, which achieves overall 
cost reductions. To understand our business, it is important to note that tobacco is not a commodity product. Flavor and smoking 
characteristics of tobacco vary based on the type of tobacco and the region where the tobacco is grown.  In addition, characteristics 
of tobacco leaves vary by their position on the stalk of the plant, which means that many different styles and grades of tobacco may 
be produced in a single tobacco crop.  A particular manufacturer, in seeking tobacco for its proprietary blend, may only want and 
have use for certain leaves of a plant.  The leaf tobacco supplier plays a vital role in the industry by finding buyers for all of the leaf 
grades and styles of tobacco produced in a farmer’s crop. This role helps to eliminate excess tobacco being produced, which improves 
leaf utilization.

In addition to leaf utilization, we bring operational efficiencies to the industry, which in turn help reduce costs.  These 
efficiencies include economical utilization of processing capacity in our facilities, an established and scalable global network of 
agronomists and technicians helping maintain a stable, productive, and sustainable farmer base, and agronomic and production 
improvements to optimize leaf yields and qualities.  In addition, we are able to offer manufacturers a complete range of services 
from the field to the delivery of the packed product that benefit from our efficiencies.  These services include such things as buying 
station optimization, processing to specific customer specifications or needs, storage of green or packed leaf tobacco, and logistical 
services.  In recent years, we have seen an increase in the level of direct purchasing and other supply chain services that we provide 
our customers, notably in the United States, Mexico, Brazil, Poland, Guatemala, and the Dominican Republic.  We believe these 
moves acknowledge the efficiencies and services that global leaf suppliers bring to the entire supply chain.

Several major manufacturers have also indicated to us their interest in reducing sourcing complexity.  We believe that these 
moves are another way for the industry to increase leaf sourcing efficiency and to reduce costs.  We maintain a strong presence in 
all of the major tobacco sourcing areas and believe that any growth in these areas would favor global leaf suppliers such as ourselves.  
In the future, we expect that increased regulations requiring stringent monitoring and testing of leaf chemistry and compliant sourcing 
documentation could place greater emphasis on major sourcing areas.

As we have said for a number of years, the production of compliant leaf for the tobacco industry continues to grow in 
importance.  To be considered compliant, leaf tobacco must be grown utilizing Good Agricultural Practices.  We have long invested 
significant resources in the programs and infrastructure needed to work with growers to produce compliant leaf and continue to 
enhance our ability to monitor and demonstrate this compliance for customers.  Our Good Agricultural Practices support an approach 
to  farming  that  is  focused  on  sustainability,  employing  sound  field  production  and  labor  management  practices  that  meet  our 
customers’  needs,  promote  farmer  profitability  and  reflect  environmental  sensitivity.  To  assist  them,  Universal  provides 
comprehensive training, technical support in the field, and crop analytics through ongoing research and development.  We believe 
that compliant leaf will continue to be important to our customers and should favor global suppliers who are able to deliver this 
product.

We also believe that a key factor in our ability to perform successfully in this industry is our ability to provide customers 
with the quality of leaf and the level of service they desire on a global basis at competitive prices, while maintaining a stability of 
supply. As the leading global leaf tobacco supplier, we add significant value to the supply chain, providing expertise in dealing with 
large numbers of farmers, efficiently selling various qualities of leaf produced in each crop to a broad global customer base, and 
delivering products that meet stringent quality and regulatory specifications. We also help stabilize the tobacco markets and influence 
crop development at the farm level.  Our key objective is to continually adapt our business model to meet our customers' evolving 
needs while continuing to provide stability of supply and the quality that distinguishes our products and services.  In addition, we 
monitor new product developments in the industry to identify areas where we can provide additional value to our customers.

32

Item 7A.   Quantitative and Qualitative Disclosures about Market Risk 

Interest Rates 

We generally use both fixed and floating interest rate debt to finance our operations.  Changes in market interest rates expose 
us to changes in cash flows for floating rate instruments and to changes in fair value for fixed-rate instruments.   We normally maintain 
a proportion of our debt in both variable and fixed interest rates to manage this exposure, and from time to time we may enter hedge 
agreements to swap the interest rates.  In addition, our customers may pay market rates of interest for inventory purchased on order, 
which could mitigate a portion of the floating interest rate exposure.  We also periodically have large cash balances and may receive 
deposits from customers, both of which we use to fund seasonal purchases of tobacco, reducing our financing needs. Excluding our 
bank term loans, which have been converted to fixed-rate borrowings with interest rate swaps, debt carried at variable interest rates 
was approximately $66 million at March 31, 2016.  Although a hypothetical 1% change in short-term interest rates would result in 
a change in annual interest expense of approximately $0.6 million, that amount would be at least partially mitigated by changes in 
charges to customers.

In addition, changes in interest rates affect the calculation of our pension plan liabilities.  As rates decrease, the liability for 
the present value of amounts expected to be paid under the plans increases.  Rate changes also affect expense.  As of the March 31, 
2016 measurement date, a 1% decrease in the discount rate would have increased the projected benefit obligation (“PBO”) for 
pensions by $34 million and increased annual pension expense by $3 million.  Conversely, a 1% increase in the discount rate would 
have reduced the PBO by $28 million and reduced annual pension expense by $2 million.

Currency

The international leaf tobacco trade generally is conducted in U.S. dollars, thereby limiting foreign exchange risk to that 
which is related to leaf purchase and production costs, overhead, and income taxes in the source country.  We also provide farmer 
advances that are directly related to leaf purchases and are denominated in the local currency.  Any currency gains or losses on those 
advances are usually offset by increases or decreases in the cost of tobacco, which is priced in the local currency.  However, the 
effect of the offset may not occur until a subsequent quarter or fiscal year.  Most of our tobacco operations are accounted for using 
the U.S. dollar as the functional currency.  Because there are no forward foreign exchange markets in many of our major countries 
of tobacco origin, we often manage our foreign exchange risk by matching funding for inventory purchases with the currency of 
sale, which is usually the U.S. dollar, and by minimizing our net local currency monetary position in individual countries.  We are 
vulnerable to currency remeasurement gains and losses to the extent that monetary assets and liabilities denominated in local currency 
do not offset each other.  We recognized $22.5 million in net remeasurement losses in fiscal year 2016, compared to $28.8 million
in net remeasurement losses in fiscal year 2015, and $14.3 million in net remeasurement gains in fiscal year 2014.  We recognized 
$8.0 million in net foreign currency transaction gains in fiscal year 2016, compared to net transaction gains of $17.7 million in fiscal 
year 2015, and net transaction losses of $6.0 million in fiscal year 2014.  In addition to foreign exchange gains and losses, we are 
exposed to changes in the cost of tobacco due to changes in the value of the local currency in relation to the U.S. dollar.  We have 
entered forward currency exchange contracts to hedge against the effects of currency movements on purchases of tobacco to reduce 
the volatility of costs.  In addition, we periodically enter into forward contracts to hedge balance sheet exposures.  See Note 8 to the 
consolidated financial statements in Item 8 for additional information about our hedging activities.

In certain tobacco markets that are primarily domestic, we use the local currency as the functional currency.  Examples of 
these markets are Hungary, Poland, and the Philippines. In other markets, such as Western Europe, where export sales are primarily 
in local currencies, we also use the local currency as the functional currency.  In each case, reported earnings are affected by the 
translation of the local currency into the U.S. dollar.

Derivatives Policies

Hedging interest rate exposure using swaps and hedging foreign currency exchange rate exposure using forward contracts 
are specifically contemplated to manage risk in keeping with management's policies.  We may use derivative instruments, such as 
swaps, forwards, or futures, which are based directly or indirectly upon interest rates and currencies to manage and reduce the risks 
inherent in interest rate and currency fluctuations.  When we use foreign currency derivatives to mitigate our exposure to exchange 
rate fluctuations, we may choose not to designate them as hedges for accounting purposes, which may result in the effects of the 
derivatives being recognized in our earnings in periods different from the items that created the exposure.

We do not utilize derivatives for speculative purposes, and we do not enter into market risk-sensitive instruments for trading 
purposes.  Derivatives are transaction-specific so that a specific debt instrument, forecast purchase, contract, or invoice determines 
the amount, maturity, and other specifics of the hedge.  We routinely review counterparty risk as part of our derivative program.

33

 
 
Item 8.   Financial Statements and Supplementary Data  

UNIVERSAL CORPORATION 
CONSOLIDATED STATEMENTS OF INCOME 

(in thousands of dollars, except share and per share data)

2016

2015

2014

Sales and other operating revenues ........................................................................................................ $

2,120,373

$

2,271,801

$

2,542,115

Fiscal Year Ended March 31,

Costs and expenses

Cost of goods sold ...............................................................................................................................

1,713,042

1,861,527

2,108,824

Selling, general and administrative expenses......................................................................................

226,685

Other income .......................................................................................................................................

Restructuring and impairment costs ....................................................................................................

(3,390)

2,389

250,186

(12,676)

4,890

262,013

(81,619)

6,746

Operating income ...................................................................................................................................

181,647

167,874

246,151

Equity in pretax earnings of unconsolidated affiliates ........................................................................

Interest income ....................................................................................................................................

Interest expense ...................................................................................................................................

Income before income taxes...................................................................................................................

Income taxes........................................................................................................................................

Net income .............................................................................................................................................

Less:  net income attributable to noncontrolling interests in subsidiaries..............................................

Net income attributable to Universal Corporation .................................................................................

5,422

1,178

15,669

172,578

54,430

118,148

(9,132)

109,016

7,137

576

17,120

158,467

38,006

120,461

(5,853)

114,608

3,897

949

20,307

230,690

75,535

155,155

(6,146)

149,009

Dividends on Universal Corporation convertible perpetual preferred stock..........................................

(14,748)

(14,824)

(14,850)

Cost in excess of carrying value on repurchase of convertible perpetual preferred stock .....................

—

(36)

—

Earnings available to Universal Corporation common shareholders ..................................................... $

94,268

$

99,748

$

134,159

Earnings per share attributable to Universal Corporation common shareholders:

Basic .................................................................................................................................................... $

Diluted ................................................................................................................................................. $

4.16

3.92

$

$

4.33

4.06

$

$

5.77

5.25

Weighted average common shares outstanding:

Basic ....................................................................................................................................................

22,683,290

23,035,920

23,238,978

Diluted .................................................................................................................................................

27,825,491

28,221,264

28,392,033

See accompanying notes.

34

UNIVERSAL CORPORATION  
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME 

(in thousands of dollars)

Fiscal Year Ended March 31,

2016

2015

2014

Net income ............................................................................................................................................. $

118,148

$

120,461

$

155,155

Other comprehensive income (loss):

Foreign currency translation, net of income taxes ..............................................................................

Foreign currency hedge, net of income taxes .....................................................................................

Interest rate hedge, net of income taxes..............................................................................................

Pension and other postretirement benefit plans, net of income taxes .................................................

Total other comprehensive income (loss), net of income taxes....................................................

Total comprehensive income ........................................................................................................

Less: comprehensive income attributable to noncontrolling interests...................................................

3,934

2,509

(5,015)

1,004

2,432

120,580

(8,920)

(22,625)

(2,603)

(1,374)

(14,023)

(40,625)

79,836

(5,890)

6,480

1,624

483

32,022

40,609

195,764

(5,547)

Comprehensive income attributable to Universal Corporation ............................................................. $

111,660

$

73,946

$

190,217

See accompanying notes.

35

UNIVERSAL CORPORATION  
CONSOLIDATED BALANCE SHEETS 

(in thousands of dollars)

Current assets

ASSETS

March 31,

2016

2015

Cash and cash equivalents.................................................................................................................................................... $

319,447   $

Accounts receivable, net.......................................................................................................................................................

Advances to suppliers, net....................................................................................................................................................

Accounts receivable—unconsolidated affiliates ..................................................................................................................

428,659   

101,890   

2,316   

248,783

434,362

114,883

1,907

Inventories—at lower of cost or market:

Tobacco..............................................................................................................................................................................

637,132   

636,488

Other..................................................................................................................................................................................

Prepaid income taxes............................................................................................................................................................

Other current assets ..............................................................................................................................................................

60,888   

17,814   

70,400   

62,195

17,811

81,570

Total current assets............................................................................................................................................................

1,638,546   

1,597,999

Property, plant and equipment

Land......................................................................................................................................................................................

Buildings ..............................................................................................................................................................................

Machinery and equipment ....................................................................................................................................................

22,987   

264,838   

591,327   

879,152   

16,790

238,372

576,010

831,172

Less accumulated depreciation..........................................................................................................................................

(553,265)   

(525,783)

Other assets

Goodwill and other intangibles ............................................................................................................................................

Investments in unconsolidated affiliates ..............................................................................................................................

Deferred income taxes..........................................................................................................................................................

Other noncurrent assets ........................................................................................................................................................

325,887   

305,389

99,071   

82,441   

23,853   

62,999   

99,146

76,512

32,888

76,515

268,364   

285,061

Total assets......................................................................................................................................................................... $

2,232,797   $

2,188,449

36

  
  
  
  
  
  
UNIVERSAL CORPORATION  
CONSOLIDATED BALANCE SHEETS—(Continued) 

(in thousands of dollars)

Current liabilities

LIABILITIES AND SHAREHOLDERS’ EQUITY

March 31,

2016

2015

Notes payable and overdrafts............................................................................................................................................... $

66,179

$

Accounts payable and accrued expenses .............................................................................................................................

120,527

Accounts payable—unconsolidated affiliates......................................................................................................................

Customer advances and deposits .........................................................................................................................................

Accrued compensation.........................................................................................................................................................

Income taxes payable...........................................................................................................................................................

Current portion of long-term debt........................................................................................................................................

8,343

16,438

27,593

7,190

—

59,862

140,112

3,281

30,183

28,232

6,559

—

Total current liabilities................................................................................................................................................

246,270   

268,229

Long-term debt........................................................................................................................................................................

370,000

370,000

Pensions and other postretirement benefits.............................................................................................................................

Other long-term liabilities.......................................................................................................................................................

Deferred income taxes ............................................................................................................................................................

92,177

41,794

29,494

97,048

36,790

19,288

Total liabilities ............................................................................................................................................................

779,735

791,355

Shareholders’ equity

Universal Corporation:

Preferred stock:

Series A Junior Participating Preferred Stock, no par value, 500,000 shares authorized, 

none issued or outstanding ........................................................................................................................................

—   

—

Series B 6.75% Convertible Perpetual Preferred Stock, no par value, 220,000 shares authorized, 

218,490 shares issued and outstanding (218,490 at March 31, 2015).......................................................................

211,562   

211,562

Common stock, no par value, 100,000,000 shares authorized, 22,717,735 shares issued 

and outstanding (22,593,266 at March 31, 2015)...........................................................................................................

208,946

206,002

Retained earnings..............................................................................................................................................................

1,066,064   

1,020,155

Accumulated other comprehensive loss............................................................................................................................

(72,350)   

(74,994)

Total Universal Corporation shareholders' equity.......................................................................................................

1,414,222   

1,362,725

Noncontrolling interests in subsidiaries..................................................................................................................................

38,840

34,369

Total shareholders' equity ...........................................................................................................................................

1,453,062

1,397,094

Total liabilities and shareholders' equity..................................................................................................................... $

2,232,797   $

2,188,449

See accompanying notes.

37

  
  
  
  
  
UNIVERSAL CORPORATION  
CONSOLIDATED STATEMENTS OF CASH FLOWS 

(in thousands of dollars)

Cash Flows From Operating Activities:

Fiscal Year Ended March 31,

2016

2015

2014

Net income ............................................................................................................................................. $

118,148

$

120,461

$

155,155

Adjustments to reconcile net income to net cash provided (used) by operating activities:

Depreciation ........................................................................................................................................

Amortization........................................................................................................................................

Provision for losses on advances and guaranteed loans to suppliers ..................................................

Inventory write-downs ........................................................................................................................

Stock-based compensation expense ....................................................................................................

Foreign currency remeasurement loss (gain), net ...............................................................................

Deferred income taxes.........................................................................................................................

Equity in net income of unconsolidated affiliates, net of dividends ...................................................

Gain on favorable outcome of excise tax case in Brazil .....................................................................

Fair value gain upon acquisition of partner's interest in joint venture ................................................

Restructuring and impairment costs ....................................................................................................

Other, net .............................................................................................................................................

Changes in operating assets and liabilities, net:

Accounts and notes receivable .........................................................................................................

Inventories and other assets..............................................................................................................

Income taxes.....................................................................................................................................

Accounts payable and other accrued liabilities ................................................................................

Customer advances and deposits......................................................................................................

Net cash provided (used) by operating activities ................................................................................

Cash Flows From Investing Activities:

Purchase of property, plant and equipment .........................................................................................

Purchase of partner's interest in joint venture, net of cash held by the business.................................

Proceeds from sale of property, plant and equipment .........................................................................

Other, net .............................................................................................................................................

Net cash used by investing activities................................................................................................

Cash Flows From Financing Activities:

Issuance (repayment) of short-term debt, net ......................................................................................

Issuance of long-term debt ..................................................................................................................

Repayment of long-term debt..............................................................................................................

Dividends paid to noncontrolling interests..........................................................................................

Issuance of common stock ..................................................................................................................

Repurchase of convertible perpetual preferred stock ..........................................................................

Repurchase of common stock..............................................................................................................

Dividends paid on convertible perpetual preferred stock....................................................................

Dividends paid on common stock .......................................................................................................

Debt issuance costs and other..............................................................................................................

Net cash used by financing activities ...............................................................................................

Effect of exchange rate changes on cash................................................................................................

Net increase (decrease) in cash and cash equivalents ............................................................................
Cash and cash equivalents at beginning of year.....................................................................................

36,754

890

815

11,899

5,206

22,517

15,046

156

—

(3,390)

2,389

12,314

(2,806)

(7,370)

(1,503)

(13,678)

(13,796)

183,591

(47,153)

(5,964)

2,982

(796)

(50,931)

4,880

—

—

(4,449)

—

—

—

(14,748)

(47,389)

—

(61,706)

(290)

70,664

248,783

35,394

1,930

3,734

18,612

6,230

28,836

(13,662)

(1,075)

(12,676)

—

4,890

(9,272)

49,414

37,751

4,790

(63,257)

14,397

226,497

(58,385)

—

4,522

(141)

(54,004)

2,618

370,000

(356,250)

(4,183)

187

(1,497)

(31,227)

(14,824)

(47,337)

(3,621)

(86,134)

(1,108)

85,251

163,532

37,257

1,642

6,705

7,654

6,278

14,322
(2,176)
3,420
(81,619)
—

6,746

2,251

(89,536)
(47,492)
11,391
(27,345)
(8,156)
(3,503)

(45,849)
—

2,746

1,033
(42,070)

(43,727)
175,000
(211,250)
(1,971)
457

—
(14,145)
(14,850)
(46,721)
(875)

(158,082)

(677)

(204,332)

367,864

Cash and Cash Equivalents at End of Year....................................................................................... $

319,447

$

248,783

$

163,532

Supplemental information—cash paid for:

Interest ................................................................................................................................................. $

Income taxes, net of refunds................................................................................................................ $

15,704

38,732

$

$

19,184

46,044

$

$

25,116

65,511

See accompanying notes.

38

UNIVERSAL CORPORATION
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

(in thousands of dollars)

Fiscal Year Ended March 31, 2016

Universal Corporation Shareholders

Series B
6.75%
Convertible
Perpetual
Preferred
Stock

Common
Stock

Retained 
Earnings

Accumulated
Other
Comprehensive
Income
(Loss)

Non-
controlling
Interests

Total
Shareholders'
Equity

Balance at beginning of year ..........................................................

$

211,562

$ 206,002

$ 1,020,155

$

(74,994) $

34,369

$

1,397,094

 Changes in preferred and common stock

Accrual of stock-based compensation ...................................

Withholding of shares from stock-based compensation for

grantee income taxes.........................................................

Dividend equivalents on restricted stock units (RSUs).........

Changes in retained earnings

Net income ............................................................................

Cash dividends declared

Series B 6.75% convertible perpetual preferred stock

($67.50 per share) ........................................................

Common stock ($2.10 per share) .....................................

Dividend equivalents on restricted stock units (RSUs).........

Other comprehensive income (loss)

Foreign currency translation, net of income taxes ................

Foreign currency hedge, net of income taxes........................

Interest rate hedge, net of income taxes ................................

Pension and other postretirement benefit plans, net of

income taxes......................................................................

Other changes in noncontrolling interests

Dividends paid to noncontrolling shareholders.....................

—

—

—

—

—

—

—

—

—

—

—

—

5,206

(2,940)

678

—

—

—

—

109,016

—

—

—

—

—

—

—

—

(14,748)

(47,681)

(678)

—

—

—

—

—

—

—

—

—

—

—

—

4,146

2,509

(5,015)

1,004

—

—

—

5,206

(2,940)

678

9,132

118,148

—

—

—

(212)

—

—

—

(14,748)

(47,681)

(678)

3,934

2,509

(5,015)

1,004

—

(4,449)

(4,449)

Balance at end of year ....................................................................

$

211,562

$ 208,946

$ 1,066,064

$

(72,350) $

38,840

$

1,453,062

39

 
 
 
 
 
 
 
 
 
UNIVERSAL CORPORATION
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY—(Continued)

(in thousands of dollars)

Fiscal Year Ended March 31, 2015

Universal Corporation Shareholders

Series B
6.75%
Convertible
Perpetual
Preferred
Stock

Common
Stock

Retained 
Earnings

Accumulated
Other
Comprehensive
Income
(Loss)

Non-
controlling
Interests

Total
Shareholders'
Equity

Balance at beginning of year............................................................

$

213,023

$ 206,446

$

993,093

$

(34,332) $

32,662

$

1,410,892

 Changes in preferred and common stock

Repurchase of Series B 6.75% convertible perpetual

preferred stock ....................................................................

(1,461)

Issuance of common stock ......................................................

Repurchase of common stock .................................................

Accrual of stock-based compensation ....................................

Withholding of shares from stock-based compensation for

grantee income taxes ..........................................................

Dividend equivalents on restricted stock units (RSUs) ..........

Changes in retained earnings

Net income ..............................................................................

Cash dividends declared

Series B 6.75% convertible perpetual preferred stock

($67.50 per share)..........................................................

Common stock ($2.06 per share).......................................

Repurchase of Series B 6.75% convertible perpetual

preferred stock ....................................................................

Repurchase of common stock .................................................

Dividend equivalents on restricted stock units (RSUs) ..........

Other comprehensive income (loss)

Foreign currency translation, net of income taxes ..................

Foreign currency hedge, net of income taxes .........................

Interest rate hedge, net of income taxes..................................

Pension and other postretirement benefit plans, net of

income taxes .......................................................................

Other changes in noncontrolling interests

Dividends paid to noncontrolling shareholders ......................

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

187

(6,439)

6,230

(1,076)

654

—

—

—

—

—

—

114,608

—

—

—

—

—

—

—

—

—

(14,824)

(47,244)

(36)

(24,788)

(654)

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

(22,662)

(2,603)

(1,374)

(14,023)

(1,461)

187

(6,439)

6,230

(1,076)

654

—

—

—

—

—

5,853

120,461

—

—

—

—

37

—

—

—

(14,824)

(47,244)

(36)

(24,788)

(654)

(22,625)

(2,603)

(1,374)

(14,023)

—

(4,183)

(4,183)

Balance at end of year......................................................................

$

211,562

$ 206,002

$ 1,020,155

$

(74,994) $

34,369

$

1,397,094

40

 
 
 
 
 
 
 
 
 
UNIVERSAL CORPORATION
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY—(Continued)

(in thousands of dollars)

Fiscal Year Ended March 31, 2014

Universal Corporation Shareholders

Series B
6.75%
Convertible
Perpetual
Preferred
Stock

Common
Stock

Retained 
Earnings

Accumulated
Other
Comprehensive
Income
(Loss)

Non-
controlling
Interests

Total
Shareholders'
Equity

Balance at beginning of year ............................................................

$

213,023

$ 202,579

$ 918,509

$

(75,540) $

29,086

$

1,287,657

 Changes in preferred and common stock

Issuance of common stock ......................................................

Repurchase of common stock..................................................

Accrual of stock-based compensation .....................................

Withholding of shares from stock-based compensation for

grantee income taxes...........................................................

Dividend equivalents on restricted stock units (RSUs)...........

Changes in retained earnings

Net income ..............................................................................

Cash dividends declared

Series B 6.75% convertible perpetual preferred stock

($67.50 per share) ..........................................................

Common stock ($2.02 per share) .......................................

Repurchase of common stock..................................................

Dividend equivalents on restricted stock units (RSUs)...........

Other comprehensive income (loss)

Foreign currency translation, net of income taxes ..................

Foreign currency hedge, net of income taxes..........................

Interest rate hedge, net of income taxes ..................................

Pension and other postretirement benefit plans, net of

income taxes........................................................................

Other changes in noncontrolling interests

Dividends paid to noncontrolling shareholders.......................

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

457

(2,049)

6,278

(1,410)

591

—

—

—

—

—

—

149,009

—

—

—

—

—

—

—

—

—

(14,850)

(46,888)

(12,096)

(591)

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

7,079

1,624

483

32,022

—

—

—

—

—

457

(2,049)

6,278

(1,410)

591

6,146

155,155

—

—

—

—

(599)

—

—

—

(14,850)

(46,888)

(12,096)

(591)

6,480

1,624

483

32,022

—

(1,971)

(1,971)

Balance at end of year ......................................................................

$

213,023

$ 206,446

$ 993,093

$

(34,332) $

32,662

$

1,410,892

41

 
 
 
UNIVERSAL CORPORATION
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY—(Continued)

Fiscal Year Ended March 31,

2016

2015

2014

Preferred Shares Outstanding:

  Series B 6.75% Convertible Perpetual Preferred Stock:

    Balance at beginning of year.................................................................................................................

218,490

219,999

219,999

    Issuance of convertible perpetual preferred stock ................................................................................

    Repurchase of convertible perpetual preferred stock............................................................................

—

—

    Balance at end of year...........................................................................................................................

218,490

—

(1,509)

218,490

—

—

219,999

Common Shares Outstanding:

    Balance at beginning of year.................................................................................................................

22,593,266

23,216,312

23,343,973

    Issuance of common stock ....................................................................................................................

124,469

96,947

    Repurchase of common stock ...............................................................................................................

—

(719,993)

110,825

(238,486)

    Balance at end of year...........................................................................................................................

22,717,735

22,593,266

23,216,312

See accompanying notes.

42

 
 
 
 
 
 
 
 
 
 
UNIVERSAL CORPORATION 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(All dollar amounts are in thousands, except per share amounts or as otherwise noted.) 

NOTE 1.   NATURE OF OPERATIONS AND SIGNIFICANT ACCOUNTING POLICIES

Nature of Operations

Universal Corporation, which together with its subsidiaries is referred to herein as “Universal” or the “Company,” is the 
leading global leaf tobacco supplier.  The Company conducts business in over 30 countries, primarily in major tobacco-producing 
regions of the world.

Consolidation

The consolidated financial statements include the accounts of Universal Corporation and all domestic and foreign subsidiaries 
in which the Company maintains a controlling financial interest.  Control is generally determined based on a voting interest of greater 
than 50%, such that Universal controls all significant corporate activities of the subsidiary.  All significant intercompany accounts 
and transactions are eliminated in consolidation.  

The equity method of accounting is used for investments in companies where Universal Corporation has a voting interest 
of 20% to 50%.  These investments are accounted for under the equity method because Universal exercises significant influence 
over those companies, but not control.  The Company received dividends totaling $3.4 million in fiscal year 2016, $5.2 million in 
fiscal year 2015, and $6.5 million in fiscal year 2014, from companies accounted for under the equity method. Investments where 
Universal has a voting interest of less than 20% are not significant and are accounted for under the cost method.  Under the cost 
method, the Company recognizes earnings upon its receipt of dividends to the extent they represent a distribution of retained earnings. 

The Company's 49% ownership interest in Socotab L.L.C. (“Socotab”), a leading supplier of oriental tobaccos with operations 
located principally in Eastern Europe and Turkey, is the primary investment accounted for under the equity method.  The investment 
in Socotab is an important part of the Company's overall product and service arrangements with its major customers.  As discussed 
further below, the Company reviews the carrying value of its investments in unconsolidated affiliates on a regular basis and considers 
whether any factors exist that might indicate an impairment in value that is other than temporary.  At March 31, 2016, the Company 
determined that no such factors existed with respect to the investment in Socotab.  The Company, together with Socotab management, 
regularly evaluates the outlook for the business, and an impairment charge could be recorded in a future period if it is determined 
that the fair value of the investment is less than the carrying value and the decline in value is not temporary.

In fiscal year 2006, the Company deconsolidated its operations in Zimbabwe under accounting requirements that apply 
under certain conditions to foreign subsidiaries that are subject to foreign exchange controls and other government restrictions.  Since 
that time, the investment has been accounted for using the cost method, as required under the accounting guidance.  The investment 
in the Zimbabwe operations was zero at March 31, 2016 and 2015.  The Company has a net foreign currency translation loss associated 
with the Zimbabwe operations of approximately $7.2 million, which remains a component of accumulated other comprehensive loss.  
As a regular part of its reporting, the Company reviews the conditions that resulted in the deconsolidation of the Zimbabwe operations 
to confirm that such accounting treatment is still appropriate.  Dividends from the Zimbabwe operations are recorded in income in 
the period received. 

The Company holds less than a 100% financial interest in certain consolidated subsidiaries.  The net income and shareholders’ 
equity attributable to the noncontrolling interests in these subsidiaries are reported on the face of the consolidated financial statements. 
During fiscal years 2016, 2015, and 2014, there were no changes in the Company’s ownership percentage in any of these subsidiaries.

43

 
UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
Investments in Unconsolidated Affiliates

The Company’s equity method investments and its cost method investments, which include its Zimbabwe operations, are 
non-marketable securities.  Universal reviews such investments for impairment whenever events or changes in circumstances indicate 
that the carrying amount of an investment may not be recovered.  For example, the Company would review such an investment for 
impairment if the investee were to lose a significant customer, suffer a large reduction in sales margins, experience a major change 
in its business environment, or undergo any other significant change in its normal business.  In assessing the recoverability of equity 
or cost method investments, the Company follows the applicable accounting guidance in determining the fair value of the investments.  
In most cases, this involves the use of discounted cash flow models (Level 3 of the fair value hierarchy under the accounting guidance).  
If the fair value of an equity or cost method investee is determined to be lower than its carrying value, an impairment loss is recognized.  
The determination of fair value using discounted cash flow models is normally not based on observable market data from independent 
sources  and  therefore  requires  significant  management  judgment  with  respect  to  estimates  of  future  operating  earnings  and  the 
selection of an appropriate discount rate.  The use of different assumptions could increase or decrease estimated future operating 
cash flows, and the discounted value of those cash flows, and therefore could increase or decrease any impairment charge related to 
these investments. 

In its consolidated statements of income, the Company reports its proportional share of earnings of unconsolidated affiliates 
accounted for on the equity method based on the pretax earnings of those affiliates, as permitted under the applicable accounting 
guidance.  All applicable foreign and U.S. income taxes are provided on these earnings and reported as a component of consolidated 
income tax expense.  For unconsolidated affiliates located in foreign jurisdictions, repatriation of the Company’s share of the earnings 
through dividends is assumed in determining consolidated income tax expense.  

The following table provides a reconciliation of (1) equity in the pretax earnings of unconsolidated affiliates, as reported 
in the consolidated statements of income to (2) equity in the net income of unconsolidated affiliates, net of dividends, as reported 
in the consolidated statements of cash flows for the fiscal years ended March 31, 2016, 2015, and 2014:

Fiscal Year Ended March 31,

2016

2015

2014

Equity in pretax earnings reported in the consolidated statements of income..................... $

5,422

$

7,137

$

Less:  Equity in income taxes...............................................................................................

Equity in net income ............................................................................................................
Less:  Dividends received on investments (1) ......................................................................
Equity in net income, net of dividends, reported in the consolidated statements of cash

(2,156)

3,266

(3,422)

(834)

6,303

(5,228)

3,897

(809)

3,088

(6,508)

flows................................................................................................................................. $

(156) $

1,075

$

(3,420)

(1) 

In accordance with the applicable accounting guidance, dividends received from unconsolidated affiliates accounted for on the equity method that represent a 
return on capital (i.e., a return of earnings on a cumulative basis) are presented as operating cash flows in the consolidated statements of cash flows.

Earnings Per Share 

 The Company calculates basic earnings per share based on earnings available to common shareholders after payment of 
dividends on the Company’s Series B 6.75% Convertible Perpetual Preferred Stock.  The calculation uses the weighted average 
number of common shares outstanding during each period.  Diluted earnings per share is computed in a similar manner using the 
weighted average number of common shares and dilutive potential common shares outstanding.  Dilutive potential common shares 
are outstanding dilutive stock options and stock appreciation rights that are assumed to be exercised, unvested restricted stock units 
and performance share awards that are assumed to be fully vested and paid out in shares of common stock, and shares of convertible 
perpetual preferred stock that are assumed to be converted when the effect is dilutive.  In periods when the effect of the convertible 
perpetual preferred stock is dilutive and these shares are assumed to be converted into common stock, dividends paid on the preferred 
stock are excluded from the calculation of diluted earnings per share.

Calculations of earnings per share for the fiscal years ended March 31, 2016, 2015, and 2014, are provided in Note 3.

Cash and Cash Equivalents

 All highly liquid investments with a maturity of three months or less at the time of purchase are classified as cash equivalents.

44

 
UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
Advances to Suppliers

In many sourcing origins where the Company operates, it provides agronomy services and seasonal advances of seed, 
fertilizer, and other supplies to tobacco farmers for crop production, or makes seasonal cash advances to farmers for the procurement 
of those inputs.  These advances are short term, are repaid upon delivery of tobacco to the Company, and are reported in advances 
to suppliers in the consolidated balance sheets.  In several origins, the Company has made long-term advances to tobacco farmers 
to finance curing barns and other farm infrastructure.  In some years, due to low crop yields and other factors, individual farmers 
may not deliver sufficient volumes of tobacco to fully repay their seasonal advances, and the Company may extend repayment of 
those advances into future crop years.  The long-term portion of advances is included in other noncurrent assets in the consolidated 
balance sheets.  Both the current and the long-term portions of advances to suppliers are reported net of allowances recorded when 
the Company determines that amounts outstanding are not likely to be collected. Short-term and long-term advances to suppliers 
totaled approximately $134 million at March 31, 2016, and $156 million at March 31, 2015.  The related valuation allowances totaled 
$29 million at March 31, 2016, and $35 million at March 31, 2015, and were estimated based on the Company’s historical loss 
information  and  crop  projections.    The  allowances  were  increased  by  net  provisions  for  estimated  uncollectible  amounts  of 
approximately $0.8 million in fiscal year 2016, $3.7 million in fiscal year  2015, and $5.5 million in fiscal year 2014. These provisions 
are included in selling, general, and administrative expenses in the consolidated statements of income.   Interest on advances is 
recognized in earnings upon the farmers’ delivery of tobacco in payment of principal and interest. Advances on which interest accrual 
had been discontinued totaled approximately $11 million at March 31, 2016, and $15 million at March 31, 2015.

Inventories

Tobacco inventories are valued at the lower of cost or market.  Raw materials primarily consist of unprocessed leaf tobacco, 
which is clearly identified by type and grade at the time of purchase.  The Company tracks the costs associated with this tobacco in 
the final product lots, and maintains this identification through the time of sale.  This method of cost accounting is referred to as the 
specific cost or specific identification method.  The predominant cost component of the Company’s inventories is the cost of the 
unprocessed tobacco.  Direct and indirect processing costs related to these raw materials are capitalized and allocated to inventory 
in a systematic manner.  The Company does not capitalize any interest or sales-related costs in inventory.  Freight costs are recorded 
in cost of goods sold.  Other inventories consist primarily of seed, fertilizer, packing materials, and other supplies, and are valued 
principally at the lower of average cost or market.

Recoverable Value-Added Tax Credits

In many foreign countries, the Company’s local operating subsidiaries pay significant amounts of value-added tax (“VAT”) 
on purchases of unprocessed and processed tobacco, crop inputs, packing materials, and various other goods and services.  In some 
countries, VAT is a national tax, and in other countries it is assessed at the state level.  Items subject to VAT vary from jurisdiction 
to jurisdiction, as do the rates at which the tax is assessed.  When tobacco is sold to customers in the country of origin, the operating 
subsidiaries generally collect VAT on those sales.  The subsidiaries are normally permitted to offset their VAT payments against the 
collections and remit only the incremental VAT collections to the tax authorities.  When tobacco is sold for export, VAT is normally 
not assessed.  In countries where tobacco sales are predominately for export markets, VAT collections generated on downstream 
sales are often not sufficient to fully offset the subsidiaries’ VAT payments.  In those situations, unused VAT credits can accumulate.  
Some jurisdictions have procedures that allow companies to apply for refunds of unused VAT credits from the tax authorities, but 
the refund process often takes an extended period of time, and it is not uncommon for refund applications to be challenged or rejected 
in part on technical grounds.  Other jurisdictions may permit companies to sell or transfer unused VAT credits to third parties in 
private transactions, although approval for such transactions must normally be obtained from the tax authorities, limits on the amounts 
that can be transferred may be imposed, and the proceeds realized may be heavily discounted from the face value of the credits.  Due 
to these factors, local operating subsidiaries in some countries can accumulate significant balances of VAT credits over time.  The 
Company reviews these balances on a regular basis and records valuation allowances on the credits to reflect amounts that are not 
expected to be recovered, as well as discounts anticipated on credits that are expected to be sold or transferred.  At March 31, 2016
and 2015, the aggregate balances of recoverable tax credits held by the Company’s subsidiaries totaled approximately $52 million
and $60 million, respectively, and the related valuation allowances totaled approximately $19 million and $23 million, respectively. 
The net balances are reported in other current assets and other noncurrent assets in the consolidated balance sheets.

Property, Plant and Equipment 

Depreciation of plant and equipment is based upon historical cost and the estimated useful lives of the assets. Depreciation 
is calculated primarily using the straight-line method.  Buildings include tobacco processing and blending facilities, offices, and 
warehouses. Machinery and equipment consists of processing and packing machinery and transport, office, and computer equipment.  
Estimated useful lives range as follows: buildings - 15 to 40 years; processing and packing machinery - 3 to 11 years; transport 
equipment - 3 to 10 years; and office and computer equipment - 3 to 10 years.  Where applicable and material in amount, the Company 
capitalizes related interest costs during periods that property, plant and equipment are being constructed or made ready for service.  
No interest was capitalized in fiscal years 2016, 2015, or 2014.

45

UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
Goodwill and Other Intangibles 

Goodwill and other intangibles principally consist of the excess of the purchase price of acquired companies over the fair 
value of the net assets.  Goodwill is carried at the lower of cost or fair value.  Accounting Standards Codification Topic 350 (“ASC 
350”) permits companies to base their initial assessments of potential goodwill impairment on qualitative factors, and the Company 
elected to use that approach at March 31, 2016 and 2015.  Those factors did not indicate any potential impairment of the Company's 
recorded goodwill.

Reporting units are distinct operating subsidiaries or groups of subsidiaries that typically compose the Company’s business 
in a specific country or location.  Goodwill is allocated to reporting units based on the country or location to which a specific 
acquisition relates, or by allocation based on expected future cash flows if the acquisition relates to more than one country or location. 
The majority of the Company’s goodwill relates to its reporting unit in Brazil.  Significant adverse changes in the operations or 
estimated future cash flows for a reporting unit with recorded goodwill could result in an impairment charge.  No charges for goodwill 
impairment were recorded in fiscal years 2016, 2015, or 2014.

Impairment of Long-Lived Assets 

The  Company  reviews  long-lived  assets  for  impairment  whenever  events,  changes  in  business  conditions,  or  other 
circumstances provide an indication that such assets may be impaired.  Potential impairment is initially assessed by comparing 
management’s undiscounted estimates of future cash flows from the use or disposition of the assets to their carrying value.  If the 
carrying value exceeds the undiscounted cash flows, an impairment charge is recorded to reduce the carrying value of the asset to 
its fair value determined in accordance with the accounting guidance.  In many cases, this involves the use of discounted cash flow 
models that are not based on observable market data from independent sources (Level 3 of the fair value hierarchy under the accounting 
guidance).  No significant charges for impairment of long-lived assets were recorded during fiscal years 2016, 2015, or 2014.

Income Taxes 

The Company provides deferred income taxes on temporary differences between the book and tax basis of its assets and 
liabilities. Those differences arise principally from employee benefit accruals, depreciation, deferred compensation, undistributed 
earnings of unconsolidated affiliates, undistributed earnings of foreign subsidiaries, goodwill, and valuation allowances on farmer 
advances and value-added tax credits. 

Fair Values of Financial Instruments

The fair value of the Company’s long-term debt, disclosed in Note 6, approximates the carrying amount since the variable 
interest rates in the underlying credit agreement reflect the market interest rates that were available to the Company at March 31, 
2016.  In periods when fixed-rate obligations are outstanding, fair values are estimated using market prices where they are available 
and discounted cash flow models based on current incremental borrowing rates for similar classes of borrowers and borrowing 
arrangements. The fair values of interest rate swap agreements designated as cash flow hedges and used to fix the variable benchmark 
rate on outstanding long-term debt are determined separately and recorded in other long-term liabilities.  Except for interest rate 
swaps and forward foreign currency exchange contracts that are discussed below, the fair values of all other assets and liabilities that 
qualify as financial instruments approximate their carrying amounts.

Derivative Financial Instruments

The Company recognizes all derivatives on the balance sheet at fair value.  Interest rate swaps and forward foreign currency 
exchange contracts are used from time to time to manage interest rate risk and foreign currency risk.  The Company enters into such 
contracts only with counterparties of good standing.  The credit exposure related to non-performance by the counterparties and the 
Company is considered in determining the fair values of the derivatives, and the effect has not been material to the financial statements 
or operations of the Company.  Additional disclosures related to the Company’s derivatives and hedging activities are provided in 
Note 8.

Translation and Remeasurement of Foreign Currencies

The financial statements of foreign subsidiaries having the local currency as the functional currency are translated into U.S. 
dollars using exchange rates in effect at period end for assets and liabilities and average exchange rates applicable to each reporting 
period for results of operations.  Adjustments resulting from translation of financial statements are reflected as a separate component 
of other comprehensive income or loss.

46

  
UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The financial statements of foreign subsidiaries having the U.S. dollar as the functional currency, with certain transactions 
denominated in a local currency, are remeasured into U.S. dollars.  The remeasurement of local currency amounts into U.S. dollars 
creates remeasurement gains and losses that are included in earnings as a component of selling, general, and administrative expense.  
The Company recognized net remeasurement losses of $22.5 million in fiscal year 2016, $28.8 million in fiscal year 2015, and $14.3 
million in fiscal year 2014.

Foreign currency transactions and forward foreign currency exchange contracts that are not designated as hedges generate 
gains and losses when they are settled or when they are marked to market under the prescribed accounting guidance.  These transaction 
gains  and  losses  are  also  included  in  earnings  as  a  component  of  selling,  general,  and  administrative  expenses.   The  Company 
recognized net foreign currency transaction gains of $8.0 million in fiscal year 2016, net transaction gains of $17.7 million in fiscal 
year 2015, and net transaction losses of $6.0 million in fiscal year 2014.

Revenue Recognition 

Revenue from the sale of tobacco is recognized when title and risk of loss is transferred to the customer and the earnings 
process is complete.  Substantially all sales revenue is recorded based on the physical transfer of products to customers.  A large 
percentage of the Company’s sales are to major multinational manufacturers of consumer tobacco products.  The Company works 
closely with those customers to understand and plan for their requirements for volumes, styles, and grades of leaf tobacco from its 
various growing regions, and extensive coordination is maintained on an ongoing basis to determine and satisfy their requirements 
for physical shipment of processed tobacco.  In most cases, customers request shipment within a relatively short period of time after 
the tobacco is processed and packed.  The customers also specify, in sales contracts and in shipping documents, the precise terms 
for transfer of title and risk of loss for the tobacco.  Customer returns and rejections are not significant, and the Company’s sales 
history indicates that customer-specific acceptance provisions are consistently met upon transfer of title and risk of loss.

While most of the Company’s revenue consists of tobacco that is purchased from farmers, processed and packed in its 
factories, and then sold to customers, some revenue is earned from processing tobacco owned by customers.  These arrangements 
usually exist in specific markets where the customers contract directly with farmers for leaf production, and they have accounted for 
less than 5% of total revenue on an annual basis through the fiscal year ended March 31, 2016.  Processing and packing of leaf 
tobacco is a short-duration process.  Under normal operating conditions, raw tobacco that is placed into the production line exits as 
processed and packed tobacco within one hour, and is then transported to customer-designated storage facilities.  The revenue for 
these services is recognized when processing is completed, and the Company’s operating history indicates that customer requirements 
for processed tobacco are consistently met upon completion of processing.

Stock-Based Compensation

Share-based payments, such as grants of stock options, stock appreciation rights, restricted stock, restricted stock units, and 
performance share awards, are measured at fair value and reported as expense in the financial statements over the requisite service 
period.  Additional disclosures related to stock-based compensation are included in Note 12.

Estimates and Assumptions 

The preparation of financial statements in conformity with generally accepted accounting principles in the United States 
requires  management  to  make  estimates  and  assumptions  that  affect  the  amounts  reported  in  the  financial  statements  and 
accompanying notes.  Actual results could differ from those estimates. 

Accounting Pronouncements 

Pronouncements Recently Adopted

In November 2015, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update No. 2015-17, 
"Balance Sheet Classification of Deferred Taxes" ("ASU 2015-17"). ASU 2015-17 eliminates the current requirement for an entity 
to separate deferred income tax liabilities and assets into current and noncurrent amounts in a classified balance sheet. ASU 2015-17 
requires that deferred tax liabilities, deferred tax assets, and valuation allowances be classified as noncurrent in a classified balance 
sheet.  Early adoption of ASU 2015-17 is permitted, and the Company made the required balance sheet presentation change effective 
for March 31, 2016 and all prior comparative periods. 

Pronouncements to be Adopted in Future Periods

In May 2014, the FASB issued Accounting Standards Update No. 2014-09, “Revenue from Contracts with Customers” (“ASU 
2014-09”), which supersedes substantially all of the current revenue recognition guidance under U.S. generally accepted accounting 
principles (“U.S. GAAP”).  ASU 2014-09 was developed under a joint project with the International Accounting Standards Board 
(“IASB”) to improve and converge the existing revenue recognition accounting guidance in U.S. GAAP and International Accounting 
Standards.  Under ASU 2014-09, the central underlying principle is to recognize revenues when promised goods or services are 
transferred to customers at an amount determined by the consideration a company expects to receive for those goods or services.  

47

 
 
 
 
UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
The guidance outlines a five-step process for determining the amount and timing of revenue to be recognized from those arrangements.  
It is more principles-based than the existing guidance under U.S. GAAP, and therefore is expected to require more management 
judgment  and  involve  more  estimates  than  the  current  guidance.  ASU  2014-09  is  effective  for  annual  periods  beginning  after 
December 15, 2017, including all interim periods within the year of adoption.   Companies are allowed to select between two transition 
methods:  (1) a full retrospective transition method with the application of the new guidance to each prior reporting period presented, 
or (2) a retrospective transition method that recognizes the cumulative effect on prior periods at the date of adoption together with 
additional footnote disclosures. Since the issuance of ASU 2014-09, the FASB has issued several amendments to provide additional 
supplemental guidance on certain aspects of the original pronouncement.  Universal expects to adopt ASU 2014-09 and the related 
supplemental amendments effective April 1, 2018, which is the beginning of the fiscal year ending March 31, 2019.  The Company 
is currently evaluating the impact that the adoption of ASU 2014-09 and the related amendments will have on its consolidated financial 
statements and has not made a decision on the method of adoption. 

In April 2015, the FASB issued Accounting Standards Update No. 2015-03, “Simplifying the Presentation of Debt Issuance 
Costs” (“ASU 2015-03”). ASU 2015-03 requires that debt issuance costs related to a recognized debt liability be presented in the 
balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. ASU 2015-03 is 
effective for fiscal years beginning after December 31, 2015. The Company will make the required balance sheet presentation change 
upon adoption of ASU 2015-03 effective for the quarter ending June 30, 2016, which is the first quarter of the fiscal year ending 
March 31, 2017.

In  July  2015,  the  FASB  issued  Accounting  Standards  Update  No.  2015-11,  “Simplifying  the  Measurement  of 
Inventory” (“ASU 2015-11”). ASU 2015-11 requires that most inventory be measured at the lower of cost or net realizable value.  
ASU 2015-11 defines net realizable value as the "estimated selling price in the ordinary course of business, less reasonable predictable 
costs of completion, disposal, and transportation."  ASU 2015-11 is effective for fiscal years beginning after December 31, 2016. 
The Company is currently evaluating the impact that the adoption of ASU 2015-11 will have on its consolidated financial statements. 
ASU 2015-11 will be applied prospectively after the date of adoption, as required by the guidance.

In January 2016, the FASB issued Accounting Standards Update No. 2016-01 “Financial Instruments-Recognition and 
Measurement of Financial Assets and Financial Liabilities” ("ASU 2016-01").  ASU 2016-01 requires all equity investments to be 
measured at fair value with changes in the fair value recognized through net income (other than those accounted for under the equity 
method of accounting or those that result in consolidation of the investee). This guidance is effective for fiscal years beginning after 
December 15, 2017. The Company is currently evaluating the impact that the adoption of ASU 2016-01 will have on its consolidated 
financial statements.

In February 2016, the FASB issued Accounting Standards Update No. 2016-02, “Leases (Topic 842)” (“ASU 2016-02”).  
ASU 2016-02 requires a lessee to recognize lease payment obligations as a lease liability and the corresponding right-of-use asset 
as a leased asset in the balance sheet for the term of the lease.   This guidance supersedes Topic 840 “Leases” and is effective for 
fiscal years beginning after December 15, 2018.  The Company will be required to adopt ASU 2016-02 effective April 1, 2019, which 
is the beginning of its fiscal year ending March 31, 2020, and is currently evaluating the impact that the updated guidance will have 
on its consolidated financial statements.

In March, 2016, the FASB issued Accounting Standards Update No. 2016-09, "Compensation - Stock Compensation (Topic 
718)" ("ASU 2016-09").  ASU 2016-09 provides simplification for the accounting for employee stock-based payment transactions, 
including the related income tax consequences, the classification of awards as either equity or liabilities, and the classification of 
transactions in the statement of cash flows.  The guidance is effective for fiscal years beginning after December 15, 2017.  Early 
adoption of ASU 2016-09 is permitted, and the Company expects to adopt the new guidance effective April 1, 2016, which is the 
beginning of its fiscal year ending March 31, 2017.  The adoption of ASU 2016-09 is not expected to have a material impact on the 
Company's consolidated financial statements.

Reclassifications 

Certain prior year amounts have been reclassified to conform to the current year’s presentation.

48

 
 
 
 
 
UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

NOTE 2.   RESTRUCTURING AND IMPAIRMENT COSTS

During the three fiscal years ended March 31, 2016, Universal recorded restructuring and impairment costs related to 
various initiatives to adjust certain operations and reduce costs.  For all three fiscal years, the restructuring and impairment costs 
incurred primarily related to operations that are part of the Other Regions reportable segment of the Company's flue-cured and burley 
leaf tobacco operations.

Fiscal Year Ended March 31, 2016  

In fiscal year 2016, the Company recorded restructuring and impairment costs totaling $2.4 million related to a decision to 
significantly scale back its operations in Zambia. Those costs included statutory employee termination benefits, impairment charges 
related to outstanding balances on loans to farmers whose contracts were terminated as a result of the decision, and impairment 
charges on certain property and equipment. 

Fiscal Year Ended March 31, 2015 

In fiscal year 2015, the Company recorded restructuring costs totaling $4.9 million, primarily related to downsizing certain 
functions at its operations in Brazil and a decision to suspend its operations in Argentina effective December 31, 2014.  The decision 
to discontinue the Argentina operations involved costs for employee termination benefits, as well as costs to exit the Company's 
business arrangements with a supplier. Restructuring costs were also incurred in connection with downsizing efforts at several other 
locations around the Company.

Fiscal Year Ended March 31, 2014 

In fiscal year 2014, the Company's operating subsidiary in Brazil closed a factory and centralized all tobacco processing 
activities in its primary facility. In connection with this initiative, the Company incurred restructuring costs of approximately $4.0 
million, including employee termination benefits, costs to relocate personnel and equipment to the main facility, and lease exit costs 
on the building that housed the closed operations.  Additional restructuring costs of approximately $2.7 million were incurred in 
connection with voluntary early retirement arrangements at several locations around the Company. 

A summary of the restructuring and impairment costs incurred during the fiscal years ended March 31, 2016, 2015, and 

2014, is as follows: 

Fiscal Years Ended March 31,

2016

2015

2014

Restructuring Costs:............................................................................................................

   Employee termination benefits ...........................................................................................

$

1,629

$

4,354

$

   Other restructuring costs .....................................................................................................

Impairment Costs: ...............................................................................................................

   Farmer loans and property and equipment..........................................................................

96

1,725

664

536

4,890

—

     Total restructuring and impairment costs..........................................................................

$

2,389

$

4,890

$

3,743

3,003

6,746

—

6,746

49

 
 
UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

A reconciliation of the Company’s liability for employee termination benefits and other restructuring costs for fiscal years 

2014 through 2016 is as follows:

Employee 
Termination 
Benefits

Other Costs

Total

Balance at April 1, 2013........................................................................................................

$

382

$

— $

382

Fiscal Year 2014 Activity:

Costs charged to expense...................................................................................................

Payments............................................................................................................................

Balance at March 31, 2014....................................................................................................

Fiscal Year 2015 Activity:

Costs charged to expense...................................................................................................

Payments............................................................................................................................

Balance at March 31, 2015....................................................................................................

Fiscal Year 2016 Activity:

Costs charged to expense...................................................................................................

Payments............................................................................................................................

3,743

(2,099)

2,026

4,354

(5,684)

696

1,629

(2,246)

3,003

(2,843)

160

536

(498)

198

96

(92)

Balance at March 31, 2016....................................................................................................

$

79

$

202

$

6,746

(4,942)

2,186

4,890

(6,182)

894

1,725

(2,338)

281

The majority of the restructuring liability at March 31, 2016 will be paid in the early part of fiscal year 2017.  Universal 
continually reviews its business for opportunities to realize efficiencies, reduce costs, and realign its operations in response to business 
changes.  The Company may incur additional restructuring costs in future periods as business changes occur and additional cost 
savings initiatives are implemented.

50

UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
NOTE 3.   EARNINGS PER SHARE 

The following table sets forth the computation of basic and diluted earnings per share:

(in thousands, except share and per share data)

Basic Earnings Per Share

Numerator for basic earnings per share

Fiscal Year Ended March 31,

2016

2015

2014

Net income attributable to Universal Corporation ........................................................................... $

109,016

$

114,608

$

149,009

Less: Dividends on convertible perpetual preferred stock ...............................................................

(14,748)

(14,824)

(14,850)

Less: Cost in excess of carrying value on repurchases of convertible perpetual preferred stock ....

—

(36)

—

Earnings available to Universal Corporation common shareholders for 

calculation of basic earnings per share .........................................................................................

94,268

99,748

134,159

Denominator for basic earnings per share

Weighted average shares outstanding...............................................................................................

22,683,290

23,035,920

23,238,978

Basic earnings per share ................................................................................................................... $

4.16

$

4.33

$

5.77

Diluted Earnings Per Share

Numerator for diluted earnings per share

Earnings available to Universal Corporation common shareholders ............................................... $

94,268

$

99,748

$

134,159

Add: Dividends on convertible perpetual preferred stock (if conversion assumed) ........................

14,748

14,824

14,850

Add: Cost in excess of carrying value on repurchases of convertible perpetual preferred stock.....

—

36

—

Earnings available to Universal Corporation common shareholders for 

calculation of diluted earnings per share ......................................................................................

109,016

114,608

149,009

Denominator for diluted earnings per share

Weighted average shares outstanding...............................................................................................

22,683,290

23,035,920

23,238,978

Effect of dilutive securities (if conversion or exercise assumed)

Convertible perpetual preferred stock............................................................................................

4,853,268

4,843,309

4,821,557

Employee share-based awards .......................................................................................................

288,933

342,035

331,498

Denominator for diluted earnings per share .....................................................................................

27,825,491

28,221,264

28,392,033

Diluted earnings per share................................................................................................................ $

3.92

$

4.06

$

5.25

For the fiscal years ended March 31, 2016, 2015, and 2014, the Company had the following potentially dilutive securities 
(stock appreciation rights) outstanding that were not included in the computation of diluted earnings per share because their effect 
would have been antidilutive: 

Potentially dilutive securities ..............................................................................................................

133,600

156,200

169,000

Weighted-average exercise price......................................................................................................... $

62.66

$

61.83

$

62.66

Fiscal Year Ended March 31,

2016

2015

2014

51

UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
NOTE 4.   INCOME TAXES 

The Company operates in the United States and many foreign countries and is subject to the tax laws of many jurisdictions.  
Changes in tax laws or the interpretation of tax laws can affect the Company’s earnings, as can the resolution of pending and contested 
tax issues.  The Company's consolidated effective income tax rate is affected by a number of factors, including the mix of domestic 
and foreign earnings, the effect of exchange rate changes on deferred taxes, and the Company’s ability to utilize foreign tax credits.

Income Tax Expense

Income taxes for the fiscal years ended March 31, 2016, 2015, and 2014 consisted of the following: 

Fiscal Year Ended March 31,

2016

2015

2014

Current

United States ..................................................................................................................... $

5,371

$

4,126

$

State and local ...................................................................................................................

Foreign ..............................................................................................................................

Deferred

United States .....................................................................................................................

State and local ...................................................................................................................

Foreign ..............................................................................................................................

1,116

32,897

39,384

5,780

(445)

9,711

15,046

657

46,885

51,668

3,352

159

(17,173)

(13,662)

1,433

507

75,770

77,710

1,686

275

(4,136)

(2,175)

Total................................................................................................................................ $

54,430

$

38,006

$

75,535

Foreign taxes include U.S. tax expense on earnings of foreign subsidiaries.  The Company has no undistributed earnings 

of consolidated foreign subsidiaries that are classified as permanently reinvested.

Consolidated Effective Income Tax Rate

A reconciliation of the statutory U.S. federal rate to the Company’s effective income tax rate is as follows:

Fiscal Year Ended March 31,

2016

2015

2014

Statutory tax rate ...................................................................................................................

35.0%

35.0%

35.0%

State income taxes, net of federal benefit .............................................................................

Dividends received from deconsolidated operations ............................................................

Effect of exchange rate changes on deferred income taxes ..................................................

Tax benefit arising from payment of a portion of a fine by a subsidiary..............................

Other, including changes in liabilities recorded for uncertain tax positions.........................

0.3

(1.5)

(1.6)

—

(0.7)

0.3

(1.3)

(4.9)

(5.0)

(0.1)

0.2

(0.9)

(1.0)

—

(0.6)

Effective income tax rate ......................................................................................................

31.5%

24.0%

32.7%

 During the first quarter of fiscal year 2015, the Company recorded a consolidated income tax benefit of $8 million arising 
from the ability of its subsidiary, Deltafina S.p.A., to pay a significant portion of a fine and related interest charges in Italy that were 
settled during that quarter following the unsuccessful appeal of a case involving anti-competitive activities in the Italian tobacco 
market.  Deltafina and Universal Corporation were jointly liable for the fine and interest charges.  The Company’s initial accrual of 
the amounts imposed in September 2011 assumed that the entire obligation would be paid by Universal Corporation due to uncertainty 
with respect to Deltafina’s financial capacity to bear any significant portion of the cost upon the eventual settlement and to uncertainty 
as to when the payment would be made.  Deltafina ultimately was able to assume responsibility for approximately $30 million of 
the total $53 million obligation for the fine and interest when those amounts were paid.  Although the portion of the fine paid by 
Deltafina was not deductible for income tax purposes in Italy, it reduced the subsidiary’s cumulative undistributed earnings and the 
associated consolidated tax liability, resulting in the $8 million benefit in the Company's consolidated income tax provision.  This 
discrete item reduced the effective income tax rate for fiscal year 2015 by 5.0%.

52

 
 
 
 
UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
Components of Income Before Income Taxes

The U.S. and foreign components of income before income taxes were as follows:

Fiscal Year Ended March 31,

2016

2015

2014

United States ........................................................................................................................ $

37,877   $

27,181   $

9,156

Foreign .................................................................................................................................

134,701   

131,286   

221,534

Total................................................................................................................................... $

172,578   $

158,467   $

230,690

Deferred Income Tax Liabilities and Assets

Significant components of deferred tax liabilities and assets were as follows:  

March 31,

2016

2015

Liabilities

Foreign withholding taxes................................................................................................................................. $

39,770   $

Undistributed earnings ......................................................................................................................................

Goodwill ...........................................................................................................................................................

All other ............................................................................................................................................................

19,553

30,851   

10,424   

Total deferred tax liabilities......................................................................................................................... $

100,598

$

Assets

Employee benefit plans..................................................................................................................................... $

43,362   $

Reserves and accruals .......................................................................................................................................

Deferred income................................................................................................................................................

12,911

3,938

Currency translation losses of foreign subsidiaries...........................................................................................

9,939   

Local currency exchange losses of foreign subsidiaries ...................................................................................

Foreign tax credit carryforward ........................................................................................................................

3,597

4,664

All other ............................................................................................................................................................

16,546   

34,339

14,510

30,851

8,922

88,622

50,977

14,039

5,387

12,167

10,674

—

9,607

Total deferred tax assets...............................................................................................................................

Valuation allowance..........................................................................................................................................

94,957

—

102,851

(629)

Net deferred tax assets ................................................................................................................................. $

94,957   $

102,222

At March 31, 2016, the Company had no material net operating loss carryforwards in either its domestic or foreign operations.

53

  
  
UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
Combined Income Tax Expense (Benefit)

The combined income tax expense (benefit) allocable to continuing operations, other comprehensive income, and direct 

adjustments to shareholders' equity was as follows:

Fiscal Year Ended March 31,

2016

2015

2014

Continuing operations........................................................................................................... $

54,430

$

38,006

$

Other comprehensive income ...............................................................................................

Direct adjustments to shareholders' equity ...........................................................................

1,423

(805)   

(21,900)

(932)   

75,535

22,190

(972)

Total................................................................................................................................ $

55,048   $

15,174   $

96,753

Uncertain Tax Positions

A reconciliation of the beginning and ending balance of the gross liability for uncertain tax positions for the fiscal years 

ended March 31, 2016, 2015 and 2014, is as follows:

Fiscal Year Ended March 31,

2016

2015

2014

Liability for uncertain tax positions, beginning of year ....................................................... $

2,894

$

3,809

$

5,385

Additions:

Related to tax positions for the current year ......................................................................

Related to tax positions for prior years ..............................................................................

Reductions:

Due to lapses of statutes of limitations ..............................................................................

Related to tax positions for prior years ..............................................................................

Effect of currency rate movement......................................................................................

98

—

(215)

—

(370)

272

—

(478)

(143)

(566)

Liability for uncertain tax positions, end of year.................................................................. $

2,407

$

2,894

$

194

168

(1,776)

—

(162)

3,809

  Of the total liability for uncertain tax positions at March 31, 2016, approximately $1.8 million could have an effect on the 
consolidated effective tax rate if the tax benefits are recognized.  The liability for uncertain tax positions includes $0.1 million related 
to tax positions for which it is reasonably possible that the amounts could change significantly before March 31, 2017.  This amount 
reflects a possible decrease in the liability for uncertain tax positions that could result from the completion and resolution of tax 
audits and the expiration of open tax years in various tax jurisdictions.

The Company recognizes accrued interest related to uncertain tax positions as interest expense, and it recognizes penalties 
as a component of income tax expense.  Amounts accrued or reversed for interest and penalties were not material for any of the fiscal 
years 2014 through 2016, and liabilities recorded for interest and penalties at March 31, 2016 and 2015 also were not material.  

Universal and its subsidiaries file a U.S. federal consolidated income tax return, as well as returns in several U.S. states and 
a number of foreign jurisdictions.  As of March 31, 2016, the Company's earliest open tax year for U.S. federal income tax purposes 
was its fiscal year ended 2013.  Open tax years in state and foreign jurisdictions generally range from 3 to 6 years.

54

UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
NOTE 5.   CREDIT FACILITIES

Bank Credit Agreements

In December 2014, the Company entered into a senior unsecured bank credit agreement that replaced its previous short-
term and long-term borrowing facilities, consolidating and extending the maturities of those facilities.  The agreement established a 
$430 million five-year revolving credit facility, along with a $150 million five-year term loan and a $220 million seven-year term 
loan.  Borrowings under the revolving credit facility bear interest at a variable rate based on either (1) LIBOR plus a margin  that is 
based on the Company's credit measures or (2) the higher of the federal funds rate plus 0.5%, prime rate, or one-month LIBOR plus 
1.0%, each plus a margin.  In addition to interest, the Company pays a facility fee on the revolving credit facility.  No amounts were 
outstanding under the revolving credit facility at March 31, 2016.  The credit agreement provides for an expansion of the facility 
under certain conditions to allow additional borrowings of up to $100 million.  Additional information related to the term loans is 
provided in Note 6.  The credit agreement includes financial covenants that require the Company to maintain a minimum level of 
tangible net worth and observe limits on debt levels.  The Company was in compliance with those covenants at March 31, 2016.

Short-Term Credit Facilities

The Company maintains short-term uncommitted lines of credit in the United States and in a number of foreign countries.  
Foreign borrowings are generally in the form of overdraft facilities at rates competitive in the countries in which the Company 
operates.  Generally, each foreign line is available only for borrowings related to operations of a specific country.  As of March 31, 
2016 and 2015, approximately $66 million and $60 million, respectively, were outstanding under these uncommitted lines of credit.  
The weighted-average interest rates on short-term borrowings outstanding as of March 31, 2016 and 2015, were approximately 2.2%
and 2.7%, respectively.  At March 31, 2016, the Company and its consolidated affiliates had unused uncommitted lines of credit 
totaling approximately $306 million. 

NOTE 6.   LONG-TERM DEBT

The Company's long-term debt at March 31, 2016 and 2015 consisted of the following:

March 31,

2016

2015

Senior bank term loans ...................................................................................................................................... $

370,000   $

370,000

Total outstanding ...........................................................................................................................................

370,000

370,000

Less: current portion..........................................................................................................................................

—   

—

Long-term debt .............................................................................................................................................. $

370,000   $

370,000

As discussed in Note 5, the Company entered into a bank credit agreement in December 2014 that established a $150 million
five-year term loan and a $220 million seven-year term loan.  Both term loans were fully funded at closing, and the Company 
concurrently repaid approximately $250 million aggregate principal amount on term loans outstanding under two previous bank 
credit facilities and reduced its revolving credit borrowings by approximately $120 million.  The term loans require no amortization 
and are prepayable without penalty prior to maturity.  Under the credit agreement, both term loans bear interest at variable rates plus 
a margin based on the Company's credit measures.  However, following closing on the term loans, the Company entered into receive-
floating / pay-fixed interest rate swap agreements that convert the variable benchmark rate on both loans to a fixed rate over their 
full terms to maturity.  With the swap agreements in place, the effective interest rate on the $150 million five-year loan and the $220 
million seven-year loan were 2.94% and 3.48%, respectively, at March 31, 2016 and 2015.  The effective rates will change only if 
a change in the Company's credit measures results in adjustments to the applicable credit spreads specified in the underlying loan 
agreement.  The $150 million five-year term loan matures in fiscal year 2020, and the $220 million seven-year term loan matures in 
fiscal year 2022.

In November 2014, the Company filed an undenominated universal shelf registration statement with the U.S. Securities 
and Exchange Commission to provide for the future issuance of an undefined amount of additional debt or equity securities as 
determined by the Company and offered in one or more prospectus supplements prior to issuance.

Disclosures about the fair value of long-term debt are provided in Note 9.

55

  
UNIVERSAL CORPORATION 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
NOTE 7.   LEASES

The Company’s subsidiaries lease various production, storage, distribution, and other facilities, as well as vehicles and 
equipment used in their operations.  Some of the leases have options to extend the lease term at market rates.  These arrangements 
are classified as operating leases for accounting purposes.  Rent expense on operating leases totaled $14.7 million in fiscal year 2016, 
$15.8 million in fiscal year 2015, and $18.2 million in fiscal year 2014.  Future minimum payments under non-cancelable operating 
leases total $10.3 million in 2017, $7.1 million in 2018, $6.1 million in 2019, $4.8 million in 2020, $4.4 million in 2021, and $15.0 
million after 2021.

NOTE 8.   DERIVATIVES AND HEDGING ACTIVITIES

Universal is exposed to various risks in its worldwide operations and uses derivative financial instruments to manage two 
specific types of risks – interest rate risk and foreign currency exchange rate risk.  Interest rate risk has been managed by entering 
into interest rate swap agreements, and foreign currency exchange rate risk has been managed by entering into forward foreign 
currency exchange contracts.  However, the Company’s policy also permits other types of derivative instruments.  In addition, foreign 
currency  exchange  rate  risk  is  also  managed  through  strategies  that  do  not  involve  derivative  instruments,  such  as  using  local 
borrowings and other approaches to minimize net monetary positions in non-functional currencies.  The disclosures below provide 
additional information about the Company’s hedging strategies, the derivative instruments used, and the effects of these activities 
on the consolidated statements of income and the consolidated balance sheets.  In the consolidated statements of cash flows, the cash 
flows associated with all of these activities are reported in net cash provided by operating activities. 

Cash Flow Hedging Strategy for Interest Rate Risk

In January 2015, the Company entered into receive-floating/pay-fixed interest rate swap agreements that were designated 
and qualified as hedges of the exposure to changes in interest payment cash flows created by fluctuations in variable interest rates 
on its two outstanding non-amortizing bank term loans (see Note 5).  Although no significant ineffectiveness is expected with this 
hedging strategy, the effectiveness of the interest rate swaps is evaluated on a quarterly basis.  At March 31, 2016, the total notional 
amount of the interest rate swaps was $370 million, which corresponded with the aggregate outstanding balance of the term loans.

Previously, the Company had receive-floating/pay-fixed interest rate swap agreements that were designated and qualified 
as cash flow hedges on an amortizing bank term loan that has since been repaid.  Those swap agreements, which had an aggregate 
notional  amount  of  approximately  $74  million  reflecting  the  principal  balance  outstanding  on  the  loan,  were  terminated  upon 
repayment of the debt in December 2014.  The fair value of the swap agreements, approximately $0.6 million, was paid to the 
counterparties upon termination and charged to expense. 

Cash Flow Hedging Strategy for Foreign Currency Exchange Rate Risk Related to Forecast Purchases of Tobacco and Related 
Processing Costs

The majority of the tobacco production in most countries outside the United States where Universal operates is sold in 
export markets at prices denominated in U.S. dollars.  However, purchases of tobacco from farmers and most processing costs (such 
as labor and energy) in those countries are usually denominated in the local currency.  Changes in exchange rates between the U.S. 
dollar and the local currencies where tobacco is grown and processed affect the ultimate U.S. dollar cost of the processed tobacco.  
From time to time, the Company enters into forward contracts to sell U.S. dollars and buy the local currency at future dates that 
coincide with the expected timing of a portion of the tobacco purchases and processing costs.  This strategy offsets the variability 
of future U.S. dollar cash flows for tobacco purchases and processing costs for the foreign currency notional amount hedged.  This 
hedging strategy has been used mainly for tobacco purchases and processing costs in Brazil.  The aggregate U.S. dollar notional 
amount of forward contracts entered for these purposes during fiscal years 2016, 2015, and 2014 was as follows:

(in millions)

Fiscal Year Ended March 31,

2016

2015

2014

Tobacco purchases ...............................................................................................................

$

43.1

$

105.6

$

Processing costs ...................................................................................................................

13.2

22.9

Total..................................................................................................................................

$

56.3

$

128.5

$

126.1

26.8

152.9

The reduced U.S. dollar notional amounts for tobacco purchases and processing costs hedged during fiscal year 2016 reflect 
the combined effect of the devaluation of the Brazilian currency since the prior fiscal year, the reduced size of the 2016 crop, and a 
variation in the timing of fixed-price orders from customers for their purchases from the respective crop years. All contracts related 
to tobacco purchases were designated and qualify as hedges of the future cash flows associated with the forecast purchases of tobacco.  
As a result, except for amounts related to any ineffective portion of the hedging strategy or any early de-designation of the hedge 
arrangement, changes in fair values of the forward contracts have been recognized in comprehensive income as they occurred, but 

56

 
UNIVERSAL CORPORATION 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
only recognized in earnings upon sale of the related tobacco to third-party customers.  Forward contracts related to processing costs 
have not been designated as hedges, and gains and losses on those contracts have been recognized in earnings on a mark-to-market 
basis. 

For substantially all hedge gains and losses recorded in accumulated other comprehensive loss at March 31, 2016, the 
Company expects to complete the sale of the tobacco and recognize the amounts in earnings during fiscal year 2017.  At March 31, 
2016, all hedged forecast purchases of tobacco not yet completed remained probable of occurring within the originally designated 
time period and, as a result, no hedges had been discontinued. Purchases of the 2016 crop are expected to be completed by August 
2016, and all forward contracts to hedge those purchases will mature and be settled by that time.

Hedging Strategy for Foreign Currency Exchange Rate Risk Related to Net Local Currency Monetary Assets and Liabilities of 
Foreign Subsidiaries

Most of the Company’s foreign subsidiaries transact the majority of their sales in U.S. dollars and finance the majority of 
their  operating  requirements  with  U.S.  dollar  borrowings,  and  therefore  use  the  U.S.  dollar  as  their  functional  currency. These 
subsidiaries normally have certain monetary assets and liabilities on their balance sheets that are denominated in the local currency. 
Those assets and liabilities can include cash and cash equivalents, accounts receivable and accounts payable, advances to farmers 
and suppliers, deferred income tax assets and liabilities, recoverable value-added taxes, and other items. Net monetary assets and 
liabilities denominated in the local currency are remeasured into U.S. dollars each reporting period, generating gains and losses that 
the Company records in earnings as a component of selling, general, and administrative expenses. The level of net monetary assets 
or liabilities denominated in the local currency normally fluctuates throughout the year based on the operating cycle, but it is most 
common for monetary assets to exceed monetary liabilities, sometimes by a significant amount. When this situation exists and the 
local currency weakens against the U.S. dollar, remeasurement losses are generated. Conversely, remeasurement gains are generated 
on a net monetary asset position when the local currency strengthens against the U.S. dollar.  To manage a portion of its exposure 
to currency remeasurement gains and losses, the Company enters into forward contracts to buy or sell the local currency at future 
dates coinciding with expected changes in the overall net local currency monetary asset position of the subsidiary. Gains and losses 
on the forward contracts are recorded in earnings as a component of selling, general, and administrative expenses for each reporting 
period as they occur, and thus directly offset the related remeasurement losses or gains in the consolidated statements of income for 
the notional amount hedged. The Company does not designate these contracts as hedges for accounting purposes. The contracts are 
generally arranged to hedge the subsidiary's projected exposure to currency remeasurement risk for specified periods of time, and 
new contracts are entered as necessary throughout the year to replace previous contracts as they mature.  During fiscal years ended  
March 31, 2016, 2015, and 2014, the Company used forward currency contracts to manage its exposure to currency remeasurement 
risk in Brazil.  At March 31, 2016, the net local monetary asset position in Brazil was not significant, and there were no foreign 
currency  contracts  to  manage  currency  remeasurement  risk  outstanding.  The  total  notional  amount  of  contracts  outstanding  at 
March 31, 2015 was approximately $80.4 million. To further mitigate currency remeasurement exposure, the Company’s foreign 
subsidiaries may utilize short-term local currency financing during certain periods.  This strategy, while not involving the use of 
derivative instruments, is intended to minimize the subsidiary’s net monetary position by financing a portion of the local currency 
monetary assets with local currency monetary liabilities and thus hedging a portion of the overall position. 

Several of the Company’s foreign subsidiaries transact the majority of their sales and finance the majority of their operating 
requirements  in  their  local  currency,  and  therefore  use  their  respective  local  currencies  as  the  functional  currency  for  reporting 
purposes.  From time to time, these subsidiaries sell tobacco to customers in transactions that are not denominated in the functional 
currency.  In those situations, the subsidiaries routinely enter into forward exchange contracts to offset currency risk for the period 
of time that a fixed-price order and the related trade account receivable are outstanding with the customer. The contracts are not 
designated as hedges for accounting purposes.

57

UNIVERSAL CORPORATION 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
Effect of Derivative Financial Instruments on the Consolidated Statements of Income

The table below outlines the effects of the Company’s use of derivative financial instruments on the consolidated statements 

of income for the fiscal years ended March 31, 2016, 2015, and 2014.

Fiscal Year Ended March 31,

2016

2015

2014

Cash Flow Hedges - Interest Rate Swap Agreements

Derivative

Effective Portion of Hedge

Gain (loss) recorded in accumulated other comprehensive loss............................................

Gain (loss) reclassified from accumulated other comprehensive loss into earnings .............

$

$

(12,824) $

(4,044) $

(5,108) $

(1,929) $

(142)

(886)

Location of gain (loss) reclassified from accumulated other comprehensive loss into

earnings ..............................................................................................................................

Interest expense

Ineffective Portion of Hedge

Gain (loss) recognized in earnings.........................................................................................

$

— $

— $

—

Location of gain (loss) recognized in earnings ......................................................................

Selling, general and administrative expenses

Hedged Item

Description of hedged item.......................................................................................................

Floating rate interest payments on term loans

Cash Flow Hedges - Forward Foreign Currency Exchange Contracts

Derivative

Effective Portion of Hedge

Gain (loss) recorded in accumulated other comprehensive loss............................................

Gain (loss) reclassified from accumulated other comprehensive 

loss into earnings................................................................................................................

$

$

1,774

993

$

$

1,410

3,099

$

$

(1,635)

(3,844)

Location of gain (loss) reclassified from accumulated other 

comprehensive loss into earnings ......................................................................................

Cost of goods sold

Ineffective Portion and Early De-designation of Hedges

Gain (loss) recognized in earnings.........................................................................................

$

685

$

257

$

(1,839)

Location of gain (loss) recognized in earnings ......................................................................

Selling, general and administrative expenses

Hedged Item

Description of hedged item......................................................................................................

 Forecast purchases of tobacco in Brazil

Derivatives Not Designated as Hedges -
Forward Foreign Currency Exchange Contracts

Gain (loss) recognized in earnings.........................................................................................

$

5,973

$

13,178

$

(6,609)

Location of gain (loss) recognized in earnings ......................................................................

Selling, general and administrative expenses

For the interest rate swap agreements, the effective portion of the gain or loss on the derivative is recorded in accumulated 
other comprehensive loss and any ineffective portion is recorded in selling, general and administrative expenses.  For the forward 
foreign currency exchange contracts designated as cash flow hedges of tobacco purchases in Brazil, a net hedge gain of approximately 
$0.5 million remained in accumulated other comprehensive loss at March 31, 2016.  That balance reflects net gains on contracts 
related to the 2016 crop.  No hedge gain or loss had been reclassified to earnings at March 31, 2016 since shipments of those tobaccos 
had  not  yet  started.   The  majority  of  the  balance  in  accumulated  other  comprehensive  loss  will  be  recognized  in  earnings  as  a 
component of cost of goods sold in fiscal year 2017 as the 2016 Brazilian crop tobacco is sold to customers.  Based on the hedging 
strategy, as the gain or loss is recognized in earnings, it is expected to be offset by a change in the direct cost for the tobacco or by 
a change in sales prices if the strategy has been mandated by the customer.  Generally, margins on the sale of the tobacco will not 
be significantly affected.

58

UNIVERSAL CORPORATION 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
Effect of Derivative Financial Instruments on the Consolidated Balance Sheets

The table below outlines the effects of the Company’s derivative financial instruments on the consolidated balance sheets 

at March 31, 2016 and 2015:

Derivatives Designated as Hedging
Instruments

Interest rate swap agreements

Forward foreign currency exchange contracts

Total

Derivatives Not Designated as Hedging
Instruments

Forward foreign currency exchange contracts

Total

Derivatives in a Fair Value
Asset Position

Derivatives in a Fair Value
Liability Position

Balance 
Sheet 
Location

Fair Value as of March 31,

2016

2015

Other
non-current
assets

Other
current
assets

Other
current
assets

$

— $

—

475

$

475

$

106

106

$

$

297

297

$

$

5,148

5,148

Balance 
Sheet 
Location

Other
long-term
liabilities

Accounts
payable and
accrued
expenses

Accounts
payable and
accrued
expenses

Fair Value as of March 31,

2016

2015

$

10,766

$

3,050

—

396

$

10,766

$

3,446

$

$

5

5

$

$

183

183

Substantially all of the Company's forward foreign currency exchange contracts are subject to master netting arrangements, 
whereby the right to offset occurs in the event of default by a participating party. The Company has elected to present these contracts 
on a gross basis in the consolidated balance sheets.

NOTE 9.   FAIR VALUE MEASUREMENTS

Universal measures certain financial and nonfinancial assets and liabilities at fair value based on applicable accounting 
guidance.  The financial assets and liabilities measured at fair value include money market funds, trading securities associated with 
deferred compensation plans, interest rate swap agreements, forward foreign currency exchange contracts, and guarantees of bank 
loans to tobacco growers.  The application of the fair value guidance to nonfinancial assets and liabilities primarily includes the 
determination of fair values for goodwill and long-lived assets when indicators of potential impairment are present.  

Under the accounting guidance, fair value is defined as the price that would be received to sell an asset or paid to transfer 
a liability in an orderly transaction between market participants at the measurement date.  The framework for measuring fair value 
is based on a fair value hierarchy that distinguishes between observable inputs and unobservable inputs.  Observable inputs are based 
on market data obtained from independent sources.  Unobservable inputs require the Company to make its own assumptions about 
the value placed on an asset or liability by market participants because little or no market data exists.  There are three levels within 
the fair value hierarchy. 

Level

1

2

3

Description

quoted prices in active markets for identical assets or liabilities that the Company has the ability to access as of the 
reporting date;

quoted prices in active markets for similar assets or liabilities, or quoted prices for identical or similar assets or liabilities 
in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability; and

  unobservable inputs for the asset or liability.

In measuring the fair value of liabilities, the Company considers the risk of non-performance in determining fair value.  
Universal has not elected to report at fair value any financial instruments or any other assets or liabilities that are not required to be 
reported at fair value under current accounting guidance.

59

 
  
  
UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

At March 31, 2016 and 2015, the Company had certain financial assets and financial liabilities that were required to be 
measured and reported at fair value on a recurring basis.  These assets and liabilities are listed in the tables below and are classified 
based on how their values were determined under the fair value hierarchy:

March 31, 2016

Level 1

Level 2

Level 3

Total

Assets

Money market funds .......................................................................................

$

— $

116,618

$

— $

116,618

Trading securities associated with deferred compensation plans ...................

Forward foreign currency exchange contracts................................................

17,817

—

—

772

—

—

17,817

772

Total financial assets measured and reported at fair value...........................

$

17,817

$

117,390

$

— $

135,207

Liabilities

Guarantees of bank loans to tobacco growers ................................................

$

— $

— $

1,628

$

Interest rate swap agreements .........................................................................

Forward foreign currency exchange contracts................................................

—

—

10,766

5

—

—

1,628

10,766

5

Total financial liabilities measured and reported at fair value.....................

$

— $

10,771

$

1,628

$

12,399

March 31, 2015

Level 1

Level 2

Level 3

Total

Assets

Money market funds ........................................................................................

$

— $

86,552

$

— $

Trading securities associated with deferred compensation plans.....................

Forward foreign currency exchange contracts .................................................

20,692

—

—

5,254

—

—

86,552

20,692

5,254

 Total financial assets measured and reported at fair value..........................

$

20,692

$

91,806

$

— $

112,498

Liabilities

Guarantees of bank loans to tobacco growers..................................................

$

— $

— $

1,695

$

Interest rate swap agreements ..........................................................................

Forward foreign currency exchange contracts .................................................

—

—

3,050

579

—

—

 Total financial liabilities measured and reported at fair value....................

$

— $

3,629

$

1,695

$

1,695

3,050

579

5,324

Money market funds

The fair value of money market funds, which are reported in cash and cash equivalents in the consolidated balance sheets, 
is based on net asset value, which is computed based on amortized cost (Level 2).  The fair values of these investments approximate 
cost due to the short-term maturities and the high credit quality of the issuers of the underlying securities.

Trading securities associated with deferred compensation plans

Trading securities represent mutual fund investments that are matched to employee deferred compensation obligations.  
These  investments  are  bought  and  sold  as  employees  defer  compensation,  receive  distributions,  or  make  changes  in  the  funds 
underlying their accounts.  Quoted market prices (Level 1) are used to determine the fair values of the mutual funds. 

60

UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
Interest rate swap agreements

The fair values of interest rate swap agreements are determined based on dealer quotes using a discounted cash flow model 
matched to the contractual terms of each instrument.  Since inputs to the model are observable and significant judgment is not required 
in determining the fair values, interest rate swaps are classified within Level 2 of the fair value hierarchy.

Forward foreign currency exchange contracts

The fair values of forward foreign currency exchange contracts are also determined based on dealer quotes using a discounted 
cash flow model matched to the contractual terms of each instrument.  Since inputs to the model are observable and significant 
judgment is not required in determining the fair values, forward foreign currency exchange contracts are classified within Level 2 
of the fair value hierarchy.

Guarantees of bank loans to tobacco growers

The Company guarantees bank loans to tobacco growers in Brazil for crop financing and has previously guaranteed loans 
to those growers for the construction of curing barns or other tobacco producing assets.  In the event that the farmers default on their 
payments to the banks, the Company would be required to perform under the guarantees.  The Company regularly evaluates the 
likelihood of farmer defaults based on an expected loss analysis and records the fair value of its guarantees as an obligation in its 
consolidated financial statements.  The fair value of the guarantees is determined using the expected loss data for all loans outstanding 
at each measurement date.  The present value of the cash flows associated with the estimated losses is then calculated at a risk-
adjusted interest rate that is aligned with the expected duration of the liability and includes an adjustment for nonperformance risk.  
This approach is sometimes referred to as the “contingent claims valuation method.”  Although historical loss data is an observable 
input,  significant  judgment  is  required  in  applying  this  information  to  the  portfolio  of  guaranteed  loans  outstanding  at  each 
measurement date and in selecting a risk-adjusted interest rate.  Significant increases or decreases in the risk-adjusted interest rate 
may result in a significantly higher or lower fair value measurement.  The guarantees of bank loans to tobacco growers are therefore 
classified within Level 3 of the fair value hierarchy.

A reconciliation of the change in the balance of the financial liability for guarantees of bank loans to tobacco growers (Level 

3) for the fiscal years ended March 31, 2016 and 2015 is provided below. 

Balance at beginning of year ..............................................................................................................................
Payments under the guarantees and transfers to allowance for loss on direct loans to farmers (removal of

prior crop year loans from the portfolio) ........................................................................................................

Provision for loss or transfers from allowance for loss on direct loans to farmers (addition of current crop

year loans).......................................................................................................................................................

Change in discount rate and estimated collection period ...................................................................................

Currency remeasurement ....................................................................................................................................

Fiscal Year Ended March 31,

2016

2015

$

1,674

$

2,270

(1,826)

(2,392)

1,834

106

(160)

2,320

130

(654)

Balance at end of year.........................................................................................................................................

$

1,628

$

1,674

Long-term Debt

The fair value of the Company’s long-term debt was approximately $370 million at March 31, 2016 and 2015.  The Company 
estimates the fair value of its long-term debt using Level 2 inputs which are based upon quoted market prices for the same or similar 
obligations or on calculations that are based on the current interest rates available to the Company for debt of similar terms and 
maturities.

61

UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
NOTE 10.   PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS 

Defined Benefit Plans

Description of Plans 

 The Company sponsors several defined benefit pension plans covering U.S. salaried employees and certain foreign and 
other employee groups.  These plans provide retirement benefits based primarily on employee compensation and years of service. 
Plan assets consist primarily of equity and fixed income investments.  The Company also sponsors defined benefit plans that provide 
postretirement health and life insurance benefits for eligible U.S. employees who have attained specific age and service levels, 
although postretirement life insurance benefits were discontinued for active employees during fiscal year 2015.  The health benefits 
are funded by the Company as the costs of those benefits are incurred. The plan design includes cost-sharing features such as 
deductibles and coinsurance.  The life insurance benefits are funded with deposits to a reserve account held by an insurance company.  
The Company has the right to amend or discontinue its pension and other postretirement benefit plans at any time.

In the following disclosures, the term “accumulated benefit obligation” (“ABO”) represents the actuarial present value of 
estimated future benefit payments earned by participants in the Company's defined benefit pension plans as of the balance sheet 
date without regard to the estimated effect of future compensation increases on those benefits.  The term does not apply to other 
postretirement benefits.  “Projected benefit obligation” refers to the projected benefit obligation (“PBO”) for pension benefits and 
the accumulated postretirement benefit obligation (“APBO”) for other postretirement benefits.  These amounts represent the actuarial 
present value of estimated future benefit payments earned by participants in the benefit plans as of the balance sheet date.  For 
pension benefits, the projected benefit obligation includes the estimated effect of future compensation increases on those benefits.

Actuarial Assumptions

Assumptions used for financial reporting purposes to compute net periodic benefit cost and benefit obligations for the 

Company's primary defined benefit plans were as follows:

Pension Benefits

Other Postretirement Benefits

2016

2015

2014

2016

2015

2014

Discount rates:

Benefit cost for plan year..........................

Benefit obligation at end of plan year ......

3.80%   

4.10%   

4.50%   

3.80%   

Expected long-term return on plan assets:

Benefit cost for plan year..........................

7.25%   

7.75%   

Benefit obligation at end of plan year ......

7.00%

7.25%

Salary scale:

Benefit cost for plan year..........................

Benefit obligation at end of plan year ......

4.50%

4.00%

4.50%

4.50%

Healthcare cost trend rate............................

N/A   

N/A   

4.20%

4.50%

8.00%

7.75%

5.00%

4.50%

N/A

3.70%   

3.80%   

4.30%   

3.70%   

3.00%   

4.30%   

3.00%

3.00%

4.50%

4.00%

4.50%

4.50%

7.00%   

7.20%   

3.90%

4.30%

4.30%

4.30%

5.00%

4.50%

7.40%

Changes in the discount rates in the above table reflect prevailing market interest rates at the end of each fiscal year when 
the benefit obligations are actuarially measured.  The reduction in the expected long-term return on plan assets assumption from 
fiscal year 2014 to fiscal year 2016 is primarily due to changes in the underlying plan assets.  These changes reflect a move toward 
a liability-driven investment strategy in the Company's ERISA-regulated U.S. defined benefit pension plan due to the high percentage 
of retired and inactive participants in the plan and the high funded status of the plan.  The healthcare cost trend rate used by the 
Company is based on a study of medical cost inflation rates that is reviewed annually for continued applicability.  The revised trend 
assumption of 7.00% in 2016 declines gradually to 4.50% in 2037.  

62

  
  
  
  
  
  
  
  
  
  
  
  
UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
Benefit Obligations, Plan Assets, and Funded Status

The following table reflects the changes in benefit obligations and plan assets in 2016 and 2015, as well as the funded 

status of the plans at March 31, 2016 and 2015:

Pension
 Benefits

March 31,

Other Postretirement
Benefits

March 31,

2016

2015

2016

2015

Actuarial present value of benefit obligation:

Accumulated benefit obligation .................................................................... $

273,479   $

287,133

Projected benefit obligation...........................................................................

275,505   

288,908

$

37,225

$

40,863

Change in projected benefit obligation:

Projected benefit obligation, beginning of year ............................................ $

288,908

$

259,928

$

40,863

$

41,846

Service cost....................................................................................................

Interest cost....................................................................................................

5,953

10,037

Effect of discount rate change .......................................................................

(10,036)

Foreign currency exchange rate changes.......................................................

Curtailment ....................................................................................................

Other ..............................................................................................................

330

—

(486)

5,099

11,215

30,744

(6,033)

—

2,879

Benefit payments ...........................................................................................

(19,201)

(14,924)

286

1,539

(402)

(215)

—

(1,104)

(3,742)

347

1,699

2,669

(444)

(1,465)

(788)

(3,001)

Projected benefit obligation, end of year....................................................... $

275,505

$

288,908

$

37,225

$

40,863

Change in plan assets:

Plan assets at fair value, beginning of year ................................................... $

224,553

$

213,282

$

2,115

$

2,535

Actual return on plan assets...........................................................................

61

Employer contributions .................................................................................

12,504

Foreign currency exchange rate changes.......................................................

(58)

Benefit payments ...........................................................................................

(19,201)

23,486

8,063

(5,354)

(14,924)

69

3,123

—

73

2,508

—

(3,742)

(3,001)

Plan assets at fair value, end of year.............................................................. $

217,859

$

224,553

$

1,565

$

2,115

Funded status:

Funded status of the plans, end of year ......................................................... $

(57,646)   $

(64,355)   $

(35,660) $

(38,748)

The curtailment for other postretirement benefits in fiscal year 2015 was attributable to the discontinuation of postretirement 
life insurance benefits for active U.S. employees.  The Company funds its non-regulated U.S. pension plan, one of its foreign pension 
plans, and its postretirement medical plans on a pay-as-you-go basis as the benefit payments are incurred.  Those plans account for 
approximately  58%  of  the  $57.6  million  unfunded  pension  obligation  and  approximately  83%  of  the  $35.7  million  unfunded 
postretirement benefit obligation shown on the funded status line in the above table at March 31, 2016.

63

  
UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The funded status of the Company’s plans at the end of fiscal years 2016 and 2015 was reported in the consolidated balance 

sheets as follows:

Pension 
Benefits

March 31,

Other Postretirement
Benefits

March 31,

2016

2015

2016

2015

Non-current asset (included in other noncurrent assets)................................... $

2,044

$

1,900

$

— $

—

Current liability (included in accounts payable and accrued expenses) ...........

(630)

Non-current liability (reported as pensions and other postretirement benefits)

(59,060)

(5,458)

(60,797)

(2,543)

(33,117)

(2,497)

(36,251)

Amounts recognized in the consolidated balance sheets .................................. $

(57,646) $

(64,355) $

(35,660) $

(38,748)

Additional information on the funded status of the Company’s plans as of the respective measurement dates for the fiscal 

years ended March 31, 2016 and 2015, is as follows:

Pension
 Benefits

March 31,

Other Postretirement
Benefits

March 31,

2016

2015

2016

2015

For plans with a projected benefit obligation in excess of plan assets:

Aggregate projected benefit obligation (PBO)............................................... $

270,058

$

283,070

$

37,225

$

40,863

Aggregate fair value of plan assets.................................................................

210,368

216,815

1,565

2,115

For plans with an accumulated benefit obligation in excess of plan
assets:

Aggregate accumulated benefit obligation (ABO).........................................

Aggregate fair value of plan assets.................................................................

268,087

210,368

281,354

216,815

N/A

N/A

N/A

N/A

Net Periodic Benefit Cost

The components of the Company’s net periodic benefit cost were as follows:

Pension Benefits

Other Postretirement Benefits

Fiscal Year Ended March 31,

Fiscal Year Ended March 31,

2016

2015

2014

2016

2015

2014

Components of net periodic benefit cost:

Service cost................................................ $

5,953

$

5,099

$

5,190

$

286

$

347

$

Interest cost................................................

10,037

11,215

12,223

1,539

Expected return on plan assets ..................

(15,110)

(15,493)

(14,218)

Curtailment gain ........................................

Settlement cost...........................................

—

—

—

—

Net amortization and deferral....................

4,394

6,169

—

1,094

6,779

(58)

—

—

(431)

1,699

(102)

(1,465)

—

(671)

527

2,106

(119)

—

—

(5)

Net periodic benefit cost............................ $

5,274

$

6,990

$

11,068

$

1,336

$

(192) $

2,509

A one-percentage-point increase in the assumed healthcare cost trend rate would increase the March 31, 2016 accumulated 
postretirement benefit obligation by approximately $1.0 million, while a one-percentage-point decrease would reduce the benefit 
obligation by approximately $900 thousand.  The aggregate service and interest cost components of the net periodic postretirement 
benefit expense for fiscal year 2017 would not change by a significant amount as a result of a one-percentage-point increase or 
decrease in the assumed healthcare cost trend rate.   

64

UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
Amounts Included in Accumulated Other Comprehensive Loss

Amounts included in accumulated other comprehensive loss at the beginning of the year are amortized as a component of 
net periodic benefit cost during the year.  The amounts recognized in other comprehensive income or loss for fiscal years 2016 and 
2015 and the amounts included in accumulated other comprehensive loss at the end of those fiscal years are shown below.  All 
amounts shown are before allocated income taxes.

Pension
 Benefits

March 31,

Other Postretirement
Benefits

March 31,

2016

2015

2016

2015

Change in net actuarial loss (gain):

Net actuarial loss (gain), beginning of year ................................................... $

81,544

$

70,488

$

(6,402) $

(9,952)

Losses (gains) arising during the year ...........................................................

Amortization included in net periodic benefit cost during the year...............

Net actuarial loss (gain), end of year .............................................................

4,787

(7,032)

79,299

23,353

(12,297)

81,544

Change in prior service cost (benefit):

Prior service cost (benefit), beginning of year...............................................

(17,630)

(22,998)

   Prior service cost (benefit) arising during the year........................................

Amortization included in net periodic benefit cost during the year...............

111

2,458

(675)

6,043

Prior service cost (benefit), end of year .........................................................

(15,061)

(17,630)

(1,263)

431

(7,234)

—

(108)

—

(108)

2,879

671

(6,402)

—

—

—

—

Total amounts in accumulated other comprehensive loss 

at end of year, before income taxes............................................................ $

64,238

$

63,914

$

(7,342) $

(6,402)

Amounts in the above table reflect the Company and its consolidated subsidiaries.  The accumulated other comprehensive 
loss  reported  in  the  consolidated  balance  sheets  also  includes  pension  and  other  postretirement  benefit  adjustments  related  to 
ownership interests in unconsolidated affiliates. 

The Company expects to recognize approximately $6.1 million of the March 31, 2016 net actuarial loss and $2.6 million

of the March 31, 2016 prior service benefit in net periodic benefit cost during fiscal year 2017.

Allocation of Pension Plan Assets

The Company has established, and periodically adjusts, target asset allocations for its investments in its U.S. ERISA-
regulated defined benefit pension plan, which represents 90% of consolidated plan assets and 81% of consolidated PBO at March 31, 
2016, to balance the needs of liquidity, total return, and risk control.  The assets are required to be diversified across asset classes 
and investment styles to achieve that balance.  During the year, the asset allocation is reviewed for adherence to the target policy 
and rebalanced to the targeted weights.  The Company reviews the expected long-term returns of the asset allocation each year to 
help determine whether changes are needed.  The return is evaluated on a weighted-average basis in relation to inflation.  As noted 
above and reflected in the table below, the Company has changed some of the underlying assets in the plan over the past two fiscal 
years to move toward a liability-driven investment strategy, resulting in a reduction of the expected long-term return on assets.  The 
assumed long-term rate of return used to calculate annual benefit expense is based on the asset allocation and expected market 
returns for the respective asset classes.

65

 
UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The weighted–average target pension asset allocation and target ranges at the March 31, 2016 measurement date and the 

actual asset allocations at the March 31, 2016 and 2015 measurement dates by major asset category were as follows:

Major Asset Category

Target
Allocation

Actual Allocation

March 31,

Range

2016

2015

Fixed income securities 

Equity securities......................................................................................
(1) .....................................................................
Alternative investments ..........................................................................

26.0% 16% - 36%

69.0% 59% - 79%

5.0% 0% - 10%

22.4%

71.5%

6.1%

25.3%

69.1%

5.6%

Total...................................................................................................

100.0%

100.0%

100.0%

(1) 

Actual amounts include high yield securities and cash balances held for the payment of benefits. 

Universal makes regular contributions to its pension and other postretirement benefit plans.  As previously noted, for 
postretirement health benefits, contributions reflect funding of those benefits as they are incurred.  The Company expects to make 
contributions of approximately $7.3 million to its defined benefit pension plans in fiscal year 2017, including $5.4 million to its 
ERISA-regulated U.S. plan and $1.9 million to its non-ERISA regulated and other plans.

Estimated future benefit payments to be made from the Company’s plans are as follows:

Fiscal Year

Pension
Benefits

Other
Postretirement
Benefits

2017 .................................................................................................................................................................... $

14,305

$

2018 ....................................................................................................................................................................

2019 ....................................................................................................................................................................

2020 ....................................................................................................................................................................

2021 ....................................................................................................................................................................

2022 - 2026.........................................................................................................................................................

17,223

22,358

16,271

16,799

90,913

2,944

2,854

2,874

2,832

2,807

12,915

Fair Values of Pension Plan Assets

Assets held by the Company's defined benefit pension plans primarily consist of equity securities, fixed income securities, 
and alternative investments.  Equity securities are primarily invested in actively-traded mutual funds with underlying common stock 
investments in U.S. and foreign companies ranging in size from small to large corporations.  Fixed income securities are also held 
primarily  through  actively-traded  mutual  funds  with  the  underlying  investments  in  both  U.S.  and  foreign  securities.    The 
methodologies for determining the fair values of the plan assets are outlined below.  Where the values are based on quoted prices 
for the securities in an active market, they are classified as Level 1 of the fair value hierarchy.  Where secondary pricing sources 
are used, they are classified as Level 2 of the hierarchy.  Pricing models that use significant unobservable inputs are classified as 
Level 3.

•  Equity securities:  Investments in equity securities through actively-traded mutual funds are valued based on the net 
asset values of the units held in the respective funds, which are determined by obtaining quoted prices on nationally 
recognized securities exchanges.  These securities are classified as Level 1.

• 

Fixed income securities:  Fixed income investments that are held through mutual funds are valued based on the net 
asset values of the units held in the respective funds, which are determined by obtaining quoted prices on nationally 
recognized securities exchanges.  These securities are classified as Level 1.  Other fixed income investments are valued 
at an estimated price that a dealer would pay for a similar security on the valuation date using observable market inputs 
and are classified as Level 2.  These market inputs may include yield curves for similarly rated securities.  Small 
amounts of cash are held in common collective trusts.  Fixed income securities also include insurance assets, which 
are valued based on an actuarial calculation. Those securities are classified as Level 3.

66

UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

•  Alternative investments:  Real estate assets are valued using valuation models that incorporate income and market 
approaches, including external appraisals, to derive fair values.  The hedge fund allocation is a fund of hedge funds 
and is valued by the manager based on the net asset value of each fund.  These models use significant unobservable 
inputs and are classified as Level 3 within the fair value hierarchy.

Fair values of the assets of the Company’s pension plans as of March 31, 2016 and 2015, classified based on how their 

values were determined under the fair value hierarchy are as follows:

March 31, 2016

Level 1

Level 2

Level 3

Total

Equity securities ......................................................................................... $
Fixed income securities (1) .........................................................................
Alternative investments..............................................................................

43,807

$

— $

— $

43,807

141,218

—

7,491

—

13,382

11,961

162,091

11,961

Total investments .................................................................................. $

185,025

$

7,491

$

25,343

$

217,859

March 31, 2015

Level 1

Level 2

Level 3

Total

Equity securities.......................................................................................... $
Fixed income securities (1) ..........................................................................
Alternative investments ..............................................................................

51,300

$

— $

— $

51,300

141,655

—

7,738

—

12,424

11,436

161,817

11,436

Total investments................................................................................... $

192,955

$

7,738

$

23,860

$

224,553

(1) 

Includes high yield securities and cash and cash equivalent balances.

Other Benefit Plans

Universal and several subsidiaries offer employer defined contribution savings plans.  Amounts charged to expense for 
these plans were approximately $1.8 million for fiscal year 2016, $1.8 million for fiscal year 2015, and $1.6 million for fiscal year 
2014.

NOTE 11.   COMMON AND PREFERRED STOCK 

Common Stock

At March 31, 2016, the Company’s shareholders had authorized 100,000,000 shares of its common stock, and 22,717,735
shares were issued and outstanding.  Holders of the common stock are entitled to one vote for each share held on all matters requiring 
a vote.  Holders of the common stock are also entitled to receive dividends when, as, and if declared by the Company’s Board of 
Directors.  The Board of Directors customarily declares and pays regular quarterly dividends on the outstanding common shares; 
however, such dividends are at the Board’s full discretion, and there is no obligation to continue them.  If dividends on the Company’s 
Series B 6.75% Convertible Perpetual Preferred Stock (the “Preferred Stock” or “Preferred Shares”) are not declared and paid for 
any dividend period, then the Company may not pay dividends on the common stock or repurchase common shares until the dividends 
on the Preferred Stock have been paid for a period of four consecutive quarters.

Preferred Stock

The Company is also authorized to issue up to 5,000,000 shares of preferred stock, 500,000 shares of which have been 
reserved for Series A Junior Participating Preferred Stock and 220,000 shares of which have been reserved for Series B 6.75% 
Convertible Perpetual Preferred Stock.  No Series A Junior Participating Preferred Stock has been issued.  In 2006, 220,000 shares 
of  Series  B  6.75%  Convertible  Perpetual  Preferred  Stock  (the  “Preferred  Stock”  or  “Preferred  Shares”)  were  issued  under  this 
authorization.  At March 31, 2016, 218,490 shares were issued and outstanding.  The Preferred Stock has a liquidation preference 
of $1,000 per share.  Holders of the Preferred Shares are entitled to receive quarterly dividends at the rate of 6.75% per annum on 
the liquidation preference when, as, and if declared by the Company’s Board of Directors.  Dividends are not cumulative in the event 
the Board of Directors does not declare a dividend for one or more quarterly periods.  Under the terms of the Preferred Stock, the 
Board of Directors is prohibited from declaring regular dividends on the Preferred Shares in any period in which the Company fails 
to meet specified levels of shareholders’ equity and net income; however, in that situation, the Board of Directors may instead declare 
such dividends payable in shares of the Company’s common stock or from net proceeds of common stock issued during the ninety-
day period prior to the dividend declaration.  The Preferred Shares have no voting rights, except in the event the Company fails to 

67

UNIVERSAL CORPORATION 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
pay dividends for four consecutive or non-consecutive quarterly dividend periods or fails to pay the redemption price on any date 
that the Preferred Shares are called for redemption, in which case the holders of Preferred Shares will be entitled to elect two additional 
directors to the Company’s Board to serve until dividends on the Preferred Stock have been fully paid for four consecutive quarters.

The Preferred Shares are convertible at any time, at the option of the holder, into shares of the Company’s common stock 
at a conversion rate that is adjusted each time the Company pays a dividend on its common stock that exceeds $0.43 per share.  The 
conversion rate at March 31, 2016, was 22.2744 shares of common stock per preferred share, which represents a conversion price 
of approximately $44.89 per common share.  Upon conversion, the Company may, at its option, satisfy all or part of the conversion 
value in cash.  

Through March 15, 2018, the Company may, at its option, cause the Preferred Shares to be automatically converted into 
shares of common stock that are issuable at the prevailing conversion rate, only if the closing price of the common stock during a 
specified period exceeds 135% of the then prevailing conversion price.  With this conversion, the Company may, at its option, satisfy 
all or part of the conversion value in cash in lieu of delivering shares.  On or after March 15, 2018, the Company may, at its option, 
redeem all or part of the outstanding Preferred Shares for cash at the $1,000 per share liquidation preference.

Share Repurchase Programs

Universal’s Board of Directors has authorized programs to repurchase outstanding shares of the Company’s capital stock 
(common and preferred stock). Under these programs, the Company has made and may continue to make share repurchases from 
time to time in the open market or in privately negotiated transactions at prices not exceeding prevailing market rates.  Programs 
have been in place continuously throughout fiscal years 2014 through 2016.  The current program, which replaced an expiring 
program,  was  authorized  and  became  effective  on  November 5,  2015.    It  authorizes  the  purchase  of  up  to  $100  million  of  the 
Company's outstanding common and/or preferred stock and expires on the earlier of  November 15, 2017, or when the funds authorized 
for the program have been exhausted.  At March 31, 2016, the full $100 million authorization remained available for share repurchases 
under the current program.

Share repurchases under the programs for the fiscal years ended March 31, 2016, 2015, and 2014 were as follows:

Common Stock

Number of shares repurchased...............................................................................................

Cost of shares repurchased (in thousands of dollars)............................................................. $

Weighted-average cost per share............................................................................................ $

Series B 6.75% Convertible Perpetual Preferred Stock

Number of shares repurchased...............................................................................................

Cost of shares repurchased (in thousands of dollars)............................................................. $

Weighted-average cost per share............................................................................................ $

Fiscal Year Ended March 31,

2016

2015

2014

—

— $

— $

—

— $

— $

719,993

238,486

31,227

43.37

1,509

1,497

992.27

$

$

$

$

14,145

59.31

—

—

—

NOTE 12.   EXECUTIVE STOCK PLANS AND STOCK-BASED COMPENSATION 

Executive Stock Plans

The Company’s shareholders have approved executive stock plans under which officers, directors, and employees of the 
Company may receive grants and awards of common stock, restricted stock, restricted stock units  (“RSUs”), performance share 
awards (“PSAs”), stock appreciation rights (“SARs”), incentive stock options, and non-qualified stock options.  Currently, grants 
are outstanding under the 1997 Executive Stock Plan, the 2002 Executive Stock Plan, and the 2007 Stock Incentive Plan.  Together, 
these plans are referred to in this disclosure as the “Plans.”  Up to 2 million shares of the Company’s common stock may be issued 
under each of the Plans; however, direct awards of common stock, restricted stock, or RSUs are limited to 500,000 shares under the 
2002 Executive Stock Plan and 1,350,000 shares under the 2007 Stock Incentive Plan. 

The Company’s practice is to award grants of stock-based compensation to officers at the first regularly-scheduled meeting 
of the Executive Compensation, Nominating, and Corporate Governance Committee of the Board of Directors (the “Compensation 
Committee”) in the fiscal year following the public release of the Company’s financial results for the prior year.  Since fiscal year 
2006, grants have been limited to restricted stock, RSUs, PSAs, and stock-settled SARs.  In fiscal years 2014 through 2016, the 
Compensation Committee has awarded only grants of RSUs and PSAs.  Outside directors automatically receive restricted stock units 
following each annual meeting of shareholders.

68

UNIVERSAL CORPORATION 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Non-qualified stock options and SARs granted under the Plans have an exercise price equal to the market price of a share 
of common stock on the date of grant.  No stock options are currently outstanding under the Plans.  SARs granted under the Plans 
vest in equal one-third tranches one, two, and three years after the grant date and expire 10 years after the grant date, except that 
SARs granted after fiscal year 2007 expire on the earlier of 3 years after the grantee’s retirement date or 10 years after the grant date.  
RSUs awarded under the Plans vest 5 years from the grant date and are then paid out in shares of common stock.  Under the terms 
of the RSU awards, grantees receive dividend equivalents in the form of additional RSUs that vest and are paid out on the same date 
as the original RSU grant.  The PSAs vest 3 years from the grant date, are paid out in shares of common stock at the vesting date, 
and do not carry rights to dividends or dividend equivalents prior to vesting.  Shares ultimately paid out under PSA grants are 
dependent on the achievement of predetermined performance measures established by the Compensation Committee and can range 
from zero to 150% of the stated award.  RSUs awarded to outside directors vest 3 years after the grant date, and restricted stock vests 
upon the individual’s retirement from service as a director.

Stock Options and SARs

The following tables summarize the Company’s stock option and SAR activity and related information for fiscal years 2014 
through 2016:

Weighted-
Average
Exercise
Price

Weighted-
Average 
Contractual 
Term 
(in years)

Aggregate
Intrinsic
Value

Shares

Fiscal Year Ended March 31, 2014:

Outstanding at beginning of year...............................................................

418,477

$

Exercised....................................................................................................

(161,137)

Outstanding at end of year .........................................................................

257,340

Fiscal Year Ended March 31, 2015:

Exercised....................................................................................................

Cancelled/expired ......................................................................................

(63,539)

(24,200)

Outstanding at end of year .........................................................................

169,601

Fiscal Year Ended March 31, 2016:

Exercised....................................................................................................

Cancelled/expired ......................................................................................

(6,200)

(11,200)

Outstanding at end of year .........................................................................

152,201

$

50.07

42.48

54.83

38.50

62.66

59.82

51.32

62.66

59.96

1.14

$

302

Fiscal Year Ended March 31,

2016

2015

2014

Total intrinsic value of stock options and SARs exercised .................................................... $

Total fair value of SARs vested.............................................................................................. $

26

$

— $

1,091

375

$

$

2,816

769

All of the grants outstanding at the end of fiscal year 2016 in the above tables represent SARs, all of which were exercisable 
at the end of the year.  Intrinsic value and aggregate intrinsic value in the tables above are based on the difference between the market 
price of the underlying shares at the exercise date or balance sheet date, as applicable, and the exercise prices of the stock options 
and SARs.  The closing market prices used to determine the aggregate intrinsic value at the end of each fiscal year were as follows:  
$56.81 at March 31, 2016, $47.16 at March 31, 2015, and $55.89 at March 31, 2014.  

69

 
UNIVERSAL CORPORATION 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
RSUs, Restricted Stock, and PSAs

The following table summarizes the Company’s RSU, restricted stock, and PSA activity for fiscal years 2014 through 2016: 

RSUs

Restricted Stock

PSAs

Weighted-
Average
Grant Date
Fair Value

Weighted-
Average
Grant Date
Fair Value

Shares

Weighted-
Average
Grant Date
Fair Value

Shares

Shares

Fiscal Year Ended March 31, 2014:

Unvested at beginning of year ..................

292,134

$

Granted......................................................

Vested........................................................

Forfeited....................................................

70,092

(69,046)

—

Unvested at end of year.............................

293,180

Fiscal Year Ended March 31, 2015:

Granted......................................................

94,539

Vested........................................................

(123,322)

Forfeited....................................................

—

Unvested at end of year.............................

264,397

Fiscal Year Ended March 31, 2016:

Granted......................................................

Vested........................................................

80,932

(42,384)

Unvested at end of year.............................

302,945

$

41.23

57.79

44.89

—

44.33

51.86

42.02

—

48.10

51.62

41.64

49.95

59,850

$

—

(11,750)

—

48,100

—

—

—

41.68

—

39.02

—

42.33

—

—

—

48,100

42.33

135,017

$

52,400

(32,464)

(5,566)

149,387

57,580

(50,092)

(3,400)

153,475

—

—

—

—

86,212

(85,387)

48,100

$

42.33

154,300

$

35.12

53.56

33.95

37.45

41.76

46.41

31.95

53.56

45.58

45.06

38.14

48.13

Shares granted and vested in the above table include dividend equivalents on RSUs and any shares awarded above the base 
grant under the performance provisions of PSAs.  Shares forfeited or canceled include any reductions from the base PSA grant under 
those same performance provisions.  The fair values of RSUs, restricted stock, and PSAs are based on the market price of the common 
stock on the grant date.

Stock-Based Compensation Expense

Fair value expense for stock-based compensation is recognized ratably over the period from grant date to the earlier of (1) 
the vesting date of the award, or (2) the date the grantee is eligible to retire without forfeiting the award.  For employees who are 
already eligible to retire at the date an award is granted, the total fair value of the award is recognized as expense at the date of grant.  
For the fiscal years ended March 31, 2016, 2015, and 2014, total stock-based compensation expense and the related income tax 
benefit recognized were as follows:

Fiscal Year Ended March 31,

2016

2015

2014

Total stock-based compensation expense ............................................................................... $

Income tax benefit recorded on stock-based compensation expense ..................................... $

5,206

1,822

$

$

6,230

2,181

$

$

6,278

2,197

At March 31, 2016, the Company had $5.1 million of unrecognized compensation expense related to stock-based awards, 
which will be recognized over a weighted-average period of approximately 1.2 years.  All stock options were exercised, cancelled, 
or expired before fiscal year 2016.  Cash proceeds from the exercise of stock options were not material for the fiscal years ended 
March 31, 2015 and 2014.

70

UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
NOTE 13.   COMMITMENTS, CONTINGENCIES, AND OTHER MATTERS 

Commitments

The Company enters into contracts to purchase tobacco from farmers in a number of the countries in which it operates.  
Contracts in most countries cover one annual growing season.  Primarily with the farmer contracts in Brazil, Malawi, Mozambique, 
the Philippines, Guatemala, and Mexico, the Company provides seasonal financing to support the farmers’ production of their crops 
or guarantees their financing from third-party banks.  At March 31, 2016, the Company had contracts to purchase approximately 
$566 million of tobacco to be delivered during the coming fiscal year and $110 million of tobacco to be delivered in subsequent 
years.  These amounts are estimates since actual quantities purchased will depend on crop yields, and prices will depend on the 
quality of the tobacco delivered and other market factors.  Tobacco purchase obligations have been partially funded by advances to 
farmers and other suppliers, which totaled approximately $102 million, net of allowances, at March 31, 2016.  The Company withholds 
payments due to farmers on delivery of the tobacco to satisfy repayment of the financing it provided to the farmers.  As noted above 
and discussed in more detail below, the Company also has arrangements to guarantee bank loans to farmers in Brazil, and payments 
are also withheld on delivery of tobacco to satisfy repayment of those loans.  In addition to its contractual obligations to purchase 
tobacco,  the  Company  had  commitments  related  to  agricultural  materials,  approved  capital  expenditures,  and  various  other 
requirements that approximated $53 million at March 31, 2016.

Guarantees and Other Contingent Liabilities

Guarantees of Bank Loans and Other Contingent Liabilities

Guarantees of bank loans to growers for crop financing and construction of curing barns or other tobacco producing assets 
have long been industry practice in Brazil and support the farmers’ production of tobacco there.  At March 31, 2016, the Company’s 
total exposure under guarantees issued by its operating subsidiary for banking facilities of farmers in Brazil was approximately $11 
million ($13 million face amount including unpaid accrued interest, less $2 million recorded for the fair value of the guarantees).  
All of these guarantees expire within one year.  As noted above, the subsidiary withholds payments due to the farmers on delivery 
of tobacco and forwards those payments to the third-party banks.  Failure of farmers to deliver sufficient quantities of tobacco to the 
subsidiary to cover their obligations to the third-party banks could result in a liability for the subsidiary under the related guarantees; 
however, in that case, the subsidiary would have recourse against the farmers.  The maximum potential amount of future payments 
that the Company’s subsidiary could be required to make at March 31, 2016, was the face amount, $13 million including unpaid 
accrued interest ($17 million as of March 31, 2015).  The fair value of the guarantees was a liability of approximately $2 million at 
March 31, 2016 ($2 million at March 31, 2015).  In addition to these guarantees, the Company has other contingent liabilities totaling 
approximately $2 million at March 31, 2016, primarily under outstanding letters of credit. 

Value-Added Tax Assessments in Brazil

As discussed in Note 1, the Company's local operating subsidiaries pay significant amounts of value-added tax ("VAT") in 
connection with their normal operations.  In Brazil, VAT is assessed at the state level when green tobacco is transferred between 
states.  The Company's operating subsidiary there pays VAT when tobaccos grown in the states of Santa Catarina and Parana are 
transferred to its factory in the state of Rio Grande do Sul for processing.  The subsidiary has received assessments for additional 
VAT plus interest and penalties from the tax authorities for the states of Santa Catarina and Parana based on audits of the subsidiary's 
VAT filings for specified periods.  In June 2011, tax authorities for the state of Santa Catarina issued assessments for tax, interest, 
and penalties for periods from 2006 through 2009 totaling approximately $14 million.  In September 2014, tax authorities for the 
state of Parana issued an assessment for tax, interest, and penalties for periods from 2009 through 2014 totaling approximately $15 
million.  These amounts are based on the exchange rate for the Brazilian currency at March 31, 2016.  Management of the operating 
subsidiary and outside counsel believe that errors were made by the tax authorities for both states in determining all or significant 
portions of these assessments and that various defenses support the subsidiary's positions.

With respect to the Santa Catarina assessments, the subsidiary took appropriate steps to contest the full amount of the claims.  
As of March 31, 2016, a portion of the subsidiary's arguments had been accepted, and the outstanding assessments had been reduced.  
The reduced assessment, together with the related accumulated interest through the end of the current reporting period, totaled 
approximately $12 million at the March 31, 2016 exchange rate.  The subsidiary is continuing to contest the full remaining amount 
of the assessment.  While the range of reasonably possible loss is zero up to the full $12 million remaining assessment, based on the 
strength of the subsidiary's defenses, no loss within that range is considered probable at this time and no liability has been recorded 
at March 31, 2016.

With respect to the Parana assessment, management of the subsidiary and outside counsel have undertaken the steps required 
to contest the full amount of the claim.  A significant portion of the Parana assessment is based on positions taken by the tax authorities 
that management and outside counsel believe deviate significantly from the underlying statutes and relevant case law.  In addition, 
under the law, the subsidiary's tax filings for certain periods covered in the assessment were no longer open to any challenge by the 
tax authorities.    In December 2015, the Parana tax authorities withdrew the initial claim and subsequently issued a new assessment 

71

UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
covering the same tax periods.  The new assessment totaled approximately $5 million at the March 31, 2016 exchange rate, reflecting 
a substantial reduction from the original $15 million assessment. Notwithstanding the reduction, management and outside counsel 
continue to believe that the new assessment is not supported by the underlying statutes and relevant case law and have taken the 
necessary steps to challenge the full amount of the claim.  The range of reasonably possible loss is considered to be zero up to the 
full $5 million assessment.  However, based on the strength of the subsidiary's defenses, no loss within that range is considered 
probable at this time and no liability has been recorded at March 31, 2016.

In both states, the process for reaching a final resolution to the assessments is expected to be lengthy, and management is 
not currently able to predict when either case will be concluded.  Should the subsidiary ultimately be required to pay any tax, interest, 
or penalties in either case, the portion paid for tax would generate value-added tax credits that the subsidiary may be able to recover.

Other Contingent Liabilities

Various  subsidiaries  of  the  Company  are  involved  in  other  litigation  and  tax  examinations  incidental  to  their  business 
activities.  While the outcome of these matters cannot be predicted with certainty, management is vigorously defending the matters 
and does not currently expect that any of them will have a material adverse effect on the Company’s business or financial position.  
However, should one or more of these matters be resolved in a manner adverse to management’s current expectation, the effect on 
the Company’s results of operations for a particular fiscal reporting period could be material.

Major Customers

A material part of the Company’s business is dependent upon a few customers.  The Company's five largest customers are 
Philip  Morris  International,  Inc.,  British American Tobacco  plc,  Imperial  Brands  plc,  Japan Tobacco,  Inc.,  and  China Tobacco 
International, Inc.  In the aggregate, these customers have accounted for more than 60% of consolidated revenue for each of the past 
three fiscal years.  For the fiscal years ended March 31, 2016, 2015, and 2014, revenue from Philip Morris International, Inc. was 
approximately $640 million, $580 million, and $590 million, respectively.  For the same periods, British American Tobacco plc 
accounted for revenue of approximately $230 million, $220 million, and $240 million, respectively, and Imperial Brands plc accounted 
for revenue of approximately $210 million, $280 million, and $340 million, respectively.  These customers primarily do business 
with various affiliates in the Company’s flue-cured and burley leaf tobacco operations.  The loss of, or substantial reduction in 
business from, any of these customers could have a material adverse effect on the Company.  

Accounts Receivable

The Company’s operating subsidiaries perform credit evaluations of customers’ financial condition prior to the extension 
of credit.  Generally, accounts receivable are unsecured and are due within 30 days.  When collection terms are extended for longer 
periods, interest and carrying costs are usually recovered. Credit losses are provided for in the financial statements, and historically 
such amounts have not been material.  The allowance for doubtful accounts was approximately $9 million and $5 million at March 31, 
2016 and 2015, respectively.  At March 31, 2016 and 2015, net accounts receivable by reportable operating segment were as follows:

March 31,

2016

2015

Flue-Cured and Burley Leaf Tobacco Operations:

North America................................................................................................................................................. $

85,985

$

38,046

Other Regions .................................................................................................................................................

Subtotal .......................................................................................................................................................

Other Tobacco Operations ..................................................................................................................................

303,932

389,917

38,742

350,122

388,168

46,194

Consolidated accounts receivable, net ................................................................................................................ $

428,659

$

434,362

Favorable Outcome of IPI Tax Credit Case in Brazil 

During the first quarter of fiscal year 2014, a longstanding lawsuit related to IPI tax credits filed by the Company's operating 
subsidiary in Brazil was concluded in the subsidiary's favor with a decision by the Brazilian Superior Court of Justice on the final 
appeal filed by the Brazilian federal government.  Although additional appeals by the government were expected in the case, the 
time period to file those appeals expired and the decision and overall outcome of the case were confirmed. 

IPI  tax  credits  were  established  under  Brazilian  tax  laws  to  allow  recovery  of  a  portion  of  the  excise  taxes  paid  on 
manufactured products when those products are sold in export markets.  In prior years, the subsidiary paid excise taxes on the 
component cost of unprocessed tobacco purchased from growers, as well as the cost of electricity, packing materials, and other inputs 
used in its manufacturing process.  Under the law, the subsidiary believed it was entitled to use IPI tax credits to recover excise taxes 
on the processed tobacco it exported.  However, specific regulations issued by the Brazilian tax authorities did not permit the subsidiary 
to claim those credits.  The suit filed by the subsidiary challenged the denial of the tax credits based on the law.  Several decisions 
72

 
 
 
UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
in lower courts were decided in the subsidiary's favor for a portion of the tax credits claimed in the suit, but those decisions were 
appealed on various grounds by both the government and the subsidiary.  The expiration of the appeal period ended the matter in the 
courts. 

The final court decision entitled the subsidiary to approximately $104 million of IPI tax credits (based on the exchange rate 
at the date of the decision), which are being used to offset payments of other Brazilian federal taxes.  That amount includes the tax 
credits generated over the period granted by the courts, as well as interest calculated from the date those credits should have been 
available to the subsidiary.  The ability to use the tax credits to offset other Brazilian federal tax payments expires five years after 
the subsidiary's right to claim the credits was confirmed.  Utilization of the credits is also subject to audit by the tax authorities.  
Based on estimates of the tax credits that were probable of being realized at the time the case was decided, the subsidiary recorded 
an allowance, reducing the net book value of the credits to approximately $90 million.  After deducting related legal fees and Brazilian 
social contribution taxes assessed on the interest portion of the total IPI tax credits received, the subsidiary recorded a net gain of 
$81.6 million ($53.1 million after tax, or $1.87 per diluted share) during the first quarter of fiscal year 2014, as a result of the favorable 
outcome of the case.  In the fourth quarter of fiscal year 2015, based on actual realization of the tax credits to date, as well as updated 
tax payment projections for future periods, revised estimates indicated that all remaining IPI tax credits would be fully utilized prior 
to expiration.  On that basis, the subsidiary reversed the full remaining valuation allowance on the credits of $12.7 million (based 
on the then current exchange rate) during the quarter.  The original gain in fiscal year 2014 and the reversal of the valuation allowance 
in fiscal year 2015 are reported in Other Income in the consolidated statements of income.

Acquisition of Partner's Interest in Tobacco Processing Joint Venture

For a number of years, the Company held a 50% joint venture ownership interest in Procesadora Unitab, S.A., a tobacco 
processing entity in Guatemala.  In December 2015, the Company acquired the 50% interest held by its joint venture partner for $6.0 
million in cash.  In accordance with Accounting Standards Codification Topic 805, "Business Combinations" (“ASC 805”), the 
transaction was accounted for using the acquisition method of accounting, which required the Company to record all underlying 
assets and liabilities of the entity at their fair values as of the transaction date and to consolidate the financial statements of the entity.  
Based on those fair values, the Company recorded a pretax gain of $3.4 million on the transaction during the third quarter of fiscal 
year 2016.  The gain is reported in Other Income in the consolidated statements of income.  The purchase price of the newly-acquired 
50% interest approximated fair value, and the gain resulted from remeasuring the Company’s original 50% ownership interest in the 
entity to fair value.  No goodwill or identifiable intangible assets were recorded as part of the transaction, and acquisition-related 
costs were not significant.

The pro forma result of operations of the combined companies would not be materially different from the Company’s 
historical results, and the revenues and earnings of the acquired entity since the date of acquisition are not material.  The allocation 
of the fair values to the net assets acquired was complete at the time the transaction was recorded.  Based on the nature of its operations, 
the net assets of the acquired entity are comprised primarily of property, plant, and equipment, and the fair values recorded for those 
assets totaled approximately $12.0 million based primarily on a third-party appraisal. The acquired entity is included in the Company’s 
North America operating segment.

NOTE 14.   OPERATING SEGMENTS

Universal’s operations involve selecting, procuring, processing, packing, storing, shipping, and financing leaf tobacco for 
sale  to,  or  for  the  account  of,  manufacturers  of  consumer  tobacco  products  throughout  the  world.    Through  various  operating 
subsidiaries located in tobacco-growing countries around the world and significant ownership interests in unconsolidated affiliates, 
the Company processes and/or sells flue-cured and burley tobaccos, dark air-cured tobaccos, and oriental tobaccos.  Flue-cured, 
burley, and oriental tobaccos are used principally in the manufacture of cigarettes, and dark air-cured tobaccos are used mainly in 
the manufacture of cigars, pipe tobacco, and smokeless tobacco products.  A substantial portion of the Company’s revenues are 
derived from sales to a limited number of large, multinational cigarette manufacturers.

The principal approach used by management to evaluate the Company’s performance is by geographic region, although the 
dark air-cured and oriental tobacco businesses are each evaluated on the basis of their worldwide operations.  Oriental tobacco 
operations consist principally of a 49% interest in an affiliate, and the performance of those operations is evaluated based on the 
Company’s equity in the pretax earnings of that affiliate.  Under this structure, the Company has the following primary operating 
segments:  North America, South America, Africa, Europe, Asia, Dark Air-Cured, Oriental, and Special Services.  North America, 
South America, Africa, Europe, and Asia are primarily involved in flue-cured and/or burley leaf tobacco operations for supply to 
cigarette manufacturers.  The Dark Air-Cured group supplies dark air-cured tobacco principally to manufacturers of cigars, pipe 
tobacco, and smokeless tobacco products, and the Oriental business supplies oriental tobacco to cigarette manufacturers.  From time 
to time, the segments may trade in tobaccos that differ from their main varieties, but those activities are not significant to their overall 
results.  Special Services includes the Company's  laboratory services business, which provides physical and chemical product testing 
and smoke testing for customers, as well as its liquid nicotine joint venture and its food ingredients business.

73

 
 
UNIVERSAL CORPORATION 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The  five  regional  operating  segments  serving  the  Company’s  cigarette  manufacturer  customer  base  share  similar 
characteristics in the nature of their products and services, production processes, class of customer, product distribution methods, 
and regulatory environment.  Based on the applicable accounting guidance, four of the regions – South America, Africa, Europe, 
and Asia – are aggregated into a single reporting segment, “Other Regions”, because they also have similar economic characteristics.  
North America is reported as an individual operating segment because its economic characteristics differ from the other regions, 
generally because its operations require lower working capital investments for crop financing and inventory.  The Dark Air-Cured, 
Oriental and Special Services segments, which have dissimilar characteristics in some of the categories mentioned above, are reported 
together as “Other Tobacco Operations” because each is below the measurement threshold for separate reporting.

Universal incurs overhead expenses related to senior management, finance, legal, and other functions that are centralized 
at its corporate headquarters, as well as functions performed at several sales and administrative offices around the world.  These 
overhead expenses are allocated to the various operating segments, generally on the basis of tobacco volumes planned to be purchased 
and/or processed.  Management believes this method of allocation is representative of the value of the related services provided to 
the operating segments.  The Company evaluates the performance of its segments based on operating income after allocated overhead 
expenses, plus equity in the pretax earnings of unconsolidated affiliates.

74

UNIVERSAL CORPORATION 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Reportable segment data as of, or for, the fiscal years ended March 31, 2016, 2015, and 2014, is as follows:

Flue-Cured and Burley Leaf Tobacco Operations:

North America......................................................... $
Other Regions (1) .....................................................

Subtotal ...............................................................
Other Tobacco Operations (2) ......................................
Segment total ...............................................................

affiliates 

Deduct: Equity in pretax earnings of unconsolidated 
(3) ................................................
Restructuring and impairment costs (4)  ..........
Add:     Other income (5) .............................................

Sales and Other Operating Revenues

Operating Income

Fiscal Year Ended March 31,

Fiscal Year Ended March 31,

2016

2015

2014

2016

2015

2014

361,827

$

305,028

$

348,627

$

31,147

$

31,060

$

23,217

1,538,971

1,739,781

1,932,228

1,900,798

2,044,809

2,280,855

219,575

2,120,373

226,992

2,271,801

261,260

2,542,115

143,596

174,743

11,325

186,068

(5,422)

(2,389)

3,390

125,839

156,899

10,326

167,225

(7,137)

(4,890)

12,676

133,447

156,664

18,511

175,175

(3,897)

(6,746)

81,619

Consolidated total ........................................................ $

2,120,373

$

2,271,801

$

2,542,115

$

181,647

$

167,874

$

246,151

Segment Assets

March 31,

Goodwill

March 31,

2016

2015

2014

2016

2015

2014

Flue-Cured and Burley Leaf Tobacco Operations:

North America......................................................... $
Other Regions (1) .....................................................

Subtotal ...............................................................
Other Tobacco Operations (2) ......................................

364,271

$

281,757

$

272,161

$

— $

— $

1,549,758

1,609,393

1,676,507

1,914,029

1,891,150

1,948,668

318,768

297,299

316,225

97,318

97,318

1,713

97,372

97,372

1,713

—

97,367

97,367

1,713

Segment and consolidated totals.................................. $

2,232,797

$

2,188,449

$

2,264,893

$

99,031

$

99,085

$

99,080

Depreciation and Amortization

Capital Expenditures

Fiscal Year Ended March 31,

Fiscal Year Ended March 31,

2016

2015

2014

2016

2015

2014

Flue-Cured and Burley Leaf Tobacco Operations:

North America......................................................... $
Other Regions (1) .....................................................

Subtotal ...............................................................
 (2) ......................................

Other Tobacco Operations

4,314

$

4,284

$

6,018

$

2,282

$

5,814

$

29,187

33,501

4,143

28,827

33,111

4,213

29,044

35,062

3,837

25,122

27,404

19,749

39,303

45,117

13,268

2,676

37,584

40,260

5,589

Segment and consolidated totals.................................. $

37,644

$

37,324

$

38,899

$

47,153

$

58,385

$

45,849

(1) 

(2) 

(3) 

(4) 

(5) 

Includes South America, Africa, Europe, and Asia regions, as well as inter-region eliminations.

Includes Dark Air-Cured, Oriental, and Special Services, as well as inter-company eliminations.  Sales and other operating revenues, goodwill, depreciation 
and amortization, and capital expenditures include limited amounts or no amounts for Oriental because the business is accounted for on the equity method and 
its financial results consist principally of equity in the pretax earnings of the unconsolidated affiliate.  The investment in the unconsolidated affiliate is included 
in segment assets and was approximately $81.8 million, $74.9 million, and $93.3 million, at March 31, 2016, 2015, and 2014, respectively.

Equity in pretax earnings of unconsolidated affiliates is included in segment operating income (Other Tobacco Operations segment), but is reported below 
consolidated operating income and excluded from that total in the consolidated statements of income.

Restructuring  and  impairment  costs  are  excluded  from  segment  operating  income,  but  are  included  in  consolidated  operating  income  in  the  consolidated 
statements of income (see Note 2).

Other income in fiscal year 2016 represents a gain from remeasuring to fair value the Company's original 50% ownership in Procesadora Unitab, S.A., a tobacco 
processing joint venture in Guatemala, upon acquiring the 50% interest held by the Company's joint venture partner (See Note 13). Other income represents  
the reversal of a valuation allowance on IPI excise tax credits in Brazil in fiscal year 2015 and the gain on the favorable outcome of the IPI tax credit case in 
fiscal year 2014 (see Note 13).  

75

UNIVERSAL CORPORATION 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Geographic data as of, or for, the fiscal years ended March 31, 2016, 2015, and 2014, is presented below. Sales and other 
operating revenues are attributed to individual countries based on the final destination of the shipment.  Long-lived assets generally 
consist of net property, plant, and equipment, goodwill, and other intangibles.

Geographic Data

Sales and Other Operating Revenues

Fiscal Year Ended March 31,

2016

2015

2014

Belgium .................................................................................................................................................... $

371,580

$

336,396

$

289,206

United States.............................................................................................................................................

Germany ...................................................................................................................................................

China ........................................................................................................................................................

Netherlands...............................................................................................................................................

Russia .......................................................................................................................................................

All other countries ....................................................................................................................................

275,147

155,180

135,032

121,767

109,559

952,108

290,950

170,338

174,872

113,297

126,652

304,527

173,872

210,956

208,031

123,114

1,059,296

1,232,409

Consolidated total..................................................................................................................................... $

2,120,373

$

2,271,801

$

2,542,115

Long-Lived Assets

March 31,

2016

2015

2014

United States............................................................................................................................................. $

84,072

$

70,929

$

61,347

Brazil ........................................................................................................................................................

Mozambique.............................................................................................................................................

All other countries ....................................................................................................................................

133,727

53,069

154,090

135,980

55,733

141,893

135,359

49,543

149,750

Consolidated total..................................................................................................................................... $

424,958

$

404,535

$

395,999

76

UNIVERSAL CORPORATION 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
 NOTE 15. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

The following table summarizes the changes in the balances for each component of accumulated other comprehensive 

income (loss) attributable to the Company for the fiscal years ended March 31, 2016, 2015, and 2014:

(in thousands of dollars)

Foreign currency translation:

Fiscal Year Ended March 31,

2016

2015

2014

Balance at beginning of year ..........................................................................................................

$ (31,138) $

(8,476) $

(15,555)

Other comprehensive income (loss) attributable to Universal Corporation:

Net gain (loss) on foreign currency translation (net of tax (expense) benefit of $(2,119),

$12,181, and $(3,489)) .............................................................................................................

Less: Net loss (gain) on foreign currency translation attributable to noncontrolling interests ....

Other comprehensive income (loss) attributable to Universal Corporation, net of income

taxes..........................................................................................................................................

3,934

212

(22,625)

(37)

6,480

599

4,146

(22,662)

7,079

Balance at end of year.....................................................................................................................

$ (26,992) $ (31,138) $

(8,476)

Foreign currency hedge:

Balance at beginning of year ..........................................................................................................

$

(1,834) $

769

$

(855)

Other comprehensive income (loss) attributable to Universal Corporation:

Net gain (loss) on derivative instruments (net of tax (expense) benefit of $(1,060), $2,304,

and $(312)) ...............................................................................................................................
Reclassification of net loss to earnings (net of tax benefit of $(291), $(903), and $(563)) (1) .....
Other comprehensive income (loss) attributable to Universal Corporation, net of income

taxes..........................................................................................................................................

1,969

540

(4,280)

1,677

2,509

(2,603)

Balance at end of year.....................................................................................................................

$

675

$

(1,834) $

580

1,044

1,624

769

Interest rate hedge:

Balance at beginning of year ..........................................................................................................

$

(1,982) $

(608) $

(1,091)

Other comprehensive income (loss) attributable to Universal Corporation:

Net loss on derivative instruments (net of tax benefit of $4,489, $1,416, and $49) ....................
Reclassification of net loss to earnings (net of tax benefit of $(1,788), $(675), and $(310)) (2) ..
Other comprehensive income (loss) attributable to Universal Corporation, net of income

taxes..........................................................................................................................................

(8,335)

3,320

(2,628)

1,254

(5,015)

(1,374)

Balance at end of year.....................................................................................................................

$

(6,997) $

(1,982) $

(93)

576

483

(608)

Pension and other postretirement benefit plans:

Balance at beginning of year ..........................................................................................................

$ (40,040) $ (26,017) $

(58,039)

Other comprehensive income (loss) attributable to Universal Corporation:

Gains (losses) arising during the year (net of tax (expense) benefit of $1,035, $9,719, and 

$(6,449))

(3) ...............................................................................................................................................
(3) ................................
(4) ..

Amortization included in earnings (net of tax benefit of $(1,576), $(2,163), and $(3,042)) 

Prior service credit arising during the year (net of tax expense of $7,751) 

(1,921)

(18,049)

—

2,925

—

4,026

11,977

14,394

5,651

Other comprehensive income (loss) attributable to Universal Corporation, net of income

taxes..........................................................................................................................................

1,004

(14,023)

32,022

Balance at end of year.....................................................................................................................

$ (39,036) $ (40,040) $

(26,017)

Total accumulated other comprehensive income (loss) at end of year..............................................

$ (72,350) $ (74,994) $

(34,332)

77

 
UNIVERSAL CORPORATION 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(1) Gain  (loss)  on  foreign  currency  cash  flow  hedges  related  to  forecast  purchases  of  tobacco  is  reclassified  from  accumulated  other 

comprehensive income (loss) to cost of goods sold when the tobacco is sold to customers. See Note 8 for additional information.

(2) Gain (loss) on interest rate cash flow hedges is reclassified from accumulated other comprehensive income (loss) to interest expense when 
the related interest payments are made on the debt or upon termination of the interest rate swap agreements prior to their scheduled maturity 
dates. See Note 8 for additional information.

(3) These items arise from the remeasurement of the assets and liabilities of the Company's defined benefit pension plans.  Those remeasurements 
are made on an annual basis at the end of the fiscal year.  In addition, the assets and liabilities of the Company's U.S.-based pension plans 
were also remeasured on an interim basis during the second quarter of fiscal year 2014 to reflect the effect of plan amendments adopted 
during the period.  See Note 10 for additional information.

(4) This accumulated other comprehensive income (loss) component is included in the computation of net periodic benefit cost. See Note 10 

for additional information.

78

UNIVERSAL CORPORATION 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
NOTE 16.   UNAUDITED QUARTERLY FINANCIAL DATA 

Unaudited quarterly financial data for the fiscal years ended March 31, 2016 and 2015 is provided in the table below.  Due 
to the seasonal nature of the Company's business, management believes it is generally more meaningful to focus on cumulative rather 
than quarterly results.

First 
Quarter

Second 
Quarter

Third 
Quarter

Fourth 
Quarter

Fiscal Year Ended March 31, 2016

Operating Results:

Sales and other operating revenues ...................................................................... $

275,419

$

456,382

$

584,592

$

803,980

Gross profit...........................................................................................................

Net income (loss)..................................................................................................

Net income (loss) attributable to Universal Corporation .....................................

Earnings (loss) available to Universal Corporation common shareholders after
dividends on convertible perpetual preferred stock .........................................

Earnings (loss) per share attributable to Universal Corporation common

shareholders:

Basic.................................................................................................................

Diluted..............................................................................................................

Cash Dividends Declared:

Per share of convertible perpetual preferred stock ...............................................

Per share of common stock ..................................................................................

Market Price Range of Common Stock:

High ......................................................................................................................

Low.......................................................................................................................

48,389

(6,125)

(5,947)

98,094

25,064

22,465

119,906

46,615

44,534

140,942

52,594

47,964

(9,634)

18,778

40,847

44,277

(0.43)

(0.43)

16.88

0.52

57.76

46.80

0.83

0.81

16.87

0.52

58.41

46.98

1.80

1.60

16.88

0.53

57.72

49.70

1.95

1.72

16.87

0.53

57.27

51.49

Fiscal Year Ended March 31, 2015

Operating Results:

Sales and other operating revenues ...................................................................... $

271,472

$

464,116

$

758,054

$

778,159

Gross profit...........................................................................................................

55,540

Net income ...........................................................................................................

Net income attributable to Universal Corporation ...............................................

Earnings (loss) available to Universal Corporation common shareholders after
dividends on convertible perpetual preferred stock .........................................

Earnings (loss) per share attributable to Universal Corporation common

shareholders:

Basic.................................................................................................................

Diluted..............................................................................................................

Cash Dividends Declared:

Per share of convertible perpetual preferred stock ...............................................

Per share of common stock ..................................................................................

Market Price Range of Common Stock:

High ......................................................................................................................

Low.......................................................................................................................

79

525

717

85,071

15,484

15,025

147,572

58,077

53,039

122,091

46,375

45,827

(2,995)

11,312

49,309

42,122

(0.13)

(0.13)

16.88

0.51

56.82

52.16

0.49

0.48

16.87

0.51

56.35

44.39

2.13

1.87

16.88

0.52

45.63

38.53

1.86

1.64

16.87

0.52

48.10

39.27

UNIVERSAL CORPORATION 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
Note:  Earnings per share amounts for each fiscal year may not equal the total of the four quarterly amounts due to differences in 
weighted-average outstanding shares for the respective periods and to the fact that the Company’s convertible perpetual 
preferred stock may be antidilutive for some periods.

Significant items included in the quarterly results were as follows:

Fiscal Year Ended March 31, 2016 

• 

First Quarter – restructuring and impairment costs totaling $2.4 million related to a decision to significantly scale back the 
Company's operations in Zambia. The costs included statutory employee termination benefits, impairment charges related to 
outstanding balances on loans to farmers whose contracts were terminated as a result of the decision, and impairment charges 
on  certain  property  and  equipment.    The  restructuring  and  impairment  costs  reduced  net  income  attributable  to  Universal 
Corporation by $1.6 million and diluted earnings per share by $0.06.

•  Third Quarter – a $3.4 million pretax gain arising from the acquisition of a joint venture partner's 50% ownership interest in a 
tobacco processing entity in Guatemala.  The transaction increased the Company's ownership interest in the entity to 100%, 
requiring consolidation of the financial statements of the entity and remeasurement of the Company's original 50% ownership 
interest to fair value, resulting in the gain. The gain increased net income attributable to Universal Corporation by $2.2 million
and diluted earnings per share by $0.08.

Fiscal Year Ended March 31, 2015 

• 

• 

First Quarter – an income tax benefit of $8.0 million resulting from the ability of the Company's subsidiary, Deltafina S.p.A, to 
pay a significant portion of a fine and related interest charges settled during the quarter following the unsuccessful appeal of a 
case brought by the European Commission related to tobacco buying practices in Italy.  The tax benefit reduced the diluted loss 
per share after dividends on the Company's convertible perpetual preferred stock by $0.34.

Second Quarter – restructuring costs of approximately $3.4 million, primarily related to workforce reductions in the Company's 
operations in Brazil, as well as the suspension of operations in Argentina.  The restructuring costs reduced net income attributable 
to Universal Corporation by $2.2 million and diluted earnings per share by $0.09.

•  Third Quarter – additional restructuring costs of approximately $1.1 million, primarily related to additional workforce reductions 
in Brazil, as well the suspension of operations in Argentina.  The restructuring costs reduced net income attributable to Universal 
Corporation by $0.7 million and diluted earnings per share by $0.03.

• 

Fourth Quarter – a gain of $12.7 million from the reversal of a valuation allowance on the remaining unused balance of IPI 
excise tax credits in Brazil. The gain increased net income attributable to Universal Corporation by $8.2 million and diluted 
earnings per share by $0.30.  The Company also recorded additional restructuring costs of approximately $0.4 million, which 
reduced net income attributable to Universal Corporation by approximately $0.3 million and diluted earnings per share by $0.01. 

80

Report of Ernst & Young LLP, Independent Registered Public Accounting Firm

The Board of Directors and Shareholders of 
Universal Corporation

We have audited the accompanying consolidated balance sheets of Universal Corporation as of March 31, 2016 and 2015, and the 
related consolidated statements of income, comprehensive income, changes in shareholders’ equity, and cash flows for each of the 
three years in the period ended March 31, 2016. Our audits also included the financial statement schedule listed in the Index at Item 
15(a).  These financial statements and schedule are the responsibility of the Company’s management. Our responsibility is to express 
an opinion on these financial statements and schedule based on our audits. 

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). 
Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements 
are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in 
the  financial  statements.  An  audit  also  includes  assessing  the  accounting  principles  used  and  significant  estimates  made  by 
management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis 
for our opinion. 

In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position 
of Universal Corporation at March 31, 2016 and 2015, and the consolidated results of its operations and its cash flows for each of 
the three years in the period ended March 31, 2016, in conformity with U.S. generally accepted accounting principles.  Also, in our 
opinion, the related financial statement schedule, when considered in relation to the basic financial statements taken as a whole, 
presents fairly in all material respects the information set forth therein.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), Universal 
Corporation’s internal control over financial reporting as of March 31, 2016, based on criteria established in Internal Control—
Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and 
our report dated May 27, 2016 expressed an unqualified opinion thereon. 

/s/ Ernst & Young LLP 

Richmond, Virginia 
May 27, 2016

81

 
 Report of Ernst & Young LLP, Independent Registered Public Accounting Firm, 
on Internal Control Over Financial Reporting

The Board of Directors and Shareholders of
Universal Corporation 

We have audited Universal Corporation’s internal control over financial reporting as of March 31, 2016, based on criteria established 
in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission 
(2013 framework) (the COSO criteria).  Universal Corporation’s management is responsible for maintaining effective internal control 
over  financial  reporting,  and  for  its  assessment  of  the  effectiveness  of  internal  control  over  financial  reporting  included  in  the 
accompanying Management’s Report on Internal Control over Financial Reporting in Item 9A.  Our responsibility is to express an 
opinion on the company’s internal control over financial reporting based on our audit. 

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States).  Those 
standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over 
financial reporting was maintained in all material respects.  Our audit included obtaining an understanding of internal control over 
financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness 
of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. 
We believe that our audit provides a reasonable basis for our opinion. 

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability 
of  financial  reporting  and  the  preparation  of  financial  statements  for  external  purposes  in  accordance  with  generally  accepted 
accounting principles.  A company’s internal control over financial reporting includes those policies and procedures that (1) pertain 
to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets 
of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial 
statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being 
made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance 
regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a 
material effect on the financial statements. 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements.  Also, projections 
of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes 
in conditions, or that the degree of compliance with the policies or procedures may deteriorate. 

In our opinion, Universal Corporation maintained, in all material respects, effective internal control over financial reporting as of 
March 31, 2016, based on the COSO criteria. 

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the 
consolidated balance sheets of Universal Corporation as of March 31, 2016 and 2015, and the related consolidated statements of 
income, comprehensive income, changes in shareholders’ equity, and cash flows for each of the three years in the period ended 
March 31, 2016 and our report dated May 27, 2016 expressed an unqualified opinion thereon. 

/s/ Ernst & Young LLP 

Richmond, Virginia 
May 27, 2016 

82

 
Item 9.   Changes in and Disagreements With Accountants on Accounting and Financial Disclosure 

For the three years ended March 31, 2016, there were no changes in independent auditors, nor were there any disagreements 

between the Company and its independent auditors on any matter of accounting principles, practices, or financial disclosures. 

Item 9A.  Controls and Procedures

Disclosure Controls and Procedures

The Company maintains disclosure controls and procedures that are designed to ensure that information required to be 
disclosed in reports filed by the Company under the Exchange Act is recorded, processed, summarized and reported within the time 
periods  specified  in  the  SEC  rules  and  forms  and  that  such  information  is  accumulated  and  communicated  to  the  Company’s 
management, including its Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for timely decisions regarding 
required disclosure.  The Company’s Chief Executive Officer and Chief Financial Officer evaluated, with the participation of the 
Company’s management, the effectiveness of the Company’s disclosure controls and procedures (as defined in Exchange Act Rule 
13a-15(e)), as of the end of the period covered by this Annual Report. Based on this evaluation, the Company’s management, including 
its Chief Executive Officer and Chief Financial Officer, concluded that the Company’s disclosure controls and procedures were 
effective.  

Management’s Report on Internal Control Over Financial Reporting

The  Company’s  management  is  responsible  for  establishing  and  maintaining  effective  internal  control  over  financial 
reporting as defined in Rule 13a-15(f) under the Exchange Act.  The Company’s internal control over financial reporting is designed 
to provide reasonable assurance to management and the Board of Directors regarding the preparation and fair presentation of the 
consolidated financial statements.  Due to inherent limitations, internal control over financial reporting may not prevent or detect all 
errors or misstatements in the financial statements, and even control procedures that are determined to be effective can provide only 
reasonable  assurance  with  respect  to  financial  statement  preparation  and  presentation.   Also,  projections  of  any  evaluation  of 
effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions.

As required by Exchange Act Rule 13a-15(c), the Company’s Chief Executive Officer and Chief Financial Officer, with 
the participation of other members of management, assessed  the effectiveness of the Company’s internal control over financial 
reporting as of March 31, 2016.  The evaluation was based on the criteria set forth in “Internal Control – Integrated Framework” 
issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (“the COSO criteria”).  Based 
on this assessment, the Company’s management concluded that the Company’s internal control over financial reporting was effective 
as of March 31, 2016.

The Company’s independent registered public accounting firm, Ernst & Young LLP, has audited the Company’s internal 

control over financial reporting as of March 31, 2016.  Their report on this audit appears on page 82 of this Annual Report.

Changes in Internal Control Over Financial Reporting

There were no changes in the Company’s internal control over financial reporting that occurred during the Company’s last 
fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial 
reporting.

Item 9B.   Other Information

None.

83

Item 10.   Directors, Executive Officers, and Corporate Governance 

PART III

Except as to the matters set forth below, information required by this Item is incorporated herein by reference to the Company’s 

2016 Proxy Statement.     

The following are executive officers of the Company as of May 27, 2016:

Name and Age
G. C. Freeman, III (52) Chairman, President, and

Position

Chief Executive Officer

A. L. Hentschke (46)

Senior Vice President and
Chief Operating Officer

D. C. Moore (60)

  Senior Vice President and
Chief Financial Officer

T. G. Broome (62)

Executive Vice President and
Sales Director, Universal
Leaf Tobacco Company, Inc.

P. D. Wigner (47)

Vice President, General
Counsel and Secretary

J. A. Huffman (54)

Senior Vice President,
Information and Planning,
Universal Leaf Tobacco
Company, Inc.

Business Experience During Past Five Years
Mr. Freeman was elected Chairman of the Board in August 2008, Chief 
Executive Officer effective April 2008, President in December 2006, 
and Vice President in November 2005. Mr. Freeman served as General 
Counsel and Secretary from February 2001 until November 2005 and 
has been employed with the Company since 1997.

Mr. Hentschke was elected Senior Vice President and Chief Operating 
Officer in April 2015.  From January 2013 to April 2015, he served as 
Executive  Vice  President  of  Universal  Leaf.  Tobacco  Company, 
Incorporated  ("Universal  Leaf").    From  November  2009  to  January 
2013, Mr. Hentschke served as President and Chief Executive Officer 
of  Universal  Leaf  Tabacos,  Limitada,  the  Company's  operating 
subsidiary in Brazil.  He has been employed with the Company and its 
affiliates since 1991.

Mr.  Moore  was  elected  Senior  Vice  President  and  Chief  Financial 
Officer effective September 2008.  Mr. Moore served as Vice President 
and  Chief  Administrative  Officer  from  April  2006  until  September 
2008, as Senior Vice President of Universal Leaf from September 2005 
until  April  2006,  and  as  Managing  Director  of  Universal  Leaf 
International SA from April 2002 until September 2005.  He has been 
employed with the Company since 1978.

Mr. Broome was elected Executive Vice President and Sales Director, 
Universal Leaf, in October 2012.  From April 2011 through October 
2012, Mr. Broome served as Executive Vice President. From September 
1998 through March 2011, Mr. Broome served as Senior Vice President-
Sales.  He has been employed with the Company since 1994.

Mr. Wigner was elected Vice President in August 2007, and General 
Counsel  and  Secretary  in  November  2005  and  also  served  as  Chief 
Compliance Officer from November 2007 until September 2012. Mr. 
Wigner served as Senior Counsel of Universal Leaf from November 
2004 until November 2005.  He has been employed with the Company 
since 2003.
Mr.  Huffman  was  elected  Senior  Vice  President,  Information  and 
Planning, Universal Leaf, in August 2007.  From September 2003 to 
August  2007,  Mr.  Huffman  served  as  Senior  Vice  President.    From 
September  2002  to  September  2003,  Mr.  Huffman  served  as  Vice 
President and Controller.  He has been employed with the Company 
since 1996.

C. C. Formacek (56)

R. M. Peebles (58)

Vice President and Treasurer Ms. Formacek was elected Vice President and Treasurer effective April 
2012.  Ms. Formacek served as Treasurer of Universal Leaf from April 
2011 through March 2012.  She joined the Company in September 2009 
and  served  as Assistant  Treasurer  of  Universal  Leaf  from  that  time 
through March 2011. 

  Vice President and Controller Mr. Peebles was elected Vice President and Controller in April 2011. 
Mr.  Peebles  joined  the  Company  in  September  2003  and  served  as 
Controller from that time through March 2011.

There are no family relationships between any of the above officers. 

84

The Company has a Code of Conduct that includes the NYSE requirements for a “Code of Business Conduct and Ethics” 
and the SEC requirements for a “Code of Ethics for Senior Financial Officers.”  The Code of Conduct is applicable to all officers, 
employees, and outside directors of the Company, including the principal executive officer, principal financial officer, and principal 
accounting  officer.   A  copy  of  the  Code  of  Conduct  is  available  through  the  “Corporate  Governance-Overview”  section  of  the 
Company’s website at www.universalcorp.com.  If the Company amends a provision of the Code of Conduct, or grants a waiver 
from any such provision to a director or executive officer, the Company will disclose such amendments and the details of such 
waivers on the Company’s website www.universalcorp.com to the extent required by the SEC or the NYSE. 

The information required by Items 407(c)(3), (d)(4) and (d)(5) of Regulation S-K is contained under the captions “Corporate 
Governance and Committees—Committees of the Board—Compensation Committee,” “Corporate Governance and Committees—
Committees of the Board—Audit Committee” of the Company’s 2016 Proxy Statement and such information is incorporated by 
reference herein.

Item 11.   Executive Compensation 

Refer to the captions “Executive Compensation” and “Directors’ Compensation” in the Company’s 2016 Proxy Statement, 

which information is incorporated herein by reference. 

Item 12.   Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 

Refer to the caption “Stock Ownership” in the Company’s 2016 Proxy Statement, which information is incorporated herein 

by reference. 

Item 13.   Certain Relationships and Related Transactions, and Director Independence    

Refer to the caption “Certain Transactions” in the Company’s 2016 Proxy Statement, which information is incorporated 
herein by reference. The information required by Item 407(a) of Regulation S-K is contained under the caption “Corporate Governance 
and Committees—Director Independence” of the Company’s 2016 Proxy Statement and such information is incorporated by reference 
herein.

Item 14.   Principal Accounting Fees and Services 

Refer to the captions “Audit Information – Fees of Independent Auditors” and “Audit Information – Pre-Approval Policies 

and Procedures” in the Company’s 2016 Proxy Statement, which information is incorporated herein by reference.

85

 Item 15.   Exhibits, Financial Statement Schedules 

(a) 

The following are filed as part of this Annual Report:

1.  Financial Statements. 

PART IV 

Consolidated Statements of Income for the Fiscal Years Ended March 31, 2016, 2015, and 2014 
Consolidated Statements of Comprehensive Income for the Fiscal Years Ended March 31, 2016, 2015, and 2014 
Consolidated Balance Sheets at March 31, 2016 and 2015 
Consolidated Statements of Cash Flows for the Fiscal Years Ended March 31, 2016, 2015, and 2014 
Consolidated Statements of Changes in Shareholders’ Equity for the Fiscal Years Ended March 31, 2016, 2015, 
and 2014 
Notes to Consolidated Financial Statements for the Fiscal Years Ended March 31, 2016, 2015, and 2014 
Report of Ernst & Young LLP, Independent Registered Public Accounting Firm
Report of Ernst & Young LLP, Independent Registered Public Accounting Firm, on Internal Control Over Financial     
Reporting

2.  Financial Statement Schedules. 

Schedule II – Valuation and Qualifying Accounts

3.  Exhibits.  The exhibits are listed in the Exhibit Index immediately following the signature pages to this Annual Report.

(b) 

Exhibits

The response to this portion of Item 15 is submitted as a separate section to this Annual Report.

(c) 

Financial Statement Schedules

Schedule II – Valuation and Qualifying Accounts appears on the following page of this Annual Report.  All other 
schedules are not required under the related instructions or are not applicable and therefore have been omitted. 

86

Schedule II - Valuation and Qualifying Accounts
Universal Corporation
Fiscal Years Ended March 31, 2016, 2015, and 2014 

Description

(in thousands of dollars)

Fiscal Year Ended March 31, 2014:

Allowance for doubtful accounts (deducted from accounts
receivable) ..........................................................................

$

Balance at
Beginning
of Year

Net
Additions
(Reversals) 
Charged
to Expense

Additions
Charged
to Other
Accounts

Deductions (1)

Balance
at End
of Year

7,968

$

419

$

— $

(1,851) $

6,536

Allowance for supplier accounts (deducted from advances
to suppliers and other noncurrent assets) ...........................

54,393

5,461

Allowance for recoverable taxes (deducted from other

current assets and other noncurrent assets) ........................

26,044

5,607

—

—

(13,776)

46,078

(2,147)

29,504

Fiscal Year Ended March 31, 2015:

Allowance for doubtful accounts (deducted from accounts
receivable) ..........................................................................

$

6,536

$

1,341

$

— $

(2,395) $

5,482

Allowance for supplier accounts (deducted from advances
to suppliers and other noncurrent assets) ...........................

46,078

3,734

Allowance for recoverable taxes (deducted from other

current assets and other noncurrent assets) ........................

29,504

1,855

—

—

(15,139)

34,673

(8,141)

23,218

Fiscal Year Ended March 31, 2016:

Allowance for doubtful accounts (deducted from accounts
receivable) ..........................................................................

$

5,482

$

6,970

$

— $

(3,353) $

9,099

Allowance for supplier accounts (deducted from advances
to suppliers and other noncurrent assets) ...........................

34,673

815

Allowance for recoverable taxes (deducted from other

current assets and other noncurrent assets) ........................

23,218

1,755

—

—

(6,623)

28,865

(6,221)

18,752

(1)

  Includes direct write-offs of assets and currency remeasurement.

87

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has 

duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. 

SIGNATURES 

May 27, 2016

UNIVERSAL CORPORATION

By:

/s/  GEORGE C. FREEMAN, III
George C. Freeman, III
Chairman, President, and Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the 

following persons on behalf of the Registrant and in the capacities and on the dates indicated. 

Signature
/s/  GEORGE C. FREEMAN, III
George C. Freeman, III

Title

  Chairman, President, Chief Executive Officer, and Director
(Principal Executive Officer)

/s/  DAVID C. MOORE
David C. Moore

  Senior Vice President and Chief Financial Officer
(Principal Financial Officer)

/s/  ROBERT M. PEEBLES
Robert M. Peebles

  Vice President and Controller
(Principal Accounting Officer)

/s/  JOHN B. ADAMS, JR.
John B. Adams, Jr.

/s/  DIANA F. CANTOR
Diana F. Cantor

/s/  CHESTER A. CROCKER
Chester A. Crocker

/s/  CHARLES H. FOSTER, JR.
Charles H. Foster, Jr.

/s/  LENNART R. FREEMAN
Lennart R. Freeman

/s/  THOMAS H. JOHNSON
Thomas H. Johnson

/s/  EDDIE N. MOORE, JR.
Eddie N. Moore, Jr.

/s/  ROBERT C. SLEDD
Robert C. Sledd

  Director

  Director

  Director

  Director

  Director

Director

  Director

Director

88

Date
May 27, 2016

May 27, 2016

May 27, 2016

May 27, 2016

May 27, 2016

May 27, 2016

May 27, 2016

May 27, 2016

May 27, 2016

May 27, 2016

May 27, 2016

  
EXHIBIT INDEX

3.1 Amended and Restated Articles of Incorporation, effective August 9, 2011 (incorporated herein by reference to the 

Registrant’s Current Report on Form 8-K Registration Statement filed August 9, 2011, File No. 001-00652).

3.2 Amended and Restated Bylaws (as of August 3, 2010) (incorporated herein by reference to the Registrant’s Current 

Report on Form 8-K dated August 3, 2010, File No. 001-00652).

4.1

Indenture between the Registrant and Chemical Bank, as trustee (incorporated herein by reference to the Registrant’s 
Current Report on Form 8-K dated February 25, 1991, File No. 001-00652).

4.2 Specimen  Common  Stock  Certificate  (incorporated  herein  by  reference  to  the  Registrant’s Amendment  No.  1  to 

Registrant’s Form 8-A Registration Statement, dated May 7, 1999, File No. 001-00652).

10.1 Form of Universal Leaf Tobacco Company, Incorporated Executive Life Insurance Agreement (incorporated herein by 
reference to the Registrant’s Annual Report on Form 10-K for the fiscal year ended June 30, 1994, File No. 001-00652).

10.2 Universal  Leaf  Tobacco  Company,  Incorporated  Deferred  Income  Plan  (incorporated  herein  by  reference  to  the 

Registrant’s Report on Form 8-K, dated February 8, 1991, File No. 001-00652).

10.3 Universal Leaf Tobacco Company, Incorporated Benefit Replacement Plan (incorporated herein by reference to the 

Registrant’s Report on Form 8-K, dated February 8, 1991, File No. 001-00652).

10.4 Universal Leaf Tobacco Company, Incorporated 1994 Benefit Replacement Plan (incorporated herein by reference to 

the Registrant’s Annual Report on Form 10-K for the fiscal year ended June 30, 1994, File No. 001-00652).

10.5 Universal Leaf Tobacco Company, Incorporated 1996 Benefit Restoration Plan (incorporated herein by reference to 

the Registrant’s Annual Report on Form 10-K for the fiscal year ended June 30, 1996, File No. 001-00652).

10.6 Universal Leaf Tobacco Company, Incorporated 1994 Deferred Income Plan, amended and restated as of July 1, 1998 
(incorporated herein by reference to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 
30, 1998, File No. 001-00652).

10.7 Universal Corporation Outside Directors’ Deferred Income Plan, restated as of October 1, 1998 (incorporated herein 
by reference to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 1998, File No. 
001-00652).

10.8 Revised Form of Universal Corporation Non-Employee Director Restricted Stock Agreement (incorporated herein by 

reference to the Registrant’s Current Report on Form 8-K dated June 9, 2010, File No. 001-00652).

10.9 Form Change of Control Agreement (incorporated herein by reference to the Registrant’s Current Report on Form 8-

K filed November 10, 2008, File No. 001-00652).

10.10 Universal  Corporation  Director’s Charitable Award Program  (incorporated  herein  by  reference  to  the  Registrant’s 

Annual Report on Form 10-K for the fiscal year ended June 30, 1998, File No. 001-00652).

10.11 Universal Corporation 1997 Executive Stock Plan, as amended on August 7, 2003 (incorporated herein by reference 
to the Registrant’s Annual Report on Form 10-K for the fiscal year ended June 30, 2003, File No. 001-00652).

10.12 Universal Corporation 2002 Executive Stock Plan, as amended on August 7, 2003 (incorporated herein by reference 
to the Registrant’s Annual Report on Form 10-K for the fiscal year ended June 30, 2003, File No. 001-00652).

10.13 Form of Restricted Stock Units Award Agreement (incorporated herein by reference to the Registrant’s Current Report 

on Form 8-K filed November 10, 2008, File No. 001-00652).

10.14 Form of Stock Appreciation Rights Agreement (incorporated herein by reference to the Registrant’s Current Report on 

Form 8-K filed June 1, 2006, File No. 001-00652).

89

10.15 Form Stock Appreciation Rights Agreement (incorporated herein by reference to the Registrant’s Current Report on 

Form 8-K filed June 3, 2008, File No. 001-00652).

10.16 Universal Corporation 2007 Amended and Restated Stock Incentive Plan effective August 7, 2012 (incorporated herein 

by reference to Exhibit A to the Registrant’s definitive proxy statement filed June 28, 2012, File No. 001-00652).

10.17 Universal Corporation Executive Officer Annual Incentive Plan, as amended (incorporated herein by reference to the 

Registrant's definitive proxy statement filed June 25, 2014, File No. 001-00652).

10.18 Form of Universal Corporation 2010 Restricted Stock Units Agreement with Schedule of Awards to named executive 
officers (incorporated herein by reference to the Registrant’s Annual Report on Form 10-K for the fiscal year ended 
March 31, 2010, File No. 001-00652).

10.19 Form of Universal Corporation Stock Appreciation Rights Agreement for executive officers (incorporated herein by 
reference to the Registrant's Annual Report on Form 10-K for the fiscal year ended March 31, 2010, File No. 001-00652).

10.20 Universal Leaf Tobacco Company, Incorporated Deferred Income Plan III, amended and restated as of December 31, 
2008 (incorporated herein by reference to the Registrant's Annual Report on Form 10-K for the fiscal year ended March 
31, 2010, File No. 001-00652).

10.21 Universal Corporation Outside Directors' Deferred Income Plan III, amended and restated as of December 31, 2008, 
and amended as of February 1, 2010 (incorporated herein by reference to the Registrant's Annual Report on Form 10-
K for the fiscal year ended March 31, 2010, File No. 001-00652).

10.22 Form  of  Universal  Corporation  2011  Restricted  Stock  Units Agreement  (incorporated  herein  by  reference  to  the 

Registrant's Annual Report on Form 10-K for the fiscal year ended March 31, 2011, File No. 001-00652).

10.23 Form of Universal Corporation Stock Appreciation Rights Agreement for executive officers (incorporated herein by 
reference to the Registrant's Annual Report on Form 10-K for the fiscal year ended March 31, 2011, File No. 001-00652).

10.24 Form  of  Universal  Corporation  Performance  Share  Award  Agreement  (incorporated  herein  by  reference  to  the 

Registrant's Annual Report on Form 10-K for the fiscal year ended March 31, 2011, File No. 001-00652).

10.25 Credit Agreement dated December 30, 2014 among the Company, JPMorgan Chase Bank, N.A., as Administrative 
Agent, SunTrust Bank and AgFirst Farm Credit Bank, as Co-Syndication Agents and Keybank National Association 
and  Capital  One,  National  Association,  as  Co-Documentation  Agents  (incorporated  herein  by  reference  to  the 
Registrant’s Current Report on Form 8-K dated December 30, 2014 (December 23, 2014), File No. 001-00652).

12 Ratio of Earnings to Fixed Charges and Ratio of Earnings to Combined Fixed Charges and Preference Dividends.*

21 Subsidiaries of the Registrant.*

23 Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm.*

31.1 Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*

31.2 Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*

32.1 Statement of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350.*

32.2 Statement of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350.*

101

Interactive Data File (Annual Report on Form 10-K for the fiscal year ended March 31, 2016, furnished in XBRL 
(eXtensible Business Reporting Language)).*

90

Attached as Exhibit 101 to this report are the following documents formatted in XBRL: (i) the Consolidated Statements 
of  Income  for  each  of  the  three years  ended March  31,  2016, 2015  and  2014,  (ii) the  Consolidated  Statements  of 
Comprehensive Income for each of the three years ended March 31, 2016, 2015 and 2014, (iii) the Consolidated Balance 
Sheets at March 31, 2016 and 2015, (iv) the Consolidated Statement of Cash Flows for each of the three years ended 
March 31, 2016, 2015 and 2014, (v) the Consolidated Statement of Shareholders’ Equity for each of the three years 
ended March 31, 2016, 2015 and 2014, (vi) the Notes to Consolidated Financial Statements, (vii) Schedule II - Valuation 
and Qualifying Accounts. 

_________

*  Filed herewith.

91

 
SHAREHOLDER INFORMATION

ANNUAL MEETING

STOCK LISTED

The Annual Meeting of Shareholders will be held at 

New York Stock Exchange

STOCK SYMBOL

UVV

DIVIDEND REINVESTMENT PLAN

The Company offers to its common shareholders an 

automatic dividend reinvestment and cash payment plan 

to purchase additional shares. The Company bears all 

brokerage and service fees. Booklets describing the plan 

in detail are available upon request.

TRANSFER AGENT AND REGISTRAR AND 
DIVIDEND REINVESTMENT PLAN AGENT

Wells Fargo Bank, N.A. 

Shareowner Services 

P.O. Box 64854 

St. Paul, Minnesota 55164-0854 

(800) 468-9716 

or 

Universal Corporation 

Shareholder Services 

(804) 359-9311

the offices of the Company, 9201 Forest Hill Avenue, 

Richmond, Virginia, on Thursday, August 4, 2016. A  

proxy statement and request for proxies are included  

in this mailing to shareholders.

INDEPENDENT AUDITORS

Ernst & Young LLP

The Edgeworth Building

Suite 201, 2100 East Cary Street

Richmond, Virginia 23223

INVESTOR RELATIONS

Contact: 

     Candace C. Formacek 

        Vice President and Treasurer

     Jennifer S. Rowe 

        Assistant Vice President, Capital Markets  

     (804) 359-9311 

Information Requests: 

     (804) 254-3789 or investor@universalleaf.com

DIVIDEND PAYMENTS

Dividend declarations are subject to approval by 

the Company’s Board of Directors. Dividends on the 

Company’s common stock have traditionally been paid 

quarterly in February, May, August, and November to 

shareholders of record on the second Monday of the 

previous month.

SEC FORM 10-K

Shareholders may obtain additional copies of the 

Company’s annual report to the Securities and Exchange 

Commission on its website or by writing to the Treasurer 

of the Company. 

P.O. Box 25099

Richmond, VA 23260

WWW.UNIVERSALCORP.COM